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Abstract 
  
Microwave mediated H/D exchanges have been studiedin this thesis. The purpose of these 
studies is to validate an efficient method for replacing hydrogen by deuterium in molecules 
with biological and pharmaceutical activity. As a result of this, such deuterated compounds 
would be helpful during the investigation of pharmacological and metabolic studies. 
At the beginning of this research, aniline derivatives weremainly employed as substrates. 
Their importance in drug synthesis makes the corresponding labelled compounds useful as 
building blocks. During these studies a Pt catalyst wasemployed. As a consequence of its 
strong efficiency, fully deuterated compounds were obtained in many cases.  
In the first part of this research, yields were based on ratios between non-deuterated and 
deuterated original compounds. However, due to solubility problems and metal-complex 
formation, this parameter was found to vary considerably. Therefore, an analytical method, 
involving introduction of a non-deuterated acetyl group to the labelled substratewas 
employed, so that the acetyl group could be regarded as an internal reference for 1HNMR 
integration, allowing quantification of deuterium incorporation at all positions in the 
molecular structure. Kinetic experiments have also enabled the best conditions to be defined 
for the exchange reactions. Lastly, as a consequence of a reductive process, Pt0 has been 
recognized as a serious problem for calculating final yield. An appropriate method for 
eliminating it from the solutions has therefore been applied.  
A valid Pt mediated H/D mechanism has been proposed, based on suggestions from the 
literature that Pt can move around both aromatic rings and alkyl side chains. To try to get 
evidence for such a mechanism, different alkylanilines have been used, giving useful 
information regarding metal activity, particularly with respect to steric aspects.  
In the last part of the work, as a consequence of its importance in pharmaceutical chemistry, 
heterocyclic derivatives have been investigated. Satisfactory results have permitted the 
method to be explioted for some relevant drugs. 
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CD3OD Methanol deuterated 
DCl Deuterium chloride 
DCM Dichloromethane 
dd. Doublet of doublets 
DMSO Dimethyl sulfoxide 
dt Doublet of triplets 
EI Electronic ionization 
eq. Equivalent 
Et Ethyl 
Et2O Diethylether 
EtOAc Ethyl acetate 
h Hour(s) 
HRMS High Resolution Mass Spectrometry 
Hz Hertz 
IR Infra Red 
J Coupling constant (in Hz) 
LRMS Low Resolution Mass Spectrometry 
m Multiplet 
Me Methyl 
MeOH Methanol 
min Minute(s) 
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mp Melting point 
Mr Molecular weight 
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1.1 History 
 
Isotopes are known as variants of chemical elements (e.g., carbon C or hydrogen H). They 
present the same atomic number(so they have same number of protons in their nuclei) buta 
different mass number(resulting from a different number of neutrons). So,eachisotope 
presents a particular molecular weight which, as we will see later, allow us to distinguish 
them. Radioactive species among them were also discoveredand characterized by a precise 
decay over time (known as half-life). Investigating such processes in 1912, Frederick Soddy1 
discoveredforty new species between uranium and lead, not yet found in the periodic table, 
and then described asradioelements (i.e. radioactive element). Furthermore, he stated that 
such specific decays(called alpha and betaaccording to the specific particles produced) 
createddifferent chemical elements2-3despite their different radioactive properties. As a 
consequence of this, he proposed that more than one of these species could occupy the same 
place on the periodic table. For this reason, he also proposed the term isotope, which arises 
from Greek meaning “at the same place”.4 
Isotopes not involved in any decay process were also discovered by Thomson in 1913. By 
investigating positive ions5-6,which were channelled streams of neon deflected by magnetic 
and electric fields, Thomson was able to show two different paths on a photographic plate. 
He proposed that some neon atoms could have a higher mass than all the others. Lastly, the 
different molecular isotopic weight was successfully determined by Aston while separating 
numerous isotopes using mass spectrometry.7 
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Nowadays, it is established that some isotopes, such as deuterium, have such a long decaying 
process (more than 250 million years) that they are described as stable. 
 
1.2 Deuterium  
 
Hydrogen (H) can exist in three different isotopic forms known as protium (1H), deuterium 
(2H/D) and tritium (3H/T). The superscript number indicates the sum of protons (1) and 
neutrons (0, 1, 2) in each nucleus. 
Deuterium, whose name arises from the Greek for “second”, was introduced in chemistry by 
the Nobel Prize winner Harold Urey in 1931. As a result of a slow distillation process from 
five litres of cryogenically liquid hydrogen,Urey was able to recover one millilitre of what 
wasthen, spectroscopically identified as pure deuterium.8-9 
 However, the significantimportance for the use of this isotope arose from the introduction of 
"heavy water"(deuterium oxide, D2O).Since it became a relevant component for nuclear 
programs, as theneutron moderator10(a means able to reduce the speed of neutrons and so to 
control any nuclear chain reaction), the interest surrounding its production increased. After 
itsisolation by Lewis via electrolysis11, many other procedures were developed, in particular, 
the Girdler sulfide process12 proved to be a relevant industrial system.13This process was 
mainly based on H/D exchange between hydrogen-deuterium sulfide (HDS) and an initial 
D2O at two different sets of temperature (usually at 30 °C and at 130 °C).A series of different 
exchanges allowed water to be progressively enriched with deuterium. The most relevant 
aspect is that such isotopes are not chemically identical.As a consequence of their different 
masses, deuterium and hydrogen show two different covalent bonds in energetic terms. 
Specific bonds, such as carbon-hydrogen (C-H), will appear less stable than carbon-
deuterium (C-D) and so will require less energy to be broken. In further support, the energy 
necessary to stretch and bend these two bonds is substantially different. In infrared 
spectroscopytechnique, the frequency at which C-D vibrates is lower thanC-H (2200 cm-1 
against 3000 cm-1). This aspect is also perfectly coherent with Hook’s law which claims a 
reduction of such vibration frequency with the increasing of atomic mass.14  The same model 
leads to the prediction of a lower zero-point energy for C–D than for C–H bonds; it is this 
which gives the former slightly greater strength. 
Lastly, the considerationsdiscussed previouslyhave seen a wide and relevant application in 
organic chemistry. In particular, deuterium played a considerable role in reaction mechanism 
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investigations. In general, any isotopic substitutions in an organic molecule couldsignificantly 
influencethe corresponding reaction rates. Due to the fact that deuterium hastwicethe mass of 
hydrogen, its consequenteffect should beparticularly pronounced. This is better described in 
organic chemistry by the relation shown below(Scheme 1.1), defined as kinetic isotope effect 
(KIE). So, deuterium introduced in replacement of hydrogen could considerably slow down 
manyspecific chemical reaction rates. This aspect is particularly relevantwhen substitution 
regardsthe breaking bond of a rate determining step. In such specific casesthe general kinetic 
isotope effect(KIE)is also called primary kinetic isotope effect(PKIE).  
 
 
 
Scheme 1.1.Kinetic isotope effectrelation. 
 
Thus, the relation described above allows rate changes to be quantified. Furthermore, when 
referring to PKIE, the value of this ratio issignificantly high. (Scheme 1.2). 
 
 
 
Scheme 1.2.Primary kinetic isotope effect example. 
 
As indicated in Scheme 1.2, KIE is around 7. Since an elimination reaction is above 
described, one of deuteriumsreplaced in methyl groups is eliminatedin forming an 
unsaturated bond. As above explained, the different reactivity here showsa subsequent 
change in reactionrate.As a result of this, the corresponding hydrogensand their bonds were 
recognized as key roles ofrate determining step.On the other hand,according to the specific 
reaction investigated, entirely different results could beobtained in KIE terms. When 
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deuterium is introduced in a position not involved in any eventual breaking bond, KIE is then 
defined as secondary kinetic isotope effect (SKIE) (Scheme 1.3). 
 
 
 
Scheme 1.3.Secondary kinetic isotope effectexample. 
 
As reported in the Scheme above, KIE is here considerably lower. As a natural 
conclusion,thereaction mechanism ofnucleophilic additionhere does not involve such 
substitutedhydrogensand its bond.  
In summary, a general description of deuterium and itsrelevant uses in organic chemistry 
have been provided. As previously mentioned, this isotope can have many different 
applications in various fields. However, it is fundamental for the aims of this project to focus 
the attention on the pharmacological context. For this reason, the next pages will offera short 
explanation of its use in this field. 
 
1.3 Drug metabolism 
 
In order to obtain the approval for every drug by the FDA (food and drug administration, for 
U.S trading) and EMEA (European medicines agency, in a European context), all 
pharmaceutical industries need to report a clear documentation of their metabolic pathways 
both in the human and animal body.15-16 
Metabolism plays a crucial role in drug discovery and development as a part of 
Pharmacokinetic (PK) studies. Defined as a discipline dedicated to optimizing the biological 
drug properties, PK attention is also focused on other pharmacological aspects such as 
absorption, distribution and excretion (in metabolism, these are recognized as ADME). All 
the parameters previously mentioned are fundamental for defining the intensity and time 
course of pharmacological (therapeutic and toxic) drug effect.17-18 
Additionally, metabolic studies should be able to state metabolite’s eventual biological 
activities. As recently reported in some papers 19-21, some metabolites often show toxic and 
carcinogenic effects which, obviously,is in contrast with various therapeutic applications. On 
the other hand, some of them have been recognized as provided pharmacologicalproperties 
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for other therapeutic fields.22-23Moreover, important interactions between drugs and 
endogenous molecules have been also revealed, in some cases avoiding serious health 
consequences.24 
The use of stable isotopes was considered really helpful for such studies. Although the 
introduction of isotope techniques in this field occurredas late as 1970s and 1980s, the 
implications of such labelled compound studies through mass spectrometry were already 
defined. In particular, following Aston’s experiment, seen previously, their application as 
metabolic tracersstrictly followed mass spectrometry’s evolution.25As will be shown in the 
next pages, the combination ofgas-chromatography with mass spectrometry (GC-MS) in a 
unique system gave a strong impulse to the development of stable isotopeapplications.The 
introduction of electrospray ionization inside themass spectrometrycontext also representeda 
great innovation, allowing most of the samples to be analyzed easily on mass analyzer.26-28 
Due to its non-radioactive property and low cost, deuterium was the first isotope to be used 
for this purpose. Moreover, the extreme sensitivity of mass spectroscopyequipment29allowed 
later other isotopic species (e.g.,15N ) to also beused and investigated in such metabolic 
studies.30 
 The first analysis of stable isotope applications reported by Baille at al.31 and Brown et al.32-
33
were crucial for defining their real efficiency. In addition, Pons34 and,later, Abramson35 
reported results of these techniques in particular contexts, such as paediatric and pregnancy 
cases. Due to their non-radioactivity, stable isotopes enable the applications in vivo without 
any significant consequences tohealth. Therefore, the use of isotopes in bio-analysis has 
always been seen as an interesting model to investigate, since its introduction in metabolic 
studies. 
 
1.4 Tracer studies 
 
As already stated, the first real isotope application in metabolic studies was only introduced 
in the 1970s.Knapp et al.36later introduced a technique known as twin-ion. In order to identify 
the metabolites of nortryptiline, a second-generation of tricicylic antidepressant, Knapp 
decided to administerthe same amounts of labelled and unlabelled drug to subjectsfor an in 
vivoassay. 
In Figure 1.1 a general example of this procedure has been reported. In order to simplify the 
main aspects, the theoretical administrated drug is represented by two parts; the unlabelled 
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species by two white keys (○-□), and the corresponding labelled species with a black key (●), 
which represents the deuterated moiety, and a white key (□). Lastly, a gas chromatography-
mass spectrometry analysis on different pools (liver, plasma, urine etc.) has been used for 
identifying the parent drug (the original drug, labelled or unlabelled, in Figure 1.1 
represented by ○-□ or ●-□) and its eventual metabolites. 
Twin-Ion Twin-ion1
2 3
 
 
Figure 1.1.Example of twin-ion technique for metabolite identification using labelled and non 
labelled drugs in a biological system.37 
 
As discussed, deuterium has been used as a labelling isotope. Although Brazier et al.38 
employed isotopes like 15N and 13Cin the same technique; deuterium was often seen as the 
favourite choice for labelling compounds. However, the synthesis of label drug is still 
nowadays technically complicated and, overall, costly.39As a consequence of this, at the 
beginning of this research, deuterium was only introduced in some target sites of molecular 
structure. The core of this technique was effectively to identify these labelled sites after 
metabolic process.Due to their different masses, labelled (●-□) and non-labelled (○-□) 
drugsgive the characteristic twin-ion mass spectrum (mass spectra 3 in Figure 1.1). Such 
particular ion clusters separated by a precise mass difference confirms undoubtedly the 
metabolic presence.However, this technique presents considerable limitation. As a 
consequence of metabolic process, the labelled site could be clipped, shearing the molecule in 
two labelled and unlabelled parts. So, two different results are likely to occur and they are 
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reported in mass spectra 1 and 2. In this last one the twin-ion is still present whilein mass 
spectra 1 only one peak can be spotted. Due to the lack of its labelled twin, this fractionhere 
cannot be definitely recognized as a metabolite.  
AlthoughWeidolf.40,Akwa41 and Morfin42, were able to define omeoprazole and steroid 
metabolites using this technique, due to the limitsdescribed above, no relevant developments 
were here introduced.Hence, the need to recover fully or almost fully labelledcompounds 
became fundamental. Due to their increasing mass, such new species could guarantee an 
efficient resolution from unlabelled parent drug on mass spectra.Subsequently to this, and in 
order to easily identify all metabolites involved, a high deuterium distribution on all 
molecular surfaces was seriously recommended. Furthermore, for the financial costs 
highlighted, it was equallyapparent that the scientific attention should focuson specific 
deuterium exchange. As it will be described in the next pages, thestudieson H/D exchange 
resulted in a development of a characteristic quantitative analytical technique based on 
internal standard use. 
 
1.5  Internal standard  
 
In order to improve the quantitative measurements of analytes in biological system, the 
concept of internal standard was considered extremely important. As principal definition, 
internal standard referred to a compound added in a constant amount for quantifying an 
otherwise unknown sample. For this aim, its initial role was on setting up an appropriate 
calibration curve. As will be explained later, a set of different mixture or "batches"composed 
by such constant amounts of internal standard and variable known amounts of analyte,were 
run in a liquid chromatograpy-mass spectrometry system (LC-MS). Thus, a series of plots 
taken from specific area ratios between the analyteandtheinternal standard signals on the 
chromatogram were recordedinforming the curve, in particular itwascrucial extrapolatinga 
linear relationship between them. Immediately after its extraction from a specific biological 
system, the analyte was injected again on LC-MS in addition to the usual amount of the 
internal standard. As will be demonstrated in the example, the just mentioned linear 
relationshipturns out to be very helpful in calculating the specific analyte’s concentration. 
In order to understand the role played by labelled compounds in such specific analysis, it is 
also necessaryto report somerelevant information. In 1940, Rittenberg et al.43produced a valid 
technique to quantify endogenous compounds, such as amino acids and fatty palmitic acid, 
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usingmainly15N and deuterated analogues. Introducing for the first time the concept of 
internal standard, Rittenberg alsoproposed to define stable isotopes as “ideal” internal 
standard. This was due principallyto their identical physical and chemical properties to the 
unlabelled analogues.So, the sameretention timeshown in LC-MS allows the area, belowto 
the chromatogram peak,to be easily calculated by an integration process.On the other hand, 
because of their different molecular weight, labelled and unlabelled 
speciescouldbesuccessfully differentiated by mass spectrometry. 
These last aspects also highlight another relevant advantage in using stable isotopes. Through 
the internal standard addition, the matrix effectis considerable reduced.44-46This term 
describes the general problems caused by unknown species co-eluted with the sample during 
the chromatography purification. Due to their difficulty to be recorded by mass, such species 
could disrupt the quantification analysis.Through this addition instead, the concentration of 
the sample is increased so that such effectis finally minimized. As a result of this, the result 
recorded with the internal standardappearsin general much more reliable than without 
it.Asevidence of the importance of such a technique in bioanalysis field, Grey et al.47 set up a 
method whichquantified paraquat and diquat, two dessicant and defoliant industrial products. 
Due to the aforementioned matrix effect, such compounds could not be properly measured in 
environmental water and vegetarian matrices. Since here 2H corresponding labelled 
compounds were used as internal standard inside a LC-IDMS procedure (see next 
paragraph),more accurate results have instead been obtained.  
 
1.6 Liquid chromatography-isotope-dilution tandem mass spectrometry 
(LC-IDMS) 
 
As previously discussed, liquid chromatography is currently the most favourable purification 
technique when an internal standard is used.The introduction of this process was fundamental 
for developing liquid chromatography-isotope dilution tandem mass spectrometry (LC-
IDMS). As indicated by this name, such technique is based on the principle of isotope 
dilution analysis, formulated by Rittenberg during his studies on the internal standards. 
Although considerable results were already obtained by the advent of gas chromatography-
mass spectrometry (GC-MS)48-49, this technique received the greatest expansionin its 
development from liquid chromatography introduction.39 Such system allowed some non-
polar andnon-thermal stable molecules to be purified and, as a result,analyzed. As already 
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mentioned at the beginning of this chapter,for similar reasons, electrospray ionization(ESI) 
was also essential for improving mass analysis.26As a consequence of such important 
changes, LC-IDMS gave the opportunity to investigate a wide range of drugs in biological 
system.47, 50-54 
 In order to offer an example of such technique application, an interesting bio-analytical 
studyhas been reported. Chau et al.55 described a quantitative analysis ofa potent narcotic 
analgesic known as fentanyl. The aim of this research was to measure theweekly variations of 
such drug concentrations in human plasma. As internal standard, a D5-analogue has been 
used. (Fig. 1.2).Asstated in the last paragraph, such labelled compound has been used mainly 
fordefining a calibration curve.  
 
 
 
Figure 1.2 Fentanyl and its D5-analogue used for LC-IDMS analysis. 
 
In particular, in such case, y=2.32x+0.00883has been found as the function act todescribethis 
curve. Specifically, yhere represents the peak area ratios between fentanyl and its deuterated 
analog (internal standard), while x is instead related to the concentrations offentanyl.  
After the drug administration, fentanyl has been regularly extracted from blood in a range of 
300 hours. The compound has been injected in LC-MS system with the additional constant 
amount of internal standard. Finally, the peak area ratios obtained were used in the relation 
examinedabove to increase the corresponding fentanyl concentration. In conclusion, 
according to the different range of time, a graphic of fentanyl concentration was realized. 
Furthermore, the experiment set up has involved two different trans-dermal fentanyl 
formulations. In Figure 1.3 the result for both has been reported. In conclusion, a series of 
information regarding this drug in human plasma, such as its emi-life and elimination, has 
been defined by LC-IDMS system. 
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Figure 1.3.Concentration-time curve obtained after LC-IDMS analysis. Two different doses of 
Fentanyl have been administrated to around 20 patients.55 
 
The work reported above is only one of many examples in literature. Yiung et al.56, for 
example, were able to measure Nudalarin-R, a hepatotoxic cyclic pentapeptide, in human 
blood.Liuet al.57instead established the concentration of neurotransmistter acethylcoline in 
cerebral extra-fluids. In order to show the expansion that this technique has recently had, Dai 
et al.58investigated the amount of ureapresent in milk, an indicator of nutritious status for 
lactating animals. Similar investigations were developed by Koh et al.59in an attempt to 
determine melamine, a toxic organic base, found inside milk powder.Furthermore, in 
microbiology Dong et al.60defined the bacterial virus Lambdathrough LC-IDMS. Lastly, Bao 
et al.61quantified Sarin and other organophosporus nerve agents, a highly toxic chemical 
category against cholinesterase(ChE), in rat plasma. 
 
1.7 Hydrogen/deuterium (H/D) studies 
 
An important consideration arises from LC-IDMS. As already seen infentanyl’s case, 
deuterium has been introduced in only one aromatic moiety. However, the deuterium 
incorporation here is so high that any form of cross-contamination 62, which could disrupt the 
fundamental isotope ratio, can be avoided. As cited above, strategies for obtaining 
homogeneous deuterium distribution throughout the chemical structure have been thought to 
beextremely relevant. Consequently, the necessity to define a highly efficient H/D exchange 
is vital.  
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For the purposes of this project, it was fundamental to focus the attention on microwave 
(Mw) H/D exchange studies. As will be explained in the next pages, its particular heating 
system could guarantee the development and validation of a rapid and efficient H/D method. 
Moreover, initial bibliographic research of such background studies was equally necessary. 
Following suchliterature research, it was considered relevant initially to investigate the role 
of transition metal in heterogeneous and/or homogeneous catalysis. In order to give a clear 
explanation of both heterogeneous and homogeneous meaning a quick description will be 
given in the next few pages. Furthermore, since interchange reaction mechanisms are 
fundamental for understanding the metal efficiency in such context, two different kinds of 
H/D exchangeshave been proposed. (Scheme 1.4).63 
 
 
Scheme 1.4.Description ofassociative and dissociative mechanisms. 
 
Although the general mechanisms proposed above arise from ligand substitution reactions, 
the experimental data recovered during this project will permit to propose new mechanistic 
considerations. Anyway, in inorganic chemistry these two different concepts are substantially 
distinguished by kinetic parameters. In particular, in associative mechanism the reaction rate 
depends onthe entering group (deuterium in Scheme 1.4).On the other hand, in a dissociative 
mechanism, the rate will be fundamentally determined by leaving group.According to the 
metal used, a different percentage of both of these two theoretical mechanisms will be 
involved in the exchange. An example of this is rhodium which is thought to be characterized 
by both mechanisms64 while in palladium associative mechanismis predominant. For the 
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importance that it will have in the development of this project, it is also very relevant tofocus 
our studies on platinum and its chemistry. In particular, such metal is thought to catalyze the 
exchange according to a prevalent dissociative mechanism.  
 
1.8 Heterogeneous H/D reactions 
 
As in all reactions where a metal catalyst is in a different phasefrom reagents and solvent, 
heterogeneous H/D exchanges presentsome benefits. In particular, they do not require 
specific treatment to separate the catalyst from the product; a regular filtration is often 
enough for this purpose. In addition, since side products have rarely been reported, no 
particular purificaration process is necessary.65In the 1980s, interesting results were 
obtainedin such context by use of rhodium.66-68Furthermore, Lockley et al.69 were able to 
achieve ortho-selective deuteration on pyridine, quinoline and phtalazine derivatives by use 
ofruthenium under D2 pressure. In addition, nickel was often considered as auseful metal 
catalyst in heterogeneous H/D exchange. Introduced by Errede et al.70 in 1954, it has been 
used often for aromatic deuterations.  
 
1.9 Homogeneous H/D reactions 
 
As a consequence of using metal catalyst souble in solvent reaction, homogeneous reactions 
deservesome specific considerations. Firstly, they can benefit from milder conditions and 
secondly,as a consequence, they can also present considerable tolerance towardsdifferent 
functional groups.  
The most relevant example of homogeneous H/D exchange is represented by cationic iridium 
complexes.71Due to their efficiency in activating C-H bonds, these species have been studied 
deeply. In particular,theircharacteristicortho-deuteration on different aryl ketones and 
acetanilide has been reported.72-73 (Scheme1.5). 
 
 
 
Scheme 1.5.Ortho-deuteration for acetamide under cation iridium (+1) catalysys. 
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Other similar metals, such as rhodium, have never been considered as efficient as iridium in 
H/D exchange. The only cases reported involverhodium-olefin complex. Here, Brookart et 
al.74 were able to obtain high deuterium incorporation from aniline and cyclopentene.Lastly, 
Joo et al.75measured an H/D exchange on C2 position of itaconic acid during its double bond 
reduction.(Scheme 1.6). The reaction has been set up with rhodium phosphate complexes as 
catalyst, soluble in D2O solvent. 
 
 
 
Scheme 1.6.Selective deuteration on C2 position of itaconic acid catalyzed by rhodium salt. 
 
Other relevant results were obtained from ruthenium catalysis. Mastubara et al.76recovered 
deuterated alkalones from alkenol substratein deutwrium oxide, while Lockley and Hesk69 
confirmed the important role played by such a catalyst in homogeneous H/D exchange for 
alcohols, cyclic and aromatic substrates. 
To conclude thisparagraph, as previously mentioned, one of targets of this project is also 
studyingthe real efficiency of microwave in H/D exchange.Chapelleet al.77have 
describedthisaspect, reporting in particular that using an iridium 
catalyst,microwaveirradiation improved the exchange reactions both in terms of time and 
deuterium incorporation. In light of this, the next pages will examinemicrowave heating in 
H/D studies. 
 
1.10 Hydrogen/deuterium (H/D) microwave-assisted-reactions 
 
Nowadays, microwave-assisted reactions in organic synthesis represent a common way for 
obtaining products in high yield in a short time.78-79Many reviews describe efforts on the use 
of this technique for the improvement of the hydrogen/deuterium (H/D) exchange. It has been 
discussed that the energy released by a MW magnetron, directed to the body of a solution, is 
able to activate the C-H bond, thus promoting H/D exchange.80 
Past studies have also revealed the important role played by solvent and catalyst.81 It is 
common knowledge that microwave heating involves the physical properties of the chosen 
 solvent and in particular its dielectric constant (
the first choice in this instance, both 
creating a deuterium enriched chemical e
compounds using microwave irradiation has also been very successful with a great variety of 
conditions and catalysts.83 
Cioffi et al.84have applied all of these considerations for introducing deuterium in a 
stereospecific fashion on carbohydrate substrates. For this purpose Raney Nickel
as catalyst producing interesting results as shown on Scheme 1.7. 
 
Scheme 1.7.Effect of MW process on 1
stereospecific positions were deuterated
 
The specific activity of metal catalysis was confirmed by Masaaki 
on primary alcohols and amines using a 
products are reported being deuterated on 
 
n-C9H15CH2OH
RuC
Mw 150
n-C7H15CH2NH2
R
Mw 15
 
Scheme 1.8.Deuteration of
 
The mechanism proposed by Masaaki 
in this process of α-deuteration. The particular catalytic effect was 
acid catalyzed reactions.  
Ullastiina et al.86-87reported a study on polyphenolic deuterations. These compounds 
represent interesting substrates in the pharmaceutical field in order to preven
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dependent diseases. Under microwave irradiation, using an ionic liquid to increase the 
solubility, deuterium was incorporated at multiple positions into one of the substrates 
(Daidzein), as reported in Scheme 1.9. 
 
 
Scheme 1.9.Deuteration of Daidzein with a high level of deuterium incorporated. 86 
 
Despite the high level of deuteration, D+ was introduced only on the positions that are 
relatively active for the electrophilic aromatic substitution. For this reason, due to the 
inactivation inherent within the chromone, the two positions indicated by the asterisks were 
not exchanged at all. 
Furthermore, in order to confirm the tendency shown by acid catalysed deuterations, Martins 
et al.88 carried out a study on different aniline substrates in the presence of hydrochloric acid 
(HCl) (Scheme 1.10).  
 
 
 
Scheme 1.10.Procedure for deuterating anilines under acid catalysed conditions. 89 
 
The environment created by HCl led to an excess of deuteronium ions which encourages the 
deuteration by an electrophilic aromatic substitution pathway. Some results obtained on 
different substituted anilines are shown in Scheme 1.11. 
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Scheme 1.11.Some anilines obtained through acid catalysed deuteration reactions. 
 
In this case deuterium is incorporated according to the rules of electrophilic aromatic 
substitution. Notably, in the context of H/D exchange, the electronic influence of the amino 
group is more pronounced than the other functional groups on the aromatic ring. The 
importance of metal catalysts in these processes was supported by a consistent investigation 
by Aztrodt et al.90Using microwave irradiation and a transition metal catalyst, deuterium was 
also introduced at non-activated aromatic positions (Table 1.1). 
 
Table 1.1 Anilines obtained through metal catalysed reactions 
 
Entry Catalyst ToC time C2a C4a C5a C6a Dmaxb Yield 
1 Pd/C 150 2h 88% 76% 45% 11% D2 61% 
2 Pd/C 150 Mw 2h 97% 96% 95% 53% D4 57% 
3 RhCl3 150 2h 92% 93% 89% 12% D3 65% 
4 RhCl3 150 Mw 2h 91% 92% 88% 12% D3 67% 
    aMeasured by 1H NMR spectroscopic analysis; MW refers to microwave heating 
    bMeasured by LC-MS. 
 
These findings establish the importance of microwave heating on H/D exchange. In particular 
entries 1-2 demonstrate different deuterium incorporation can be promoted at relatively 
inactivated positions (C5 and C6). On the other hand, for a rhodium (Rh) based catalyst, the 
last two examples in entry 3 and 4 show no differences between the two different heating 
methods for such an exchange.  
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Furthermore, according to the review, NaBD4 could be used as a means to activate the Pd 
catalyst. In this casethe considerations regarding associative/dissociative mechanism 
seemsnot valid.Sincein such reaction is not involved any ligand substitutions (Pd0 does not 
present any attached ligands),analternative mechanisms needed to be proposed. 
Hypothetically, it could be suggestedthat an intermediate, obtained through oxidative 
addition, links on its surface both D- and to the aromatic substrates, allowing the subsequent 
electrophilic substitution (Scheme 1.12). The concept of oxidative addition/reductive 
elimination will be mentioned again in the next chapters when Pt behaviour will be described. 
 
 
Scheme 1.12.Mechanism for deuterating the aromatic substrates. The intermediate is formed 
through oxidative additionThe final product instead obtained through reductive elimination. 
 
Currently, microwave-assisted deuteration processes represent a quite complex branch of 
research. The general overview just reported indicates most of these difficulties, which 
include such issues: harsh experimental conditions, varietyof thechoice of the catalyst and, 
last but not least, how to obtain a good deuterium incorporation in all structural positions. 
 
1.11 Aims and Objectives 
 
A general overview of deuterium importance in bio analysis has been provided. As one of the 
aims of this project, a rapid method for improving H/D exchange will be investigated and 
then validated in the next chapters. S 
Such method will be then expanded to a series of different substrates with relevance in 
biology and pharmacology. In particular, starting materials involved in drug synthesis will be 
specifically considered. As a result of this, their use could have a relevant role in defining 
fully deuterated syntheses for biological active compounds. 
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2.1 Introduction 
2.2 First attempt of process validation 
2.3 Deuterated compound analysis 
2.5 Acid effect on metal catalyst 
 
2.4 Calculation of deuteration yields 
2.6 Effect of the amount of catalyst 
2.7 Kinetic experiments 
2.8 Conclusions
 
 
2.1 Introduction 
 
In the previous chapter a general overview of isotopes, deuterium and their applications and 
studies has been provided. In this chapter, the research for reaching a valid and efficient 
deuteration process will be described. As already mentioned, this experimental approach will 
be focused on microwave irradiation effect on H/D exchange. Parallel to these studies an 
analytical investigation will also be developed. In particular, nuclear magnetic resonance 
(NMR) and mass spectrometry aspects will be investigated. Since a clear form to present the 
results is necessary, a precise way to show them has been proposed. So, labelled molecules 
will be drawn with the corresponding deuterium percentage on all positions. When such 
percentages are not required to be reported, the molecules will instead be presented with 
deuterium in replace of hydrogen. This substitution will occur only when deuterium 
incorporation surpasses the limit of 50%. In addition, when the alkyl group is analyzed, the 
percentage of exchange will be referred to a singular C-D bond. In order to indicate its 
characterization in the experimental section, the acetylated compound number will be 
indicated by adding a letterto the corresponding aniline substrate number.  
 
 
 
 
 
Chapter 2 
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2.2 First attempt of process validation 
 
After having defined the importance of labelled compounds in bio-analytical fields, a new 
method for obtaining deuterated molecules was established. As a first strategy, it was thought 
to recover labelled compounds from their labelled starting materials in their corresponding 
synthesis. McNeil et al.91reported detailed studies whereby 14C was introduced into an 
antimalari drug during its synthesis. Following this example, and with the target of 
recovering fully deuterated compounds, it was thought to investigate small molecules directly 
involved in these synthetic processes. Consequently, in light of previous reports, anilines 
were considered ideal substrates to test the aims of this project. In addition, as will be 
explained in the next pages, these compounds are particularly appropriate in order to quantify 
the H/D exchange at all their positions.  
So, following the considerations reported in McNeill’s work91, 3-chloroaniline was chosen as 
example to explore. 
Starting from Atzrodt’s fundamental work90, already mentioned in the introduction, an initial 
reaction consisting of a mix of Pd/C (10 mol%, 10% on carbon), Pt/C (10 mol%, 6% on 
carbon), NaBD4 (10 mol%, 98% D) in D2O was stirred at 150 °C for 1 h. (Scheme 2.1). 
 
 
 
Scheme 2.1.Aztrodt’s procedure using 3-chloroaniline. 
 
As Atzrodt suggested in his investigations, the mixture of Pd/Pt/C represents a reasonably 
good way for increasing the efficiency of deuteration. In addition, hydrogen atmosphere was 
also used in order to liberate D2 as a consequence of its reaction with NaBD4. In fact Sajiki et 
al.92-93have proposed that D2 could be directly involved in H/D exchanges. Even though this 
hypothesis seems perfectly adaptable for unsaturated hydrocarbons, deuterohalogenation of 
aryl chlorides or bromides, benzil positions94, opening of epoxide rings and reductive 
methods95-96, the recommended process proved more difficult when applied to aromatic 
compounds. A comparison with the experiment reported in Tab 1.1 gives the opportunity to 
consider some relevant aspects. In this case some considerable results have been obtained. As 
a first possible explanation, the shorter time of reaction here (1 h against 2 h on Table 1.1) 
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could have had a negative influence on the final result. Otherwise, following the mechanistic 
suggestion proposed in the last chapter, hydrogen atmosphere could have been exchanged 
with deuterium on NaBD4. As a consequence of a reduced deuterium concentration, the H/D 
exchange on the aromatic system could not have been developed as expected. 
. 
Furthermore, after the extraction in diethyl-ether (Et2O), only 3 mg of product from 300 mg 
of 3-chloroaniline were obtained. Arguably, due to solubility problems, much of the crude 
product was lost in the aqueous phase. Although deuterium oxide acts mainly as a solvent 
here, it also represents an important deuterium source. As a consequence, it should play an 
active role in H/D exchange. So, it was thought relevant to investigate its efficiency. For this 
reason a reaction using only D2O was set up (Scheme 2.2). 
 
 
Scheme 2.2. Attempted deuteration of 3-chloroaniline using only deuterium oxide.. 
 
Although no relevant H/D exchanges were recorded in the experiment above, the result was 
nevertheless coherent with the research present in the literature. Most of the examples 
recovered required very harsh conditions. Werstiuk and Ju97, for example, were able to 
deuterate pyridine derivatives with remarkable yields (>80%) and high levels of deuteration 
(Scheme 2.3). Junk and Catallo98 achieved almost complete deuteration of phenanthrene at 
380°C-430°C (Scheme 2.4). 
 
Scheme 2.3. Werstiuk and Ju’s experiments on pyridine derivatives and their levels of deuteration 
obtained.97 
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Scheme 2.4.Junk and Catallo’s experiment on phenanthracene.98 
 
Conversely, Edlund and Berson99 were able to establish a method without such extreme 
conditions. [1, 1, 3, 3-tetradeutero]-2-Indanone (Scheme 2.5), was obtained through repeated 
heating cycles of the starting material in D2O under reflux, giving a consistently high 
percentage of deuteration regioselectivity on the α-carbon positions.  
 
 
 
Scheme 2.5.Edlund and Berson’s experiment obtaining [1,1,3,3-tetradeutero]-2-indanone.99 
 
This final example also demonstrates how the use of deuterium oxide will only work 
efficiently under these conditions for exchange at acidic positions. Starting from these 
considerations, base catalysis was thought to give a relevant contribution in such cases. Many 
studies report considerable results for ketons100, esters101, aldehydes102 and carboxylic acids103 
via a mechanism involving keto-enol equilibria.71 However, as we will see shortly, for 
different reasons connected with solubility and metal activation, such conditions were not 
considered suitable for this project. 
In view of the bibliographic considerations, extreme conditions of temperature and time were 
undoubtedly fundamental parameters. In order to establish the real effectiveness of 
microwave irradiation, a conventionally heated reaction (reflux at 100 °C for 24 hours) was 
set up in parallel with an analogue microwave-assisted reaction. However, due to the high 
pressure control associated with the microwave synthesis instrument, this device is able to 
perform reactions at temperatures over 200 °C and consequently above the solvent boiling 
point. As a result of this, in this trial the reaction conditions were considerably different. This 
fundamental microwave aspect was relevant for a number of reasons. Firstly, it enabled a 
quick and practical method for deuteration to be tested under controlled conditions at high 
reaction temperatures using commercial instruments. Secondly, it allowed H/D exchange 
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experiments to be performed under conditions little explored using conventional heating. As 
a consequence of these considerations, the first microwave reaction was set up at 180 °C for 
one hour in the absence of any additional catalyst to establish the scope of this process. 
(Table 2.1). 
 
Table 2.1.H/D exchange of 3-chloroaniline in D2O using conventional and microwave heating. 
 
Entry Heating Time Temperature oC m/z peaka Dmax 
1 Conventional 24 h 100 127 d0 
2 Microwave 1 h 180 127 d0 
              a
m/z refers to dominant peak observed by mass spectrometry. 
 
Additionally, in order to circumvent the problems connected with the solubility of the 
products in diethyl ether (Et2O), dichloromethane (DCM) was chosen as a more efficient 
solvent for the work up. 
These two attempts revealed no substantial deuteration of the substrate. Mass spectrometry in 
fact showed only one peak, corresponding to the starting material (Mr=127). For this reason 
the reactions were stopped and the corresponding yields were not calculated.  
This result confirmed once again the importance of metal catalysts in such experiments. 
However, parallel to metal catalysis, acidic catalysis H/D exchange was also investigated. As 
we will see shortly, the pH will influence metal activity and final results. In particular, two 
different kinds of such acids could be described. Strong Brønsted acids, such as deuterium 
sulfuric acid (D2SO4), or, alternatively, Lewis acid in combination with a deuterium source 
could be used. Wahala et al.104demonstrated that combining both methods could result in a 
high level of deuteration at only the activated position. Substrates as flavonoids, 
isoflavonoids and lignans were deuterated at temperatures between 20 and 50°C. However, in 
order to improve the level of exchange, the same authors decided to increase the reaction time 
(reaching 20 hours). As a result of this, enterolacetone, one of the substrates chosen for this 
investigation, was almost fully deuterated (99%) in all of its active and inactive positions. 105 
Microwave irradiation gave a considerable contribution to such acidic catalyzed H/D 
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exchange development. This was due in principle to the reduction of reaction time and, on the 
other hand, into preserving an identical level of deuteration.106-107 
Atzrodt et al.71 have previously highlighted the interesting role played by CF3COOD, D2SO4, 
AcOD and DCl on H/D exchange. However, in the introduction, it was already described 
how difficult it was exchanging at less active aromatic positions. With the prospect of 
performing synergism between acidic and metal catalysis in our reactions, it was considered 
relevant to develop an accurate study of acidic efficiency. For the initial trials deuterium 
chloride (DCl) was chosen as a reasonably cheap product in the quantities needed for this 
project. Hence, a series of experiments was developed, dedicated to establishing the effect of 
this acid on deuteration. The first step of this investigation involved measuring the variability 
of the m/z values of molecular ions in the mass spectra according to different quantitites of 
DCl added (Table 2.2). Lastly, in order to accelerate the experimental data recovering, it was 
considered helpful to set up reactions in a time range of 30 minutes. 
 
Table 2.2.Results for H/D exchange of 3-chloroaniline using variable equivalents of DCl over time. 
Entry Heating Time (min) T oC DCl (Eq.) m/za Dmax 
1 Mw 30 180 1 130 d3 
2 Mw 30 180 2 130 d3 
3 Mw 30 180 3 130 d3 
4 Mw 30 180 4 130 d3 
               aAnalysis developed on DCM as solvent. 
               b
m/z refers to the dominant peak observed by mass spectrometry of the crude reaction mixture. 
 
As Table 2.2 shows, in all of these experiments a considerable deuteration of 3-chloroaniline 
occurred. This was confirmed by mass spectra, where the main peak corresponded to the 
trideuterio structure. So, the next step was to explore the effect of DCl over different reaction 
times. After having seen the results on Table 2.2, it was decided to use four equivalents of 
DCl for this investigation. After also having reported difficulties in solving 3-chloroanline, 
this decision was necessary to guarantea better solubility of this substrate in deuterium oxide 
(Table 2.3). Furthermore, for the similar reason reported above, the reaction times chosen for 
this second trial were relatively short. This aspect gave us the opportunity again to accelerate 
the investigation and, on the other hand, to obtain considerable information on time 
dependant acidic trend. In particular, a first look of the results recorded showed that time is a 
parameter strictly connected with H/D exchange. As we will see later, the necessity to 
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clarifythis relationship will force us to set up a series of kinetic experiments which will 
further clarify this aspect. 
 
Table 2.3.Results of reactions set up at different times with identical DCl equivalents. 
Entrya Heating Time (min) T oC DCl (Eq.) m/zb Dmax 
1 Mw 10 180 4 130 d3 
2 Mw 20 180 4 130 d3 
3 Mw 30 180 4 130 d3 
4 Mw 40 180 4 131 d4 
        aAnalysis developed on dichloromethane as solvent 
        bm/z refers to dominant peak observed on mass spectra. 
 
In addition, Heinkele et al.108 were able to completely deuterate dextrometethorphan using a 
50 to 100 fold excess of 1-deuterio-pyridinium-chloride under extreme conditions. (Scheme 
2.6).As a result of this, the impressive efficiency of microwave irradiation in such field has 
been one more time confirmed. 
 
 
 
Scheme 2.6.Heinkele’s H/D exchange reaction. 
 
This experiment is correlated with the results reported in Table 2.3. The most relevant 
product (3-d4-chloroaniline)has been recorded only in Entry 4. As a consequence of this, an 
appropriate balance time/acid has been thought to be an important parameter in H/D 
exchange. In addition, this last consideration indicates that the fourth, less active position on 
3-chloroanline could be deuterated only under appropriate conditions. 
In conclusion, it has been demonstrated that good deuterium incorporation could be attained 
using reasonable experimental parameters, such as appropriate temperatures and even short 
time-scales, and only 4 eq. of DCl as an acidic environment. Furthermore, the considerations 
taken from Heinkele and the results shown in Table 2.2 and 2.3 confirm that DCl would be a 
good point from which to begin validating an efficient method. 
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2.3 Deuterated compounds analysis 
 
2.3.1  Mass spectrometry 
. 
In general, deuteration consists of a series of H/D exchanges that could have different effects 
on every molecule present in solution. As a result, the mixture will show a set of deuterated 
species characterized by different levels of isotopic incorporation and molecular weight. 
Mass spectrometry allows the distinction of all these species during the analysis and the 
consequent spectra will display the typical cluster for the deuterated compounds. 
In Fig 2.1 the mass spectrum of 3-d3-chloro-aniline obtained from Entry 4 Table 2.2. is 
displayed. The cluster linked to the substrate (main peak 130) is indicated. This peak is 
present with other strict signals beside which represent the isotopic species mentioned above. 
Lastly, other clusters arising from fragments are reported and easily distinguishable because 
of their characteristic shapes. 
 
 
Fig 2.1.Mass spectra of 3-d3-chloroaniline. Clusters are indicated with their characteristic shapes. 
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In addition, a cluster includes molecules with the same chemical structure but different 
isotopic incorporation. Such species are better known as isotopologues. On the other hand, a 
single peak represents several different molecules with the same structure and total isotopic 
incorporation (meaning same molecular weight and m/z) but different deuterium distribution. 
Such species are instead called isotopomers (Scheme 2.7). 
 
Isotopologues 
 
Isotopomers 
 
 
Isotopomers 
 
 
Isotopomers 
 
 
Scheme 2.7.Example of isotopologues and isotopomers. 
 
In order to clarify this concept, in Fig 2.2 the specific cluster relating to Entry 4 of table 2.3 
has been reported. The position of isotopologues and isotopomers is once again indicated. 
As mentioned before and reported in Table 2.3 and 2.4, all the mass spectrometric analyses 
were conducted with DCM solutions. The choice of this solvent was suggested when 
scrambling process arose as a relevant problem for the correct spectrum interpretation. Since 
it was thought that the amino group on the 3-chloroaniline could be partially or completely 
involved in eventual H/D exchange during the spectrometric run, methanol and other protic 
solvents were definitely abandoned. This decision was made in order to obtain a spectrum 
able to describe the reality of the solution investigated. Since DCM guaranteed any exchange 
on the most activated position, such solvent was seen as the best choice.  
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2.3.2 1H-NMR 
 
Since mass spectrometry could not provide the detailed information required, another 
analytical method needed to be investigated. Although in the 
presented as a theoretical technique 
analytical information recovered from it was not as valid as 
analytical importance in organic chemistry,the main interest was inevitably based on nuclear 
magnetic resonance.  
 However, establishing deuterium incorporation on every 
structure was not easy. A comparison between a 
corresponding deuterated analogue reported in Figure 2.3 highlights strong difference in 
intensity and in shape. 
 
 
Fig.2.3. Comparison betwee
The signals arising from labelled compound (spectrum 
protons still present in the molecule. However, because the level of deuterium incorporation 
is here high, their intensity is so low that no particular coupling can be spotted. The 
-assisted H/D exchange
previous chapter IR has been 
to distinguish labelled and unlabelled compounds, the 
1H-NMR. As a result of its 
single position of a chemical 
1H-NMR signals for a proton and its 
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integration reveals the ratios of the peaks areas, permitting only to understand which 
positions are relatively more deuterated than others. As it will be explained shortly, the use of 
1H-NMR in such project requires aclearly defined proton l. As a result of this, deuterium 
incorporation can be easily established at every position of the product. 
In literature, much research involves addition of a known amount of chemical or solvent to 
the 1H-NMR samples in order to act as a standard for measuring the absolute isotopic amount 
of component in the mixture. Guoet al.110reported that 1-4-dioxane was added for their 
purpose. On studying aromatic substrates this solvent was chosen because of its intensity, the 
absence of coupling giving a singlet and finally, the chemical shift, which is quite far from 
the aromatic region. Derdau et al.90, instead, preferred tartaric acid for their deuterium 
analysis. 
 At the beginning of this project, it was decided that a similar procedure would be followed. 
Acetic anhydride (Ac2O) was used for this aim, but immediately all the difficulties in adding 
a strictly precise amount of this compound into the 1H-NMR samples became clear.  
For this reason, it was thought to introduce a proton containing functional group directly to 
the molecule just deuterated, so that the integration values for the deuterated locations could 
be compared to those for protons of the added group, thereby providing an internal reference. 
The acetyl group (Ac) was considered to be the best choice and, consequently, an acetylation 
reaction was carried out on 3-chloroaniline (Scheme 2.8). 
 
 
Scheme 2.8.General procedure for acetylation of deuterated anilines. 
 
As shown in Scheme 2.8, the methyl group (Me) is not deuterated at all, so it provides the 
reference against which other integrations can be compared (Fig 2.4 and 2.5). 
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Fig.2.41H-NMR for N-(3-chlorophenyl)acetamide. As a result of chromatographic process 
(petroleum ether/ethylacetate 2:1), traces of ethylacetate (EtoAc) are present.
 
Fig. 2.5.1H-NMR for N-(2,3,4
region present no coupling due to the high level of deuterium incorporated (94% each).
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With the additional acetyl group it was possible to calculate the deuteration percentage of 
different hydrogen environments by integrating each peak against the integration of the acetyl 
group (peak number 7). 
A very simple calculation was needed to obtain such percentages. For example, a comparison 
between peak 6 (δ= 7.71) in Fig 2.5 and peak 6 (δ= 7.73) in the Fig 2.4 highlights a 
considerable difference in their corresponding integrated area. In labelled case, 0.06H versus 
the methyl group (peak number 7) was recovered. This hydrogen amount opposes the true 
value of 1.00 H in unlabelled analogue. An easy subtraction can finally quantify deuterium as 
0.94 of 1.00. As a result, 94% of deuterium is present in this position. The same 
considerations can be extended to all other environments to give the deuteration level of each 
active hydrogen position.  
In conclusion, a consideration regarding the deuterated solvent chosen regularly for this 
analysis needs to be faced. Solubility problems sometimes necessitated a change of solvent, 
and d4-methanol-deuterated (CD3OD) was seen as the best choice. As will be clear following 
the reading of the next chapters, all of the substrates investigated in this work were aromatic 
compounds. Because of the necessity of having an isolated signal in the aromatic area in the 
NMR spectrum, d-chloroform (CDCl3) was found not to be very useful for this purpose. 
Since its typical chemical shift signal (δ= 7.26) is in the aromatic region, hence it may be 
difficult to obtain accurate data. Similar considerations can be advanced for d6-dimethyl-
sulphoxyde (DMSO); in this case the solvent shows a peak (δ= 2.50) in that is a very close to 
the acetyl signal (δ= 2.10). That could cause serious difficulties for establishing the 
integration value of 3H signal of the acetyl group and disrupt the rest of integration process. 
As a consequence of these considerations, methanol was judged the best option. It’s typical 
chemical shift signals (δ= 3.31 for solvent and δ= 4.92 for water) reduce the integration 
problems in the NMR experiments. That leads to a more reliable and accurate deuterium 
incorporation figure for every single position of the compound explored.  
 
2.3.3 13C-NMR  
 
Strong deuterium incorporation can also cause considerable changes on the 13C-NMR 
spectrum. In Fig 2.6 the corresponding 13C-NMR spectrum for 3-d4-chloroaniline is shown. 
The difference from the corresponding non-deuterated spectrum is significant. Due to a 
different resonance frequency, deuterium is not involved in any form of decoupling process. 
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As a result of this, 13C-NMR records every carbon bonded to a deuterium (C-D) as a 
multiplicity signal. Since deuterium’s spin is 1, the corresponding C-D coupling (J) results in 
a particular triplet with the ratio of intensity recorded equal to 1:1:1. 
 
Fig.2.6.13C-NMR spectrum for d4-3-chloroaniline. The C-D peaks are now triplet with a Jc-d around 
25.5 Hz. The specific C-D triplets for 2 and 6 carbons have been expanded. 
 
However, in the spectrum above, the intensity of the C-D peaks seems not to deviate from the 
regular ratios 1:1:1. Notably, the last signal on the left seems to be more intense than all the 
others. That is as a result of an overlapping with the non-deuterated isotopologues, which 
gives a singlet peak due to 13C-H decoupling.  
As Dziembowska et al.111have described in their studies, deuterium chemical shift is moved 
from the natural C-H chemical shift, and it is also measured by referring to the central peak of 
the triplet. 
Finally, it is important to highlight that these peaks are observable only if the concentration of 
deuterated product is particularly high.Due to splitting, the C-D signal’s intensity could be 
quite low. As a consequence of this, for low concentrations it is very difficult to see any 
relevant C-D signals. 
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2.3.4 DEPT (distorsionless enhancement polar transfer) 
 
This NMR technique is usually used for establishing the environment around each carbon 
atom and in particular for calculating the number of Hs bonded to it. The key of this 
experiment is based on polarization transfer through which13C signal intensity has the chance 
to be varied. The concept of this process is directly connected with gyromagnetic ratio γ 
parameter. As a way to indicate specific resonance frequencies, gyromagnetic ratio γ is 
responsible for NMR intensity signal. So, polarization transfer occurs from one nucleus with 
a larger parameter γ (meaning high resonance frequency), such as a proton, to a smaller one, 
such as a 13C. As we will see shortly, this experiment involves the use of an additional pulse. 
As a result of this, a selective inversion of one of proton transition inside a carbon-hydrogen 
coupling system occurs. According to its degree, such pulse causes considerable change on 
13C signal intensity. Three different pulse sequences are usually used with regards three 
different impulses being sent at specific angles (45°, 90° and 135°). As mentioned above, 
carbon environment can be established. In particular, CH, CH2 and CH3 bonds became easily 
distinguishable. While at 45° all of these intensities are preserved, at 90° CH2 and CH3 are 
instead equal to zero. As a consequence, while CH can be initially recognized, CH2 and CH3 
need to wait the last pulse at 135°. Here CH2 intensity becomes negative and distinguishable 
from CH3. Lastly, due to the hydrogen absence, quaternary carbons are instead not recorded 
with this technique. Since the experiment described until now is set up according to proton 
parameters, having deuterium different resonance frequency, it cannot be involved in any 
polarization transfer. As a consequence of this, generic C-D bond can be considered equal to 
quaternary carbon and so not be recorded on the spectrum. However, if peaks are still present, 
they are directly due to the unexchanged hydrogens after the deuteration process. (Fig 2.7). 
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Fig.2.7. DEPT-NMR for 3-d4-
compound is also reported. No signals are recorded in the labelled substrates.
 
As Fig 2.7 shows, only signals arisen from non
spectrum. In conclusion, the complete disappearance of these signal
experiment would confirm complete deuteration.
 
2.4 Calculation of the deuteriation yield
 
At this point a description of how yield calculations are conducted is necessary. Firstly, an 
average molecular weight (Mr’) 
Scheme 2.9.Calculations of the average molecular weight (Mr’) of a deuteration product mixture.
Using the value of Mr’ obtained above, the percentage yield is calculated i
manner. (Scheme 2.10). 
-assisted H/D exchange
nitroaniline. A corresponding DEPT-NMR for non-deuterated 
 
-deteuterated species are displayed in this 
s in this kind of 
 
 
is determined. (Scheme 2.9). 
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Scheme 2.10.Calculations for mmol and yield. 
 
2.5 Acid effect on metal catalysis 
 
As will be explained shortly, this project has been based on homogenous catalysis. As 
described in the introduction, the advantages from such catalysis are considerable. In 
particular, the results appear to be much more impressive than the ones in heterogeneous 
case. The key role played by deuterium oxide in microwave irradiation system has been 
already highlighted. Its importance as the main deuterium source was equally fundamental. 
As a consequence of this, the scientific interest for H/D exchange was focused mainly on the 
aqueous phase. Following this conclusion, appropriate conditions and metal catalyst were 
necessary to be stated. In such research bibliographic investigations gave an important 
contribution. In particular, the work reported by one of the first chemists to investigate H/D 
exchanges, John Garnett112, who succeeded in achieving great recognition in this field was 
significant. 
Initially used by Garnett as a means of investigation for reaction mechanisms in 
heterogeneous catalysis, homogeneous catalysis earned more and more importance when it 
revealed to be a real valid method for H/D exchange. Furthermore, Pt2+ and Pt4+ salts, which 
until then were used as catalysts for completely different reactions, such as hydrogenation 
and oxidations113, were regularly employed. 
In particular, H2PtCl6112was the first one to be explored. Kinetic studies showed that H2PtCl6 
was not involved in any role as a catalyst because the rate of exchange did not follow its 
mmol’ =  
Mr’ 
Mass of Recovered Product 
yield =  
mmol’ 
mmol starting material 
X 100 
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concentration’s variations. Different conclusions were reached for the salt K2PtCl4. New 
kinetic studies showed a high dependence of H/D exchange on the amount of catalyst used. 
Although more soluble than K2PtCl4 in D2O, Na2PtCl4 was a second choice in these trials 
because its level of hygroscopicity was considered unsuitable for such experiments. 
Focusing all the attention on K2PtCl4 it was apparent that the acidic conditions had a great 
influence on catalyst’s efficiency. Garnett, established that a high HCl concentration was 
needed to avoid a strong precipitation of Pt0 from [PtCl4]2-. This consideration was also 
confirmed by H2PtCl6, which generated Pt0 unless HCl was present in strong excess. This last 
condition was also fundamental for the success of the experiment. Catalysis by Pt0 was in fact 
inhibited by acids still present in solution; therefore, if Pt0 was formed the metal could no 
longer be used as a catalyst. Subsequently, the H/D exchange could not proceed and 
deuterium incorporation recovered would be very low. The conclusions reached by Garnett 
were coherent with that one recorded in Tab 2.2. So, the acidic influence studies on H/D 
exchange helped us to define an efficient method.  
Furthermore, since all Garnett’s experiments were conducted under conventional heating, an 
investigation into DCl and K2PtCl4 under microwave irradiation was natural and essential.  
Choosing an appropriate substrate for this attempt was also deemed imperative. At the 
beginning of this study, aniline was seen as the best choice for establishing the efficiency of 
deuteration without any other electronic influence than the amine group.  
Garnett’s experiments were set up at 130 °C for over 168 hours. Considering the typical 
performance of microwave to reach high temperatures in a short time107, standard parameters 
of time/temperature were selected as 2h at 200 °C. 
The same standard amount of K2PtCl4 applied by Garnett in his experiments (20 mol %, 
respect the amount of the substrate explored) was also applied (Table 2.4). 
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Table 2.4.Set of experiments with different DCl amounts. 
 
Entry N°c DCl K2PtCl4 D2a D3a D4a D5a D6a Yieldb 
1 N.A 0 (eq.) 20 mol% 95% 45% 95% 45% 95% 46% 
2 N.A 2 (eq.) 20 mol% 91% 91% 91% 91% 91% 90% 
3 2a 4 (eq.) 20 mol% 91% 91% 91% 91% 91% 44% 
4 2c 4 (eq.) 2 mol% 91% 25% 91% 25% 91% 80% 
a
 Deuterium incorporation calculated followed acetylation. 
b
 Yield calculated as in Scheme 2.10. 
c
 Structure number assigned to the deuterated aniline intermediate in the particular experiment, as correlated 
in the experimental section. 
 
As described above, in Entry 1 the absence of DCl caused relevant Pt0 precipitation. So, in 
this case, metal catalysis has been replaced by acidic catalysis resulting in H/D exchange 
occurring prevalently on the active aromatic positions. 45% on D3/D5 could be due to a 
partial contribution of metal catalyst before Pt0 precipitation occurring. Furthermore, such 
metal formation here has been confirmed by a black powder on the bottom of the vial. 
Therefore, a filtration process could permit an efficient separation of this metal from aqueous 
phase. On the other hand, in Entry 2 this work appeared to be more complicated. Due to a 
reduced precipitation process caused by acidic presence, Pt0 tended to not be accumulated on 
the bottom of the vial. As a consequence of this, some traces could be suspended in solution 
and here hardly eliminated. In addition, due to the very small size of Pt0 particle, no accurate 
filtration process could guarantee the complete elimination of the metal from aqueous phase. 
Lastly, because of its considerable molecular weight, its presence could disrupt the weight of 
the final crude recorded. Consequently, the yield could not be dependable. This problem will 
be faced again when other experiments show excessively high yields. In Entry 3 (2a)the 
balance between DCl and catalyst respects perfectly Garnett’s forecast and so, in this case, no 
Pt0 precipitation was observed. For this reason the yield was also considered much more 
reliable than the previous experiments. Due to maybe a partial catalyst extraction in organic 
phase, the result in Entry 4 (2c) shows that a better overall yield was achieved than in Entry 
3, while substantial level of deuterium exchange was also observed, with only one tenth of 
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amount of catalyst. Lastly, as a consequence of the cost of this catalyst, a detailed study on its 
quantity/efficiency relationship was also necessary in order to work whthin financial 
restraints. 
 
2.6 Effect of the amount of catalyst 
 
While the result in Entry 4 of Table 2.4 encouraged a reconsideration of the influence that 
different catalytic amounts could have on the level of deuterium exchange, at the same time it 
was thought that this new area of investigation could be used for studying H/D exchange on 
an alkyl chain. Garnett reported many helpful studies114-115 for advancing the hypotheses of 
the mechanisms of such reactions. 
Simple alkylbenzenes provided useful targets for this purpose. These substrates permit the 
opportunity to study on a part of hydrocarbons which is activated differently from the 
aromatic systems. For this purpose, 4-butylanilinewas chosen. This molecule presents a chain 
of four carbons with different reactivity. The alkyl group, in para relationship with amino 
group, allows analysis of the electronic effect of two electron donor groups (amino and alkyl 
groups) on the four remaining positions of the aromatic ring. The experiment is indicated in 
Table 2.5 show the series of experiments set up. 
Table 2.5.Set of experiments with different catalyst amounts.
 
Entry N°c K2PtCl4 D2/D6 D3/D5 D7 D8 D9 D10 Yielda 
1 N.A 1 mol% 95% 12% 18% 4% 0% 46% 99% 
2 N.A 5 mol% 95% 29% 70% 39% 56% 91% 99% 
3 N.A 10 mol% 94% 38% 84% 53% 63% 92% 99% 
4 N.A 15 mol% 98% 48% 87% 63% 68% 92% 99% 
5 3b 20 mol% 89% 43% 87% 56% 61% 81% 50% 
  aYield calculated following acetylation. 
  bThis experiment is one reported in the experimental section. 
  cStructure number assigned to the deuterated aniline intermediate in the particular experiment, as correlated  
inthe experimental section 
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The results obtained are better displayed in a graph reported in Scheme 2.11. The graph 
below joins simultaneously catalyst amount, positions and H/D percentage exchange. 
Scheme 2.11.Variations of the l
 
Some considerations arise from these studies
high. Although one reasonable explanation could be that one already reported for Entry 4
in Table 2.4, the yield in Entry 5 
complex formation. In this case Pt could interact with the basic amino group, perhaps playing 
a role as a Lewis acid, which could reduce the amount extracted into the organic pha
the the work up. So, this tendency seems directly proportional with the increasing catalytic 
amount. This aspect will be also faced in the next chapter. Lastly, although the result in Entry 
4 appears to be much better than Entry 5, for the reason
case seems much more reliable. As a consequence of this, 20% mol of K
the best catalytic conditions for our H/D exchange.
The considerable decrease of deuterium incorporation in Entry 5 
D10 (Table 2.5) could be explained in term of 
catalytic amount here allows the H/D process to carry on in an 
deuterium rich because it was already consumed during the exchang
explained by the deuterium on the substrate being displaced by proton and subsequently 
reducing the amount of deuterium observed.
Last considerations regard once more these last positions mentioned above. It is clear from 
the results in Table 2.5 that amine group has undoubtedly the greatest effect on the aromatic 
ring. Ortho positions (D2 and D6) are strongly activated while 
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amount of catalyst to present considerable deuterium incorporation. The same conclusion 
could be made for D10 position. As will be shown in chapter 4, this carbon atom represents 
the most active position on the alkyl chain. This may be due to steric reas
consequently to the ability of the catalyst to interact here much more easily than on all the 
other alkyl positions. 
This aspect could be supported by the way in which deuterium was incorporated on alkyl 
chain itself. At every catalytic amount D10 
others. In Entry 5 (3) (Table 2.5) instead D7 overtakes D10. As mentioned some pages 
before, a reverse exchange could have occurred here again. As proof of this, sensitive 
changes are also observable on act
a new exchange process could permit hydrogen replacing deuterium. Steric effect could also 
clarify some aspects. In particular, D7 reduced activation could be explained in term 
ofK2PtCl4 difficulties to interact properly with this carbon atom. As a consequence of this, the 
reverse exchange cannot occur and the level of incorporated deuterium does
significantly. For the aim of this project, in this instance, it is also important to highli
particular exchange pathway along the alky chain. (Scheme 2.12).
Scheme 2.12.Level of deuteration for different catalytic amounts on alky chain.
 
This scheme confirms some of the aspects faced previously. Firstly, the level of deuterium 
introduced is changeable, moving from 1% to 5% of K
is also more undergone to a reverse exchange and apparently this process is evident only with 
a 20% amount of Platinum catalyst.
-assisted H/D exchange
appears always to be more deuterated than all the 
ivated D2/D6. So, on all such positions it was thought that 
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Finally, as further proof of the role played by steric effect, the internal positions are 
always much less deuterated than the external ones. This last conclusion represents an 
unexpected observation will need to be investigated in more depth during the mechanistic 
studies on H/D exchange in chapter 4. 
 
2.7 Kinetic Experiments 
 
2.7.1 Temperature 
 
Even though the homogeneous catalysis usually involves milder conditions than 
heterogeneous catalysis116Garnett and others117-118 recorded H/D exchanges as reactions 
inneed of high temperature and extended time parameters even with the homogeneous 
catalysts. 
For this reason another series of experiments were set up in order to establish the contribution 
made by temperature to the deuteration. Due to reasons connected with Pt0 precipitation and 
consequently yield reliability, Entry 5(3) in Table 2.5 was chosen as a good point for starting 
this investigation. So, reaction conditions as time, catalytic amount and DCl equivalents were 
preserved, while temperature instead was treated as variable parameter. Consequently , as in 
previous experiments, 4-butylaniline was chosen as the substrate (Table 2.6). 
Table 2.6.Set of experiments with different temperatures.
 
Entry N°b T °C D2/D6 D3/D5 D7 D8 D9 D10 Yielda 
1 N.A 50 10% 0% 0% 0% 0% 0% - 
2 N.A 100 10% 0% 0% 0% 0% 0% - 
3 N.A 150 10% 3% 0% 0% 0% 0% - 
4 3 200 89% 43% 87% 56% 61% 81% 50% 
a
 Yield calculated following acetylation. 
b
 Structure number assigned to the deuterated aniline intermediate in the particular experiment, as 
correlated in the experimental section      
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The corresponding graph recovered from these results clearly shows the most interesting 
aspect of this investigation (Scheme 2.13
 
 
Scheme 2.13.Variation on deuteration level according to diffe
 
According to this graph, the effect of temperature on all positions is significantly important. 
Certainly, 200°C seems the best parameter to be used.
 
2.7.2 Time 
 
As previously seen in Garnett’s experiments, the attempts set up we
times, from days to sometimes weeks. Due to different heating dispersion forms, it is 
reasonable to think that the reactions investigated by Garnett could actually be set up at a 
lower temperature. As a direct consequence of the 
for these experiments was only rarely that one expected. So, not only could the final result 
not be considered completely reliable but the corresponding reaction also resulted in very 
long processes. The strict correlation existing between time and temperature has been 
interestingly studied bySabot et al.
temperature, they were able to show how much these conditions influ
reaction times. These in fact became particularly long, passing from twelve hours to 3 days. 
As alreadyobserved, microwave system is instead able to reduce reaction
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solution, avoiding any form of energetic dispersion. As a result of this, the temperature 
achievable by microwave could be approximately close to that onereally expected. In using a 
device with these characteristics, it was considered relevant to investigate the variations of 
H/D exchange under different time conditions. Furthermore, as it is quite unusual to find 
microwave assisted methods which last for more than 2 hours, this parameter was seen as the 
upper limit. The results of these experiments are reported in Table 2.7. 
Table 2.7.Effect of different reaction times. 
 
Entry N°b Time D2/D6 D3/D5 D7 D8 D9 D10 YIELDa 
1 N.A 30’’ 87% 6% 0% 0% 0% 0% 98% 
2 N.A 1’ 92% 2% 0% 0% 0% 0% 98% 
3 N.A 2’ 97% 6% 7% 0% 0% 6% 94% 
4 N.A 5’ 88% 3.5% 6% 0% 0% 21% - 
5 N.A 10’ 92% 10% 22% 8% 13% 48% 98% 
6 N.A 15’ 94% 9% 27% 6% 17% 58% - 
7 N.A 30’ 95% 19% 49% 23% 35% 79% 64% 
8 N.A 45’ 96% 26% 68% 37% 60% 91% 93% 
9 N.A 60’ 89% 20% 61% 33% 50% 76% 82% 
10 N.A 75’ 96% 37% 81% 39% 57% 93% 70% 
11 N.A 90’ 88% 31% 78% 50% 67% 85% 99% 
12 N.A 105’ 94% 33% 81% 51% 69% 91% 99% 
13 3 120’ 89% 43% 87% 56% 61% 81% 50% 
  a
 Yield calculated following acetylation. 
  b
 Structure number assigned to the deuterated aniline intermediate in the particular experiment, as correlated in 
the experimental section      
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Even though the Hs in ortho are able to be exchanged easily after only 30’’, the rest of the 
positions need to reach 75’ before reaching a considerable de
of this, ortho positions seem to be completely independent from time. Furthermore, as 
mentioned before, D10 is also an activated position. Its low exchange in the firststeps ofthis 
investigation (form Entry 1 to Entry 5) is 
the catalyst to reach this position. As it will be explained in C
suggest that K2PtCl4 could start its H/D exchange from the aromatic moiety and then move to 
the alkyl chain beside. Lastly, following the considerations developed previously, the reverse 
exchange seems to influence the results for each experiment. In particular in Entry 9, 11 and 
13 there is considerable reduction of deuterium incorporation. The yield in Entry 13
also be explained again as a result of platinum complex formation which is apparently a not 
so relevant problem for all the other attempts. 
The considerations just reported ab
2.14). 
 
Scheme 2.14.Variation on deuteration level according to different reaction
 
As a result of this, in order to obtain relevant deuterium incorporation in most of the 
molecular structure investigated, time represents another crucial parameter. 
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2.8 Conclusion 
 
In conclusion of this investigation, the right conditions for each parameter were established. 
Table 2.8 reports the best conditions found for validating a microwave-assisted deuteration 
method. 
 
Table 2.8.Best parameters found during the validation process. 
Time Temperature Solvent Acid Catalyst 
2 h 200 °C D2O DCl (4 eq.) K2PtCl4 (20% mol) 
 
A complex analytical system for deuterated compounds was perfected. The system presents a 
rigorous way for establishing the deuterium incorporation with accuracy and precision. A 
series of technical parameters for microwave-assisted reactions were studied thoroughly. The 
conditions chosen at the end of these investigations offer the best balance between cost and 
time. It was also demonstrated that the system just validated offers a more reliable yield, and 
a reduction in the risk of metal precipitation. 
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3.1 Introduction 
 
The microwave assisted system validated in Chapter 2 showed the first results only from a 
small set of aniline compounds. As was discussed there, aniline derivatives were selected for 
their importance as building blocks in drug synthesis.120 Chosen already by Garnett as a good 
way of investigation, these substrates were also able to provide the basis for understanding 
and improving the validated method.  
 In order to appreciate the efficiency of this process a much larger range of similar aniline 
substrates needed to be explored (Scheme 3.1). Clearly, it is relevant to report the 
corresponding level of H/D exchanges and yields for every single substrate investigated. 
 
 
 
Scheme 3.1.Platinum-catalysed deuteriation of a range of aniline derivatives. 
 
However, Scheme 3.1 shows only the first deuteration step of the process. The following 
acetylation step is omitted, even though its importance in establishing the yield and deuterium 
incorporation is fundamental. As mentioned in the introduction of Chapter 2, such 
compounds will be reported in the experimental data with a letter associated to their 
corresponding aniline substrate numbers.  
Chapter 3 
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Occasionally it will be necessary to compare catalytic data generated by Pt catalystalso 
necessary to compare the metal catalytic results, described in the scheme above, with that 
generated by DClthe correspondent acidic catalytic type (Scheme 3.2).  
 
 
 
Scheme 3.2.Acid-catalysed deuteriation of a range of aniline derivatives. 
 
This aspect allowed the clarification of the role played by catalyst and by acid on some of this 
set of molecules and at the same time to advance the possible mechanism of reaction for H/D 
exchange. 
 Lastly, in Chapter 2, Pt0 precipitation revealed itself to be a serious inconvenience when 
trying to obtain an accurate final yield. For this reason this problem will be faced specifically 
in the next pages and a practical way to reduce its negative effect will be proposed. 
 
3.2 Methoxyanilines 
 
Methoxyanilines were chosen as the first group to be explored. Their importance in drug 
design and synthesis is reasonably known and developed. For example, Favoret al.121 used 3-
methoxyaniline as a building block for 4-arylpiperazine derivatives. Actually, arylpiperazine 
template is still currently considered relevant according to a pharmacological point of view 
for its interesting biological activity. 
 In order to have a reasonable view of deuterium incorporation on their aromatic ring, all 
methoxyanilines were investigated. (Table 3.1). 
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Table 3.1.Methoxyanilines deuterations results. 
 
Entry N°c OCH3 D1a D2a D3a D4a D5a D6a OCD3a Yieldb 
1 4 Para - 93% 91% - 91% 93% - 11% 
2 5 Meta - 93% - 88% 81% 81% - 44% 
3122 N.A Ortho - - - - - - - - 
a
 Deuterium incorporation calculating through acetylation. 
b
 Yield calculated through the relation on Chapter 2. 
c
 Structure number assigned to the deuterated aniline intermediate in the particular experiment, as correlated in 
the experimental section      
 
 
As shown in Table 3.1, the yields reported appear dramatically low. Entry 3122 experiment in 
particular requires some deeper analysis. In this case no product was recovered. As a 
consequence of this, it was thought that an interaction between catalyst and oxygen/nitrogen 
could have influenced the final result of this experiment. (Scheme 3.3). 
 
 
 
Scheme 3.3.Reaction where the complex between 2-methoxyaniline and platinum tetrachloride anion 
is formed. 
 
Generally, Pt shows a well-known tendency to form metal complexes. Starting from 
cisplatinum, many of its analogues are currently successfully applied to the chemotherapeutic 
field.123-124Their properties to link DNA are in fact used nowadays in cancer treatments. In 
this case [Pt(Cl)4]2- presents interesting abilities to interact with heteroatoms.125 Possibly due 
to the high concentration of chlorine, the central metal could actas electrophilic species. 
Consequently the data suggest a nucleophilic interaction between either nitrogen/oxygen 
from the substrate and the Pt of the catalystA comparison between this metal-catalyzed result 
and a corresponding acidic process126 could confirm this hypothesis. (Table 3.2) 
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Table 3.2 Methoxyanilines deuteration under acidic catalyzed conditions. 
 
Entry OCH3 D1a D2a D3a D4a D5a D6a OCD3a Yieldb 
1126 Para - 90% 89% - 89% 90% - 21% 
2126 Meta - 94% - 96% 2% 96% - 31% 
3126 Ortho - - 94% 95% 95% 96% - 58% 
 aDeuterium incorporation calculating through acetylation. 
 bYield calculated through the relation on Chapter 2. 
 
Pt efficiency in these set of experiments has been shown by a direct comparison of D5 
exchange in 5 (Table 3.1) and entry 2 in Table 3.2. The D5 position is inactiveposition 
because of the two electron donor groups aremetato D5. In these two trials the difference of 
deuterium incorporation is impressive (2% against 81%). This observation highlights As a 
result of this, the enormous advantage of using Pt metal catalystover conventional acid 
catalyst; the opportunity in fact to obtain H/D exchange even in inactivated positions 
permitted us to obtain almost fully deuterated compounds. The yield reported in Entry 3122 
(Table 3.2) confirms that platinum considerably influences the final result. The hypothetical 
complex described in Scheme 3.4 could be significant here.  
 Similar considerations are also suggested from Entry 1(4)(Table 3.1). The corresponding 
acidic and metal yields are both significantly low. Even after the basification of the aqueous 
solution. In fact, only a few mg of crude product were collected in organic phase in both of 
the experiments. This result could have also occurred as a consequence of solubility problems 
in deuterium oxide.  
Inthe case of 3-methoxyaniline case (5 inTable 3.1and Entry 2 in Table 3.2) some points need 
to be clarified. Thioglycolic acid ligand was taken into consideration when calculating the 
final yield. However, in this caseno improvement in yield was observed.. 
 Additionally, the interaction between Pt and oxygen  wasalso studied. Essentially, in all of 
these attempts the catalyst was not able to obtain a major deuteration on the three hydrogens 
of the methoxy group. It was assumed that the Pt would form a stable complex with the 
oxygen. Anderson et al.127 have accurately studied the right conditions for forming such 
complex. Therefore, it was thought that oxygen could play the role of the electron-donor 
through the help of methyl group which could increase its nucleophilicity. The strongly 
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Electron withdrawing chloride ligand attached to the Pt helps to reduce the electronic 
repulsions between the electron of oxygen atom and the metal d orbitals. These lone electron 
pairs here could be pushed mostly towards halogen atoms allowing platinum to become so 
electronpositive to interact with oxygen species.As a result of this Pt is able to form a stable 
bond and consequently a stable metal-organic complex. It is necessary to highlight the 
importance of oxidation state IV for platinum. In this state the electrons on d orbitals are 
closer to the nucleus for electrostatic attraction and subsequently the electronic repulsion is 
lower. That allows the stabilization of the system as explained in the scheme below. (Scheme 
3.4). 
 
 
 
Scheme 3.4.Hypothetical complex formed between platinum (IV) catalyst and oxygen of methoxy 
group.  
 
In scheme 3.6 platinum (IV) was reported as species obtained by oxidative addition by DCl. 
This aspect will be explored in the next few pages when a mechanism for Pt0 precipitation 
will be proposed.  
All these considerations also suggest that kinetic factors could be involved in thecatalytic 
mechanism. The level of deuterium introduced on to the aromatic rings (Table 3.1) presents 
an  homogeneous distribution. The Methoxy group seems not to have any particular effect on 
the H/D exchanges. In this sense Pt could be thought of as a catalyst, which is able to activate 
all positions without any particular difficulty. Although this aspect will be explored in the 
next chapter, it is quite relevant to observe that the complex stabilities shown in Scheme 3.6 
seem to respect the electrophilic aromatic substitution. It is also relevant to specify that no 
specific H/D mechanism has been proposeduntil now. In Chapter 4, these considerations will 
be addressed there particularly in the light of Garnett’s discoveries. However, here, Pt(IV) 
seems to play a relevant role.  
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3.3 4-Fluoroaniline 
 
The idea reported above gave the suggestion to investigate a substrate where the substituent 
could not present the difficulties faced before. Fluoroaniline is widely used in drug 
synthesis128 and it was chosen for this purpose. In this sense 4-fluoroaniline derivative 
isparticularly interesting for the considerations about complex stability just proposed above. 
The scheme below (Scheme 3.5) reports the result obtained through this experiment. 
 
 
Scheme 3.5.4-Fluoroaniline deuteration experiment. 
 
As Scheme 3.5 shows, 6 showsall aromatic positions deuterated in a high percentage. 
However, C3 and C5 present a lower percentage. As a result of ortho inactivation by 
fluorine’s electron-withdrawing inductive effect, these two positions offer a comparison with 
this result of the correspondent aniline explored in Chapter 2. Here the level of incorporated 
deuterium is considerably higher (92%), hydrogen in C6 is not able to apply a similar effect 
on the correspondent ortho carbons. Consequently the electron density here for 4-
fluoroaniline is importantly reduced, giving the right explanation for the result just reported. 
 The interesting aspect of this experiment is nevertheless represented by the yield. While in 
the last paragraph it was suggested that the presence of Pt-O complex could have influenced 
the extraction of methoxyanilines in organic phase, here this consideration could not be 
considered valid anymore. 
 Many examples in the literature deal with the tendency of Pt to form complex with nitrogen 
in aniline substrates.129-130 Consequently, it could be relevant to suggest a hypothetical 
complex is formed in solution between catalyst and fluoroaniline.(Scheme 3.6). 
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Scheme 3.6.Pt-4-fluoroaniline complex formation. 
 
As reported above, here the species of Pt(IV) formed through oxidative addition was yet 
again considered to be the most active in this process. A substitution reaction could occur 
therefore, through such species and basic nitrogen on the aniline; favoured also by harsh 
experimental conditions. It was additionally proposed that a further reductive elimination 
could follow this process according to the scheme below (Scheme 3.7). 
 
 
 
Scheme 3.7.Reductive elimination for Pt-4-fluoroaniline complex. An intermediated reaction 
substitution has been also occurred.  
 
Reasonably, the heating could favour the acid chloride (HCl)/deuterium chloride (DCl) 
elimination and subsequently move the equilibrium towards the right. 
 Furthermore, it is relevant to reflect upon the behaviour of such a substrate under strong 
acidic conditions. This compound presents a pKa of 4.66. This value permits keepingthe 
aniline in a protonated state (Scheme 3.8). 
 
 
Scheme 3.8.4-Fluoroaniline formation. The equilibrium is shifted on the right due to excess of 
acid in solution. 
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 Even though this aspect seems not to cause any modification on ortho activation, a very 
good level of deuterium incorporation is still present. As a consequence of this, it was 
thought that instead fluorine could be directly involved in some sort of conjugation process. 
As halogen, this atom couldoverlap its 2p orbital with 2p carbon orbital. In particular, as the 
resonance form shown below, such interaction could occur through an empty sp2 orbital 
offered in carbon in 4. (Scheme 3.9). 
 
 
Scheme 3.9.Complex formed during the reaction ongoing. 
 
As a result of this, position 1 is activated. So Pt(IV) could be seen as Lewis acid or possibly 
as a species with its nucleus positively charged due to five electron-withdrawing ligands. The 
interaction shown in the Scheme 3.9 brings to obtain the final complex.  
Although the presence of these complexes was not proved, this hypothesis could be helpful in 
finally explaining the yields obtained for the methoxyanilines experiments. The process 
reported above and the interaction Pt-O could give a double contribution and reduce 
dramatically the yield.  
 
3.4 (Trifluoromethyl)anilines 
 
The considerations recovered from the last paragraph moved the interest towards different 
compounds. It was considered fundamental to expand this results to different substrates. For 
this purpose (trifluoromethyl)anilines were retained as the fittest examples. These compounds 
are important for their use in drug design and synthesis.131Moreover trifluoromethyl electron-
withdrawing group (CF3) could allow suggesting a series of interesting consequences. Firstly 
it could be shown in which way such substituent could influence the H/D exchange, secondly 
it could be investigated how it could influence the final yield. 
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So 4-(trifluoromethyl)aniline was the first compound explored. The result obtained is quite 
unusual and it is reported in Scheme 3.10.  
 
 
Scheme 3.10.4-(Trifluoromethyl)aniline experiment. Aniline is the unexpected final product. 
 
Many hypotheses were advanced to explain this strange result. For this purpose, it was 
necessary to make a comparison with the corresponding acidic-catalyzed reaction.126(Scheme 
3.11). 
 
 
 
Scheme 3.11.4-(Trifluoromethyl)aniline experiment under acidic catalyzed condition. Aniline is still 
the final product. 
 
The data reported above show interesting aspects. In both of the experiments, ortho and para 
positionswere deuterated with approximately the same percentage. In meta instead any 
relevant exchange was observed under acidic catalysis. Finally, the yields for both are quite 
similar. After these conclusions two reasonable mechanisms were proposed for explaining the 
final aniline formation. 
 
3.4.1 Trifluoro-carbocation (CF3+) elimination 
 
In this reaction a trifluorocarbocation (CF3+) was thought to be the key of this mechanism. As 
a very good leaving group, it could also enable the consequent electrophilic aromatic 
substitution. The electron withdrawing effect generated by this substituent could also activate 
the correspondent carbon (position 4) on the aromatic ring and allowing the attack by both D+ 
and Pt-catalyst. (Scheme 3.12 and 3.13). 
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Scheme 3.12.Pt attack to position 4 on 4-(trifluoromethyl)aniline. The final result is the formation 
of one σ bond between metal and carbon.  
 
 
 
Scheme 3.13.deuterium ion attack to 4 position on 4-(trifluoromethyl)aniline. The reaction is a 
typical electrophilic aromatic substitution.  
 
Even though in literature there are no particular references to confirm this mechanism, Olah 
et al.132 reported a study about trihalomethyl carbocations’ stability in which their extreme 
reactivity was reported. CF3+ in this context results the most reactive species due to the 
highest electronegativity of the three fluorine atoms present. However, a conjugation of a 
lone pair on one of them could stabilise the positive charge on carbon atom and allow the 
reduction of energy activation. (Scheme 3.14). Add to that the extreme condition reproduced 
in the microwave reaction; all the processes described above show promise 
 
 
 
Scheme 3.14.Resonance forms of trifluoro carbocations. In three of them the positive charge is 
delocalized through electronic conjugation. 
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3.4.2 CO2 elimination 
 
Even though the proposed mechanism below appears reasonable, the presence of trifluoro-
carbocation remains controversial. For this reason another explanation, supported by more 
literature references, was advanced.  
 The amine group plays a fundamental role for C-F activation.133This bond is usually very 
difficult to involve in every step of reactions. However Liddle et al.134 reported a study where 
this bond was able to take part in the synthetic process. The considerations recovered from 
this paper were used to advance hypotheses for 4-(trifluoromethyl)aniline stability. (Scheme 
3.15). 
 
Scheme 3.15.Resonance forms of 4-(trifluoromethyl)aniline. 
 
As a consequence of hyperconjugation interaction, C-F bond might be weakened. Starting 
from this consideration, Liddle et al. obtained relevant results in using inorganic base such as 
KOH and NaOH. As possible explanation, the metal cation here played a fundamental role 
catching fluoride and stabilizing the ionic resonance form (on the right of scheme 3.15). In 
strong acidic media something similar was observed. As a consequence of heating system, 
hydrofluoride (HF) could be in fact eliminated resulting in a similar process described above. 
 So, a difluoridemethyl (CF2) species which is easily attacked by any weak nucleophile 
species present in solution. The presence of this activated part is so beneficial that many 
researchers, such as Qiao et al.135, have adopted it for C-F activation and heterocycles 
synthesis.  
 In our case deuterium oxide represents the only nucleophilic species able to attack (CF2). 
Moreover, the necessity of reforming the aromatic system brings the reaction to give the 
correspondent aniline. The Scheme 3.16 describes the main points of this theoretical 
mechanism.   
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Scheme 3.16.Deuterium introduction in replacement of CF3. It is shown the attack directly by D+ 
or by Pt(IV). Carbon-dioxide is eliminated at the end of this process. 
 
The procedure finally could be favoured by carbon dioxide (CO2) elimination under the high 
temperatures used for the reaction. 
 The hypothesis reported above need to be confirmed by further experimental investigations. 
So, similar substrates, such as 2-(trifluoromethyl)aniline, shows some analogies with the 4-
subsituted one. The electron-withdrawing substituent in fact is in a position that an electron-
donor conjugation can be proposed again. (Scheme 3.17). 
 
 
Scheme 3.17.Resonance forms of 2-(trifluormethyl)aniline. Again fluoride could be the key to fix 
the equilibrium. 
 
The resonance forms described in Scheme 3.17 were already investigated by Strekoswski et 
al.136who applied similar considerations to synthesize heteroaromatic rings. Although an 
imine-difluoridemethyl species has been here obtained by ionization and then fluoride 
elimination, the consequent nucleophilic attack has resulted identical to Scheme 3.16. As 
described above, the high temperature and the consequent HF elimination could stabilize here 
the ionic resonance form.   
So, 2-(trifluoromethyl)aniline was explored from H/D exchange point of view.122(Scheme 
3.18). 
 
Scheme 3.18. 2-(Trifluormethyl)aniline experiment. It is shown the final product which is again a 
deuterated aniline. 
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As the scheme above illustrates, aniline is again the final product of the experiment. 
Furthermore, the mechanism involved could be the same proposed for 4-
(trifluoromethyl)aniline. (Scheme 3.16). 
After these last results, it was thought that the position of CF3 on the aromatic ring was 
fundamental for activating C-F bond and consequently to eliminate this substituent. However, 
in order to confirm this, it was finally necessary to investigate 3-(trifluoromethyl)aniline 
which was the last substrate not yet explored. (Scheme 3.19). 
 
 
Scheme 3.19. 3-(Trifluormethyl)aniline experiment. In this case CF3 has been preserved maybe 
because the presence on meta does not allow the right activation on carbon 3. 
 
As shown above, in this case the electron-withdrawing group was not eliminated. The 
clearest explanation of this result could be due to a different activation of correspondent 
carbon 3 on aromatic ring mediated by trifluoromethyl group.  
 Furthermore, as reported above, it is quite hard to expect any hyperconjugation here. Due to 
its instability, the ionic resonance form was not formed. In conclusion, although CF3 was 
preserved, its influence seems not to be so relevant in H/D exchange. 
 As reported above the metal catalyzed reaction is able to deuterate all the aromatic positions 
with high efficiency. 
 The corresponding acidic-catalyzed experiment126 was set up to show once again the 
efficiency of this catalyst and at the same time to display its influence on the final yield. 
(Scheme 3.20). 
 
 
 
Scheme 3.20. 3-(Trifluormethyl)aniline acidic catalyzed experiment. 
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As Scheme 3.20 shows, position 5 was modestly exchanged. Otherwise the yield reported is 
considerable high. As suggested before, CF3 in meta position could not permit any relevant 
hyperconjugation interaction. As a result of this, the electronic lone pair on amine group is 
still available for interacting with Pt and forming corresponding complex. As mentioned 
above, the proposed complex could be the main reason for the low yield. 
On the other hand, the result obtained in acidic-catalyzed reaction reveals a very high yield. 
 It is clear after that metal catalyst interacts in some way with this kind of anilines. As already 
stated in the first pages of this chapter, Pt has always shown a tendency to form stable bonds 
with heteroatoms and in particular with nitrogen. Moreover, as mentioned earlier, Pt(IV) 
could play a role as electrophilic species. Following this consideration, it was thought that 
this metal species could attack the aromatic ring on the more activated, hence electron-rich 
positions. It was also suggested that carbon bonded nitrogen (position 1) could not be 
excluded from this process. According to the nature of the substituent present on the ring, this 
position could result more or less activated; so the importance of this specific electrophilic 
attack is fundamental. The proximity of nitrogen could in effect generate a stable bond with 
Pt and avoid the extraction of consequent complex formed in the organic phase, eventually 
reducing the final yield. (Scheme 3.21). 
 
 
 
Scheme 3.21.Pt-aniline compex formation. Arisen from the yield obtained from 
trifluoromethylanilines, this mechanism shows the hypothetical electrophilic attack by the Pt 
catalyst. 
 
 Lastly, the proposed mechanism explains the yield’s obtained for (trifluoromethyl)anilines. 
Table 3.3 shows a summary of these results. 
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Table 3.3. (Trifluoromethy)anilines yields. 
 
Entry N°a CF3 Position Yield 
1 N.A Ortho 70% 
2 8 Meta 40% 
3 7 Para 70% 
aStructure number assigned to the deuterated aniline intermediate in the 
particular experiment, as correlated in the experimental section 
 
Entry 1 and 3(7) present interesting yields. These results could be due to a different 
interaction with catalyst according to the mechanism explained before. In this case position 1 
could be deactivated by the electron-withdrawing effect of CF3. As a result, this carbon 
became too electron-poor to be attacked by Pt. 3-(trifluoromethyl)aniline shows a lower yield 
which is likely due to a reduced deactivation of position 1. The effect of this substituent in 
meta allows one toobtain a carbon more prone to interact with the catalyst and, consequently, 
revealing a reasonable explanation the final result reported. 
The positive aspect of the hypothesis just proposed is to extend these considerations to the 
other substrates just explored. (Table 3.4). 
 
Table 3.4.Summary of aniline yields. 
 
Entry N°a R substituent Yield 
1 N.A o-OCH3 - 
2 5 m-OCH3 44% 
3 4 p-OCH3 11% 
4 6 p-F 55% 
aStructure number assigned to the deuterated aniline intermediate in 
the particular experiment, as correlated in the experimental section . 
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The results reported in Table 3.4 follow the guideline established before. Entry 1 presents no 
yield, maybe due to the combination of these effects. Adding to the activation on carbon 1 
made by an electron-donor group (OCH3) towards electrophilic attack, it is necessary to 
consider the hypothetical chelating effect that oxygen and nitrogen could exercise on Pt. The 
consequence is finally a stable metal complex. This last aspect cannot be found in Entry 3 (4). 
The methoxy group is so far from the amine one that any similar effect on the metal cannot 
be realized. Consequently in this case the yield is only a little bit higher. Entry 2 (5)shows the 
best result in this group. This is possibly due to a reduced effect by substituent on meta. 
Carbon 1 is less electron-rich, as a result the complex formation is more unlikely and the 
yield is considerably increased (See Scheme 3.11). Lastly, in Entry 4 (6), fluoro conjugation 
allows the increase of electro density on carbon 1. Although this element presents the same 
Hammet σ value of hydrogen (Table 2.5, Entry 3), that means a similar electronic effect on 
the aromatic ring,the final result is nevertheless slightly different (44% compared to 55%). In 
this case the elevation of the halogen electronegativity is responsible for generating the final 
balance of yield to around 50%. 
 
3.5 Nitroanilines 
 
After reaching all of these conclusions for different substituents of aniline derivatives, a 
further investigation regarding in particular the electron-withdrawing groups was necessary. 
For this purpose, nitroanilines were the last kind of such compounds to be explored.137 
 As shown below, the H/D exchanges here suggest some interesting aspects, in particular 
arising from the comparison with the result obtained before. 
 Scheme 3.22 shows the nitroanilines used and their correspondent reactions set up. 
 
Scheme 3.22. Experiments set up for nitroanilines exploration. 
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The correspondent table (Table 3.5) reassumes the results obtained and the consequent yield 
for both. 
 
Table 3.5.Summary of nitroanilines results. 
Entry N°c NO2 D1a D2a D3a D4a D5a D6a Yieldb 
1 9 Para - 93% 33% - 33% 93% 23% 
2 10 Meta - 94% - 94% 94% 94% 86% 
                  a Deuterium incorporation calculating through acetylation. 
  b
 Yield calculated through the relation on Chapter 2. 
  c Structure number assigned to the deuterated aniline intermediate in the particular experiment, as  
correlated in the experimental section      
 
In Entry 1 (9) the most relevant aspect is not linked to the distribution of deuterium, which 
respects perfectly the electrophilic aromatic substitution, butit is instead the final 
yieldrecorded. Conversely, in Entry 2(10), in addition to the good deuteration in all positions, 
the yield is considerably higher. The result just shown is consequently different from CF3 
anilines. Here in fact meta derivative seems to be the best substrate for the balance between 
yield and H/D exchange.  
 Some hypotheses also can be proposed only by comparing the results just obtained with that 
from acidic-catalyzed reactions.126 (Table 3.6). 
 
Table 3.6.Summary of nitroanilines results under acidic catalyzed conditions. 
 
Entry NO2 D1a D2a D3a D4a D5a D6a Yieldb 
1 Para - 97% 0% - 0% 97% 78% 
2 Meta - 95% - 95% 0% 95% 96% 
aDeuterium incorporation calculating through acetylation. 
bYield calculated through the relation on Chapter 2. 
 
The data shown above reflect again the electrophilic aromatic substitution ongoing. Both of 
the experiments in fact display the completely absence of any H/D exchange on their 
correspondent meta inactivated positions. The difference of deuterium incorporated between 
acidic and catalyzed reactions could be due to a continuous exchange process on activated 
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positions mediated by platinum catalyst. Hydrogen finally could replace deuterium at the end 
of this process.  
 However the most interesting aspect of these last results is represented by final yields. In 
particular a direct comparison between 9 and Entry 1 in Table 3.6 could establish the 
important role played by Pt in this case. 
 The consequent hypothesis proposed to explain this result regards mainly the effect that nitro 
group could play according to the position on the aromatic ring. 
 Considering the further presence of an amino group here, it was suggested again that an 
aromatic resonance form could explain the activation for the electrophilic attack. 
 Following the mechanism proposed for alkylation of nitroalkanes14, it was thought that a 
similar procedure could further happened for nitroaniline. 
 Starting from para-derivative, a correspondent nitro-stabilized anion could be formed 
through the conjugation of 2p orbital with the aromatic system. (Scheme 3.23). 
 
Scheme 3.23. Mechanism through which a nitro stabilized anion is formed. 
 
The anion illustrated above could activate position 4 towards any electrophilic species. 
Consequently, the platinum (IV), whose structure was already shown,could be attacked on 
this carbon according the scheme below.(Scheme 3.24). 
 
 
Scheme 3.24. Pt catalyst (IV) attacks the nitro-anion on position 4. The product obtained is quickly 
removed to reform the aromatic system. 
 
The product just obtained by the electophilic attack is removed for reforming the aromatic 
system. This could be favoured by an oxygen bond formation.(Scheme 3.25). 
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Scheme 3.25. Pt catalyst (IV) attacks the nitro-anion on position 4. The product obtained is quickly 
removed to reform the aromatic system. 
 
As already explained for 2-methoxyanilines, here a chelating action,mediated by oxygen and 
nitrogen, could entrap Pt and form a stable complex to cause consequently a reduction of the 
yield. (Table 3.5). 
 The considerations stated until now could be confirmed by the 3-nitroaniline experiment. In 
this case the result (10 in Table 3.5) shows strong differences from the correspondent para 
derivative. All the positions were highly and homogenously deuterated. An analysis of the 
conjugation process could also explain why such a result was achieved. (Scheme 3.26). 
 
 
Scheme 3.26. Resonance forms for 3-nitroaniline. Resonance number 5 is prohibited because any 
conjugation can be formed. 
 
As scheme 3.26 shows, resonance 5 is prohibited due to absence of elements of conjugation. 
As a result of this, any Pt complex could be formed according to the procedure described in 
Scheme 3.27 and consequently the yield recovered is very high (86%, Entry 2 Table 3.5). 
 
3.6 Platinum ligand 
 
All the conclusions reached in the previous paragraphs show that the platinum complexes 
represent serious problems for the aims of this project. Until now unreliable and low yields 
were obtained and a method for improving them seems necessary. 
 Another aspect also appears relevant. Nowadays, some studies are dedicated to showing the 
efficiency of deuterium-containing drugs in pharmacology and chemotherapy.138As a 
NH2
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consequence of this, the interest towards to our method for recovering deuterated compounds 
with biological and pharmaceutical activities could be reduced by the presence of toxic Pt. 
 Even though recent research was able to synthesize platinum compounds with strong anti-
tumoral activity and low toxicity139, the general knowledge that platinum can be seriously 
toxic for the human body140 is agreed. According to many studies in this field, platinum (II) 
complexes are able to bind sulfydril (SH) group of proteins and enzymes causing their 
deactivation.141 The consequences of such interactions are mainly based on nephro and 
gastrointestinal toxicity. 
 Starting from the binding between Pt(II) and a series of endegeneous thiols, such as L-
glutathione (GSH) and L-cysteine, kinetic studies were developed for establishing its 
characteristics These revealed a very intensive interaction. Hagrama et al.142 stated that this 
interaction is so intensive in human cancer cells that the bioavailability of Pt-drugs is strongly 
reduced as well as its chemotherapeutic effect. Petrovic et al.143-144were also able to 
investigate the main aspects of this interaction according to kinetic and nucleophilic studies. 
Furthermore, the size of thiol used was addressed as fundamental. Due to steric effect, big 
ligands of this kind were unable to attack Pt. 
 For this reason, thioglycolic acid was chosen as thiol derivatives to explore. As nucleophilic 
ligand with consequently a strong affinity towards Pt, the molecule could be also seen as a 
way to entrap the metal (Scheme 3.27). 
 
 
 
Scheme 3.27.Nucleophilic attack by thioglycolic acid. The following basification allows the left 
the metal compex in aqueous solution. 
 
Pt shows a strong affinity towards sulphur. As a result of substitution reaction, R is got 
replaced by thiol.In particular, as Scheme 3.27 shows, aniline derivatives could be recovered 
from the work up through an appropriate basification (DCM). 
Such considerations are valid for Pt (II). It was assumed in previous pages of this chapter that 
[Pt(Cl)4]2-, the anionic species from the correspondent potassium salt, could be react with  
DCl according to the scheme below. (Scheme 3.28). 
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Scheme 3.28. Oxidative addition reaction set up through DCl. The excess of acid could increase the 
number of oxidation (+2) of most of catalytic molecules and avoid the black platinum precipitation. 
 
According to Scheme 3.28, the Pt(IV) complex obtained could avoid black platinum 
precipitation. The high excess of acid could be able to oxidate all Pt(II) species present in 
solution. The species just formed should also not be able to disproportion and thus, to 
produce Pt(0). 
 Moreover many kinetic studies stated that this complex Pt(IV) performs slower reactions, 
such as ligand substitution, than the correspondent Pt(II).145 According to Elding et al.146 thiol 
groups are directly involved in reductive process from Pt(IV) to Pt(II). So, as a reductive 
agent, thioglycolic acid could play another additive role. The double effect of this compound 
for the aims of the projectwas considered relevant. A direct quenching at the end of reaction 
and a strong effect with a reasonable excess of thiol (4 equivalent, referred to catalytic 
amount) could guarantee the removal of Pt(II) from the aqueous solution. 
 As already stated in the last chapter, black Platinum (0) could precipitate as a result of 
disproportionate process among two [PtCl4]2-catalytic molecules.(Scheme 3.29). 
 
 
Scheme 3.29.Dismutative process among the catalytical molecules. The final products are black 
platinum and [Pt(IV)(Cl)6]2-. 
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3.7 3-Chloroanilines 
 
In order to quantify Pt0 present in our aqueous solution, we decided to control its amount by 
atomic absorption spectrometry, probably the most common technique to evaluate the 
concentration of metals in solution. In Table 3.7 are shown the absorbance for precise 
amounts of Pt0 concentrations, evaluated with a calibration curve. 
However, the core of our experiment was to calculate the correspondingabsorbance value for 
3-chloroaniline. This substrate was chosen for investigating the effect of thioglycolic acid in 
removing the metal. Table 3.7 describes the characteristics of this final trial. 
Table 3.7.Absorbance (abs) results for two 3-chloroaniline. 
 
Entry N°a Thioglycolic acid Abs ppm µg Yield 
1 1 Yes 0.025 52 15 96% 
2 N.A No 0.069 230 66 95% 
  aStructure number assigned to the deuterated aniline intermediate in the particular 
experiment, as correlated in the experimental section      
 
 
The absorbances consequently recovered for both of these two experiments and the 
correspondent ppm values, permit to know the amount of Pt inside. Even though in Entry 2 
the platinum recorded is already low enough for not representing a serious problem for the 
reliability of the yield, the data reported in Table 3.12 show without any doubt the strong 
efficiency of thioglycolic acid in removing this metal. 
 
3.8 Chloroanilines 
 
The results obtained for 3-chloroaniline inevitably focused the interest towards all the other 
substrates of this series. The data obtained are summarized in Table 3.8. 
Unfortunately, because of lack of time in the last part of the project, we have not been able to 
apply such method of the platinum elimination excess with to the previously synthesised 
deuterated products. The comparison between p-chloro and p-fluoroaniline results, would 
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have been especially meaningful but, anyway, in the next chapters we will demonstrate the 
usefulness of this method with a number of other different substrates. 
 
Table 3.8 Summary of chloroanilines substrates. 
 
Entry N°c Cl
 
D1a D2a D3a D4a D5a D6a Yieldb 
1 11 Para - 95% 41% - 95% 41% 86% 
2 1 Meta - 94% - 94% 94% 94% 96% 
3 12 Ortho - - 32% 92% 92% 92% 92% 
                aDeuterium incorporation calculating through acetylation. 
                 bYield calculated through the relation on Chapter 2. 
     cStructure number assigned to the deuterated aniline intermediate in the particular experiment, as 
correlated in the experimental 
 
3.9 Conclusions 
 
 A first set of molecules was investigated by the method validated in Chapter 2. For this 
purpose aniline derivatives were chosen for the fact they have a large application on drug 
synthesis. However many difficulties arose during these tests, in particular during the yield 
recording. A valid explanation was advanced to try to justify every single experiment. So 
interactions between platinum catalyst and different aniline substrates were suggested. Such 
interactions can change quite differently according to the chemical and electronic properties 
of the compound explored. In 4-(trifluoromethyl)anilines case an unexpected product was 
obtained. Explanations which were suggested to clarify this process were shown to be quite 
reasonable. One in particular was confirmed by both the results of the acidic catalyzed and 2-
(trifluoromethyl)anilines. In order to avoid any doubt regarding the yields’ reliability, a Pt 
concentration was monitored by atomic absorption spectroscopy. The data obtained 
confirmed the purity of deuterium compound recovered and consequently the reproducibility 
of our method to many other substrates 
 
 
 
Chapter 3: New aromatic substrates for H/D exchange 
 
- 69 - 
 
4.1 Introduction                                          
4.2 Garnett’s H/D exchange mechanism 
4.3 Pt(II)/Pt(IV) redox cycle 
4.4 Methylanilines 
4.5 Ethylanilines 
4.6 Propylanilines 
4.7 Butylanilines 
4.8 1-Phenylpiperazine 
4.9 Conclusion
 
 
 
 
 
4.1 Introduction 
 
In the last chapter, a report of the initial H/D exchange results was presented. Some 
considerations of Pt-interactions and metal-complex formations were also faced. However, 
the conclusions recovered were useful for explaining yields rather than suggesting 
mechanistic H/D process. For this reason, in view of the results reported in previous chapters 
and in comparison with the corresponding acid catalyzed trials, a study of Pt role in H/D 
exchange was considered crucial. Although in the last chapter some mechanistic aspects were 
offered, here this part they will be expanded. Following bibliographic research147 and the 
experimental data recovered a theoretical mechanism will be proposed. Additionally, a set of 
new anilines will be explored. In accordance with Garnett’s studies on effective substrates, 
alkyl-derivatives will be used. Subsequently, a considerable evaluation of Pt mediated H/D 
exchanges both on the aromatic rings and on the alkyl chains will be established.  
 
4.2 Garnett’s H/D exchange mechanism 
 
In Chapter 2 Garnett’s studies have been considered as the key reference for this project. In 
order to propose a reliable H/D mechanistic exchange, his results have been meticulously 
studied. However, in light of the results recovered during this project, some further 
considerations have been introduced. This will be seen later when this conclusion are adapted 
to a hypothetical H/D exchange mechanism on the alkyl chain.  
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 In 1971, Garnett published a review148 where platinum was classified as an important metal 
for regulating H/D exchange. However, classical associative and dissociative mechanisms 
already described in Chapter 1 (Scheme 1.4) showed some unclear points for explaining H/D 
aromatic exchange. In particular, relevant chemical considerations, such as ionisation 
potential and delocalised systems, resulted in Garnett’s new alternative research. Since no 
loss of energy resonance was recorded, associative context was also excluded from playing a 
relevant role in this process. Garnett and Hodges149 also established the important role played 
by delocalized molecular orbitals in this process. Finally, introducing a pi-complex concept 
where pi- electrons were preserved. (Scheme 4.1). 
 
 
 
Scheme 4.1.Associative pi-complex and classical associative intermediates. The arrow in pi-complex 
indicates the net charge flow. 
 
In this particular case, C-H is considered a double-electron donor while the metal an acceptor 
through its empty d orbitals. Even though this definition usually referred to metal-alkyl H/D 
exchanges, some interesting aspects could be moved to the aromatic context. Due to pi-
electron-rich cloud and the metal empty orbitals, a pi-intermediate was considered reliable. As 
will be considered later, the formation of such a complex could be also explained in terms of 
bonding orbital overlapping. Consequently, the complex shows a net charge flow in direction 
of the metal.  
 
4.3 Pt(II)/Pt(IV) redox cycle 
 
Platinum tetrachloride anion [Pt(Cl)4]2- appears to be a stable species in an aqueous solution. 
Like most of d8 transition metal complexes, this species is characterized by one typical square 
planar conformation, which also becomes extremely stable through geometrical and steric 
factors. Moreover, according to the corresponding electronic configuration, platinum is 
surrounded by only 16 electrons. In contrast to the 18 electron rule which is valid for most of 
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the transition metals, the catalytic species explored here shows a considerable stability toward 
this oxidation state. Lastly, as mentioned above, the empty orbital bondings available here are 
responsible for pi-electrons overlapping and the corresponding pi-complex formation. 
However, under the strong acidic conditions set up for the experiments, one of these empty 
orbitals could fill in through oxidative addition reaction, whose general aspects were already 
highlighted in Chapter 2. (Scheme 4.2). 
 
 
 
Scheme 4.2.Oxidative addition’s scheme. At the centre of platinum tetrachloride an empty d orbital 
is reported where DCl attacks. 
 
The final product of this process is a Pt(IV) octahedral complex. As explained in Chapter 3, 
this species is likely to not reduce Pt2+ to Pt0. Despite the acidic excess, some traces of 
original Pt tetrachloride could still be reasonably present in solution. According to Garnett’s 
considerations, this catalyst could still regulate the H/D process. So, as will be explained 
shortly, the general mechanism could be seen as a consequence of Pt(II)/Pt(IV) redox 
cycle.150-151 
In order to clarify the hypothetical H/D mechanism on the aromatic ring, aniline has been 
chosen as the best initial substrate. As a first step of this investigation, this compound was 
able to exclude all substituent influences from these processes. 
During his research, Garnett was able to establish that activating and deactivating substituents 
on the aromatic ring did not influence the rate of exchange. This was later confirmed by the 
work of Kanski and Kanska.152-153Ultimately, this aspect was also coherent with a 
dissociative mechanims for platinum as already discussed in Chapter 1. Thus, after having 
joined this last consideration to the pi-complex concept, a new mechanism was subsequently 
proposed. (Scheme 4.3). 
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Scheme 4.3.Dissociative mechanism with a reversible pi-σ conversion. 
 
The scheme above describes the main aspects of H/D process proposed by Garnett. In 
addition, he also suggested a mechanism where Pt(II) was the only metallic species involved 
(scheme 4.4).  
 
 
Scheme 4.4.General description of the hypothetical H/D aromatic exchange mechanism where Pt 
(II) played a significant role in the process. As shown, the process is also based on only pi-bond. 
 
As will be discussed later, the mechanism on Scheme 4.3 was particularly adaptable for the 
alkyl chain experimental data. Moreover, as is shown, the processes in both Scheme 4.3 and 
4.4 ultimately cause one σ-bond between Pt and phenyl ring. This final metal intermediate 
seems to be one of the best explanations for multiple H/D exchanges, which assumes that 
every hydrocarbon undergoes a continuous series of such exchanges during the reaction time. 
Specifically, H/D exchange could occur as a result of carbon activation mediated by Pt. In 
conclusion, this mechanism seems to be based on a reversible C-H bond-cleavage and C-D 
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bond-formation which occurs when the hydrocarbon molecule is on the coordination sphere 
of Pt.154 
 
4.4 Methylanilines 
 
4.4.1 Aromatic H/D exchange 
 
As established in the introduction of this chapter, alkylanilines represent the best substrates 
for alkyl H/D exchange mechanism. At the beginning of this investigation a series of 
methylaniline derivatives was chosen because of their small side chain. (Scheme 4.5). 
 
Table 4.1 Methylanilines deuterations results. 
 
Entry N°c -CH3 D1a D2a D3a D4a D5a D6a CD3a Yieldb 
1 13 Para - 94% 63% - 63% 94% 92% 85% 
2 14 Meta - 89% - 89% 46% 91% 45% 97% 
3 15 Ortho - - 46% 92% 93% 91% 77% 85% 
   aDeuterium incorporation calculating through acetylation. 
   bYield calculated through the relation on Chapter 2. 
   cStructure number assigned to the deuterated aniline intermediate in the particular experiment, as correlated in 
the experimental section      
 
Table 4.1 reports the relevant results both for the deuteration levels and for the yields. The 
interesting difference between D2 and D3 in Entry 1 (13) is due to the stronger influence that 
amino group played on the aromatic electronic density distribution. However, the consistent 
level of deuterium recorded on D3 can only be explained by the inductive electron-donor 
effect of methyl group on this position. While, in Entry 2(14) the H/D exchanges respect 
uniformly the electrophilic aromatic substitution rules. Here, D5 carbon is strongly 
deactivated by the contributions of both substituents.  
The most pertinent aspect in this set of experiments regards the data in Entry 3 (15). D3 
position shows very low deuterium incorporation (46%). This value is clearly contrasting 
with the opposite D5 where the H/D exchange is instead successfully high. Considering that 
both receive the same electronic activation, other factors must be involved. Naturally, the 
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attention was directed towards steric aspects. Starting from this, Garnett introduced the 
specific concept of ortho steric effect.148 Following the mechanistic scheme in 4.3, Pt, and in 
particular Pt(IV) , which is undoubtedly the most sizeable platinum species involved, could 
face relevant difficulties in introducing itself in D3. In the light of H/D results in D5, this 
catalyst further confirms its efficiency to work on both activated and deactivated aromatic 
positions. Accordingly, ortho steric effect remains the single factor responsible for the low 
percentage of deuteration in D3. This aspect will be investigated in the next experiments 
when larger alkyl chains will be used. Lastly, this conclusion also highlights another relevant 
point. The shifting movement on the aromatic ring could cause the catalyst to interact with its 
substituents. Therefore, some aspects of this interaction will be faced in the next pages and a 
H/D mechanism for the corresponding alkyl chain then proposed. 
 
4.4.2 Methyl H/D exchange 
 
After having seen the results in Table 4.1, a further mechanistic investigation is necessary. 
The ortho steric effect is not the only aspect to arise from these experiments. The different 
percentages of deuteration recorded for the methyl groups are also significant. In order to 
summarize the results from this new point, a summary of deuterium incorporations was 
reported. (Table 4.2). 
 
Table 4.2 Summary of methyl exchange for methylanilines. 
Entry N°a -CH3 CD3 
1 13 Para 92% 
2 14 Meta 45% 
3 15 Ortho 77% 
aStructure number assigned to the deuterated aniline 
intermediate in the particular experiment, as 
correlated in the experimental 
 
Garnett et al.63 were able to establish that H/D mechanism exchanges on alkyl chain showed 
common aspects with the aromatic context. Furthermore, they observed that alkyl chains on 
alkylbenzenes were more reactive than the corresponding saturated aliphatic ones. The easiest 
explanation could be the pi-electronic cloud presence which could activate the alkyl chain 
through a conjugation and hyperconjugation process. For this reason, they proposed an 
alternative alkyl dissociative pi-complex in competion with that one in Scheme 4.3. This 
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mechanism deserves a clear description. In particular, for this aim a η3-allylplatinum complex 
as intermediate needs to be introduced. As Khusnutdinova et al.155 have established, these 
complexes are generally formed as a consequence of an allylic C-H deprotonation. 
Coherently with what was assumed in scheme 4.3 the process could be characterized by a 
hydride migration. Since the Pt acts as an electrophilic species, hydride could be in fact 
forced to move in the direction of the metal, forming here a σ-bond. Although in the allylic 
metal complex studies where both cyclic and acyclic unsaturated systems were often 
investigated, aromatic rings were never considered as valid substrates. For this reason, the 
relevant work developed by Driver et al.156was fundamental for expanding this aspect to the 
aromatic context. After highlighting once again the importance of pi electrons on activating 
the aliphatic hydrogen, they thought that the key to this process was based on a reversible 
equilibrium between a pi-arene complex and a pi-allylic one.(Scheme 4.5). 
 
 
 
Scheme 4.5.Mechanism for methyl H/D exchange. The equilibrium between pi-arene and pi-allylic 
complex is shown. 
 
For the current purpose, the behaviour of platinum towards the methyl group needs to be 
specified. In the η3-allylic complex, Pt (II) has been synthetically transformed in Pt (IV) by 
DCl addition. However, this process could appear to be more complicated than actually 
described. For this reason, many studies were developed in order to define this aspect. 
Garnett and Hodges149, 157 suggested that a σ-complex could be involved, whereas other 
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research elaborated on different conclusions. In particular, Shestakov et al.158 gave an 
important contribution in the understanding of such interactions. Their research reports an 
interesting explanation about H/D exchange on alky chain. The core of their conclusions is 
based on the presence of C-H....Pt bond, through which deuterium can be introduced in the 
methyl group. (Scheme 4.6). 
 
Scheme 4.6.General description of H/D exchange on methyl group for 2-methylaniline. The 
hydrogen bond and the corresponding Pt three membered cyclic intermediate are reported. 
 
Such interaction is favoured on Pt(II) complex159, where apparently an empty d orbital metal 
can act as a hydrogen-bond acceptor. This interaction could direct platinum towards methylic 
carbon instead of toward the aromatic one. As previously described, ortho steric effect on the 
aromatic ring gives an important contribution to direct the result toward this direction. In 
addition, the electronic activation could play a relevant role. After having formed a σ-bond 
here, Albinati et al.160suggest that the system could be considered as a two electrons three-
centre bond (see Scheme 4.6). The consequent C-H activation could finally favour the 
exchange here and concertedly bring back Pt (IV) to Pt (II). 
 The process on the methyl group just described could be repeated cyclically until the 
deuterium incorporation reported in Table 4.2 is reached. 
Lastly, considerations regarding H/D exchange on methyl group according to its aromatic 
position are necessary. In view of the process described in Scheme 4.6 and the results 
reported in Table 4.2, the different allyl intermediate stability seems to play a key role. In 
Scheme 4.7 these different stabilities have been shown. It appears evident that ortho and para 
methyl substituted species can form corresponding, more stable allylic system than 
metaanalogues. As a consequence of this, kinetic and energetic parameters could undoubtedly 
favour methyl H/D exchange on ortho and para positions.  
Chapter 4: Alkylanilines for H/D exchange 
 
- 77 - 
 
 
Scheme 4.7.Methylanilines allyl intermediates.Ortho and para have the opportunity to delocalize 
the positive charge better than meta. 
 
4.5 Ethylanilines 
 
4.5.1 Aromatic H/D exchange 
 
An investigation of a new set of compounds was essential for accumulating further 
experimental data. In order to confirm the theoretical mechanisms described until now. So, 
being the natural sequence of methylanilines, because of only one carbon more present in 
their alkyl chain, ethylanilines were consequently explored. (Table 4.3). 
Table 4.3 Ethylanilines deuterations results 
 
Entry Noc -Et
 
D1a D2a D3a D4a D5a D6a CD2a CD3 Yieldb 
1 16 Para - 87% 65% - 65% 87% 91% 92% 56% 
2 17 Meta - 92% - 92% 92% 92% 89% 90% 81% 
3 18 Ortho - - 23% 92% 92% 92% 82% 92% 75% 
a
 Deuterium incorporation calculating through acetylation. 
b
 Yield calculated through the relation in Chapter 2. 
cStructure number assigned to the deuterated aniline intermediate in the particular experiment, as  
correlated in the experimental 
 
As is shown, the ethyl chain has been fully deuterated in all the experiments set up.  
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In Entry 1(16), D2 and D6 show exchange percentages slightly lower than the other 
substrates. As already mentioned in previous chapters, in the most active positions a further 
exchange process could have occurred and have replaced hydrogen instead of the 
corresponding isotope. However, alternative explanation could be proposed. Although here 
the activation by amino group is relevant, the competitive inductive effect by ethyl group 
could have caused an incomplete activation for these positions. 
D3 and D5 results are indicative of this. The aromatic deuterium incorporation could once 
again be a direct consequence of strong competition between these two substituents. 
Therefore, the final electron activation could explain the final H/D exchange.The same 
consideration could be proposed in Entry 2 (17) for D5. Despite these substituents being on 
meta relationship, exchange results are as equally activated as the others. Therefore, the 
deuterium exchanged here is considerably high. One possible explanation could be connected 
with the mechanism proposed previously (Scheme 4.3). Furthermore, Pt could be easily 
exchanged here due to the fact that any important steric hindrances are present.  
As already established in methyl H/D exchange, the steric contribution in such a mechanism 
is strongly relevant. In this set of trials more evidence of this aspect was observed. In 
particular, in Entry 3 (18), D3 position shows a level of deuterium surprisingly lower than in 
the corresponding methyl experiment. (23% against 46%, Entry 3, Table 4.1). 
 
4.5.2 Ethyl chain H/D exchange 
 
The H/D exchange mechanism on the methyl chain described in the last paragraph could be 
further expanded here. In each of the three experiments, ethyl chain shows high deuterium 
incorporation. In order to summarize the results obtained Table 4.4 illustrates this exchange. 
Since some slight differences amongst each entry are observed, some considerations will be 
offered in this section.  
 
Table 4.4 Summary of ethyl exchange for methylanilines. 
Entry Noa -Et
 
CD2 CD3 
1 16 Para 91% 92% 
2 17 Meta 89% 90% 
3 18 Ortho 82% 93% 
aStructure number assigned to the deuterated aniline 
intermediate in the particular experiment, as correlated in 
the experimental section. 
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So the suggestions reported by Garnett and Hodges115, 157, 161 during the 60s and 70s need to 
be expanded in the light of new organometallic discoveries. 
Mustafin et al.162-164have studied the initial asymmetric deuterium distribution on the two 
ethyl carbons. In particular, they focused their attention on Pt-H shifting on this alkyl chain. 
Their kinetic studies on how hydrogen can move from carbon to platinum shows interesting 
conclusion. Overall, they established that the 1,2 shifting process could occur more slowly 
than Pt dissociation or 1,1 shifting process itself.  
Although Flood165 and later, Jones166were able to investigate this deuterium migration aspect 
on rhodium (Rh) catalysis, only few recent examples in the literature offer the chance to 
investigate the Pt context.  
Initially it was thought that Pt (II) and Pt (IV) spatial conformations could bring chloro 
ligands and ethyl hydrogen closer. Furthermore, due to the drastic conditions inside the 
microwave, hydrochloric acid could be eliminated. Subsequently, a new three-member cyclic 
intermediate could then be formed (Scheme 4.10). Although mechanisms like this are 
reported in literature mainly for Pt (II) 167, it is also reasonable to suggest that it could occur 
for Pt (IV) as well. So, DCl addition could play a key role. As a consequence of 
conformational changing, the chloro ligands could be in the right position for interacting with 
the alkyl hydrogens.  
After the cyclic intermediate formation, deuterion (D+) could move to the ethyl chain 
according to two possible directions. The favourite orientation could be determined by steric 
factors, establishing the final distribution of deuterium. In Scheme 4.8 a specific description 
of ethyl context is provided. As shown in Table 4.4, deuterium is y incorporated on this chain 
in all of the molecules explored. The steric aspect is maybe not so relevant for 3 and 4 
ethylanilines. The importance of the steric factor instead becomes relevant for the 2-
ethylaniline result. As previously mentioned, the final exchange could be directly connected 
with the amine group present beside. Because of this obstacle, the D+ attack on carbon 1 is 
undoubtedly favourable. In this way Pt(II) complex is shifted on carbon 2 and free to carry on 
the exchange. As a result of this mechanism, the percentage in this last position is slightly 
higher than the first one. 
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Scheme 4.8. Initial mechanism proposed. Two possible orientations are present in Pt-cyclic 
intermediate. Both attacks can cause H/D exchange on carbon 1 and carbon 2. 
 
However, the proposed H/D methyl chain exchange in the last paragraphs could represent a 
good referential point for a reasonable and logical application on the ethyl group. For this 
reason, another mechanism has been coherently considered. Once again, Driver et al.156 
contributed greatly to these studies. After they established that Pt interaction starts through pi-
electronic cloud, they proposed a mechanism substantially suitable for the results 
reportedhere. In order to justify the particular deuterium distribution, they noted that specific 
alkyl chain conformation could play a key role. (Scheme 4.9). 
 
 
Scheme 4.9.General description of ethylic chain H/D exchange. The particular conformation of ethyl 
chain could allow hydride on CH3 to interact with the catalyst and then to form a subsequent allyl system. 
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Following what was assumed before and synthesized in Scheme 4.6, a C-H interaction with 
the catalyst could cause a hydride migration from CH3. As a consequence of this, a η2-pi- 
complex is obtained (A). Due to its conjugation with the aromatic ring, this system could be 
energetically favoured. In addition, as a consequence of steric reasons explained in Scheme 
4.7, deuterium could be introduced in ethyl CH3 allowing a subsequent allyl system to be 
formed (B). Then the process could follow the pathway described for methylaniline context.  
Furthermore, the lowest deuterium incorporation in 18 D3 (23%, Table 4.3) could be 
explained one more time in terms of an increasing ortho steric effect as a consequence of a 
larger alkyl chain.  
As is clear from Table.4.4, deuterium distribution is homogeneous on the ethyl chain. 
Although in 18 methylene (CH2) has been exchanged less than methyl due, probably, again to 
steric reasons, deuterium distribution generally shows no particular differences between these 
two carbons. As possible explanation, a competition between CH2 and CH3 could occur. As 
will be seen later, two different allyl intermediates could be formed resulting in two different 
H/D exchange on this alkyl chain. This aspect could be also clarified by Collman et 
al.168studies.Here a certain tendency of forming the most hindered η3-allylmetal chloride 
intermediate is established. As a consequence of this, it is reasonable to assumethat a 
competition could occur providing the explanation of the homogeneous deuterium 
distribution on the ethyl chain. Finally, any relevant differences are also recorded for the 
ethyl chain on different aromatic positions. The most reasonable explanation could be in 
replacing hydrogen with methyl group, the corresponding allyl intermediates could be more 
stable than that of the methyl context. So, as a result of more important inductive electron 
donor effect, the considerations reported in Scheme 4.8 are not so relevant in this case. 
 
4.6  Propylanilines 
 
The considerations described above enable us to expand the proposed mechanism to a further 
series of alkylanilines. For this purpose, propylanilines were considered the natural follow up 
of ethylanilines. In the light of steric conclusions reached before, a proper substituent in 2 
position was chosen. In order to create the maximum hindrance, 2-isopropylaniline was 
explored. (Scheme 4.10) Later, n-propyl chain will also be investigated and useful 
considerations will be finally recovered from these results. In addition, such results will show 
a sound consistency towards the mechanism until now described.  
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Scheme 4.10. H/D exchange results for 2-isopropylaniline. 
 
The data recorded in this first experiment confirm a certain correlation between alkyl size and 
Pt activity. In Table 4.6 a summary of the H/D exchange in D3 is reported. So, it is initially 
evident that the level of deuterium introduced here is reduced proportionally with the size of 
the alkyl chain. From this table it appears quite clear that steric effect has a strong influence 
on such general processes. 
 
Table 4.5.Summary of D3 exchanged for 2-alkyl-substitued-anilines. 
 
aStructure number assigned to the deuterated aniline 
intermediate in the particular experiment, as correlated in the 
experimental section      
 
Additionally, it is relevant to present some mechanistic considerations about isopropyl H/D 
exchange. After having considered the structural similarities with ethyl chain, a similar 
process has been proposed. In Scheme 4.11, a mechanism has been drawn according to the 
guidelines already defined in Scheme 4.5 and 4.9. 
Entry Noa 2-Alkyl-substituent
 
D3 
1 15 Me 46% 
2 18 Ethyl 23% 
3 19 Isopropyl 6% 
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Scheme 4.11.Scheme of H/D exchange on 2-isopropyl chain. . 
 
In particular, here D7 shows very low deuterium incorporation. Furthermore, as a 
consequence of a free rotation process, both of two methyl groups (8 and 9 in scheme 4.12) 
on the isopropyilic chain could attain an identical steric influence by the amino group. 
Therefore, both of these positions are finally, equally involved in the H/D exchange. As 
shown in Scheme 4.13, isopropyl chain can be thought of as an ethyl chain, where one 
hydrogen was replaced by a methyl group. As a result of this, the consequent general system 
became more hindering. This effect results in a very low percentage of deuterium 
incorporation in D3 position (6%). Similar considerations could be also proposed for D7 
(28%). In conclusion, it appears that space is a fundamental aspect for catalyst to attack the 
alkyl chain.  
Then it was decided to explore 4-propyl substrates. Here iso and normal propyl groups 
(Scheme 4.14 and 4.15) were also investigated. As will be treated in the next pages, these two 
compounds gave the opportunities to study the contribution that steric and electronic-donor 
inductive effect have on the H/D exchange.  
The results for 4-isopropylaniline were reported in Scheme 4.14. 
Chapter 4: Alkylanilines for H/D exchange 
 
- 84 - 
 
 
Scheme 4.12.Scheme of H/D exchange on 4-isopropylaniline. 
 
Below 4-n-propylaniline H/D exchange is reported. (Scheme 4.13). 
 
 
Scheme 4.13.General scheme of H/D exchange on 4-n-propylaniline. 
 
Many considerations can be claimed from these two experiments.  
Firstly, the H/D exchange on D3 and D5 positions. Although the two positions should reveal 
the same electron activation in both experiments, the deuterium incorporation is significantly 
different. It is also interesting that the most bulky isopropyl species displays the highest level 
of deuterium on it. Since these two alkyl groups have similar chemical properties, it was not 
logical to propose a different electronic activation here. So, reasonably, this aspect could be 
explained in terms of their specific alkyl conformation. It was thought that in n-propyl case, a 
methyl group could get closer to the aromatic D3 and D5 positions than to the isopropyl one. 
Thus, the exchange in the normal chain could be more favoured than to the iso one. (Scheme 
4.14). So, spatial availability could be again a relevant factor to explain this aspect. In 
addition, in both of these cases, deuterium will be subtracted from D3 and D5 positions in the 
aromatic ring.  
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Scheme 4.14. Different alkyl conformation could allow a different catalytic interaction. 
 
In order to explain the particular deuterium distribution on n-propyl chain, where deuterium 
has been mainly exchanged on D7 and D9 positions, another alternative mechanism has been 
considered. This mechanism could be identical with what is assumed in the ethyl context. 
There, referring to a competion between CH2 and CH3 in allyl intermediate formation. So, 
although methylene species are less reactive in forming allyl system than methyl group168, 
one of their hydrogens could nevertheless be close enough to the catalyst to create 
competition with CH3 group. (Scheme 4.15). 
 
 
Scheme 4.15.Scheme to show the hypothetical mechanism for deuterating the propyl chain. 
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Following this description, D8 could undergo a similar exchange. However, the steric 
hindrance could reduce the H/D efficiency here causing the final result reported in Scheme 
4.13 (72% against 80% in D7and 86% in D9). 
As will be revealed in the next paragraph, this mechanism could be in part confirmed by the 
kinetic studies already developed in Chapter 2. Although in this case n-butylaniline was the 
subject of that investigation, the results recovered there were linear with that one reported 
here. In particular, it was relevant to observe that in both of these cases the internal alkyl 
positions were less deuterated than the external ones. 
 
4.7 Butylanilines 
 
The conclusions achieved until now give a substantial understanding of the hypothetical 
mechanisms involved in H/D exchange. The next set of experiments should further confirm 
this knowledge. However, due to cost and time limitations, the range of these compounds has 
been restricted. Only two species of 4-butylanilines were investigated in this attempt.  
In order to expand the considerations on 4-n-propylaniline, 4-n-butylaniline was undoubtedly 
very helpful. The results for this substrates show a perfect linearity with the data recovered 
until now (Scheme 4.16). 
 
Scheme 4.16.Scheme of H/D exchange mechanism on 4-n-butylaniline. 
 
Remarkably, the deuterium incorporation in D3 and D5 is identical to that one in 4-isopropyl 
context. (Scheme 4.14). As discussed there, the alkyl conformation could once again play a 
key role. However, it was thought that the major size of this chain could create some 
difficulties for methyl group in D10 to interact with the catalyst. Otherwise, the electron-
donor action could also expand the influence to the ortho aromatic positions. Due to this 
strong competition, the exchange in D3 and in D5 could be expected similar to n- 
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propylaniline context.(Scheme 4.13).In order to reach aaccurate conclusion, it was relevant to 
investigate the particular deuterium distribution on this alkyl chain. Differently from the other 
experiments, here D7 is more deuterated than D10. Once again, one of the most reasonable 
explanations could be a strong competition between the two intermediates reported in 
Scheme 4.17. 
 
Scheme 4.17. Two intermediates forming. As a result of steric hindering, the structure on the left is 
favoured. 
 
 
As proof of this tendency to arise from kinetic experiments. As already discussed in Chapter 
2, H/D exchange in 2 n-butylanilinewas already investigated. An experiment with different 
reaction times has been set up (Table 2.7). So, after 2’, D7 was more deuterated than D10 
(7% against 6%) showing that the corresponding intermediate (on the left in Scheme 4.17) 
could be maybe kinetically favoured. Therefore, this set of experiments confirms that this 
process starts definitely from the aromatic ring (all these positions are in fact deuterated first). 
The increase of time also allows η2-pi-intermediate favouring H/D exchange in D10 to 
stabilize. So, the interaction of methyl group in pi-platinum complex could be relevant. As 
shown in Table 2.7, deuterium incorporation passes from 91% at 105’ to 82% due to a 
reverse exchange which again introduces hydrogen. In conclusion, methyl group in D10 
appears to be still directly involved in H/D exchange. Furthermore, in the light of the results 
in D3 and D5, it is reasonable to think that deuterium incorporation here depends strongly on 
the inductive electron donor effect mediated by n-butyl chain.  
Lastly, 4-tert-butylaniline was also a good point for other relevant considerations. In 
particular, the tert-butyl chain can confirm the mechanism proposed. In the absence of 
hydrogen for forming a conjugated system, the eventual alkyl H/D exchange could be due to 
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a regular catalyst shifting from D5/D3 to D7/D9. Although Scheme 4.18 shows a 
homogeneous deuterium distribution in all CH3 of tert-butyl chain, in the light of what 
assumed above, deuterium could only be drawn in D7 and D9 position as described in 
Scheme 4.19. 
 
 
Scheme 4.18. Description of H/D exchange results for 4-tert-butyl-aniline. 
 
 
Scheme 4.19.Hypothetical mechanism for deuterating D7 and D9 positions. 
 
In conclusion, steric effect in combination with tert-butyl chain electron donor could be 
responsible for the low deuterium level in D3 and D5.  
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4.8 1-Phenylpiperazine 
 
The last experiment gave the opportunity to further expand this investigation. 1-
Phenylpiperazine was chosen for a new particular branch of studies. In certain aspects, this 
substrate respects many 4-tert-butylaniline characteristics. Although a quaternary carbon was 
replaced by a tertiary amine, the absence of hydrogen confirms once again its importance in 
the general H/D alkyl exchange. However, the context here is appreciably different because 
of the presence of one heteroatom between aromatic ring and alkyl chain.  
The results recorded for this final experiment were fundamental for establishing accurate 
conclusions. (Scheme 4.20). 
 
 
Scheme 4.20. Description of H/D exchange results for 1-phenylpiperazine. 
 
D5/D3 positions show a considerable lower deuterium incorporation than compound 2a. As a 
reasonable explanation, piperazine could have a stronger electron donor effect than amine. 
So, ortho/para positions could receive a more relevant activation than meta. 
However, the most interesting consideration concerns the pi-allyl system formation proposed 
until now. Since this intermediate seems difficult to form, no H/D exchange is observed in 
piperazine moiety. Perhaps the extreme acidic conditions could result in nitrogen protonation.  
In view of the results obtained until now, it is also necessary to expand some considerations 
already made in Chapter 3. Although in that case hetero-complex formation mediated by 
Pt(IV) was noted, we reached similar conclusions. In both case in fact, the metal is not 
allowed to move further on the alkyl chain. In particular, in methoxyaniline context, it was 
shown that methyl group could not be exchanged at all. As a possible explanation, oxygen 
could be protonated as well, forbidding the formation of any pi-allyl system.  
In conclusion, both of these processes could equally take part during the H/D exchange. 
Amino and methoxygroup could in fact act as nucleophile/base causing complex/acid 
conjugation species formation.  
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4.9 Conclusions 
 
Through a series of bibliographic and experimental data, an initial H/D aromatic and alkyl 
exchange mechanism was studied and then proposed. Starting from a set of methylanilines, 
this mechanism was then successfully applied to a progressive series of alkylaniline 
derivatives. These final results were also able to highlight new aspects of H/D exchange. In 
particular it was established that steric hindrance strongly influenced the deuterium 
distribution. While an equilibrium between Pt(IV)/Pt(II) was presumed to be the key species 
in the validated conditions, the pi-complex was also a fundamental part involved in such a 
process. Additionally, a proposed allyl intermediate was suggested. The existence of this 
species was then directly linked to hydride replacement on the corresponding alkyl chains. 
In the end, it was fundamental to highlight that the process studied above could have its 
natural application to many different substrates, including the ones already described. So, the 
conclusions achieved here will be generally and synthetically recalled in the next chapters 
where they will be related to the specific contextual considerations of the other compounds 
explored there. 
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5.1 Introduction 
 
In this chapter heterocyclic molecules will be explored. It was considered fundamental to 
validate our method on this new set of molecules. Nowadays their presence in pharmaceutical 
drugs is commonplace and obviously their synthesis169 is correspondingly quite developed. 
As a consequence, this type of compounds seem to be particularly relevant for the aims of 
this project. However, the different reactivity of heterocyclic compounds towards 
electrophilic aromatic substitution meant that the method for analyzing the labelled 
compounds described previously needed to be changed. In addition, the H/D mechanisms 
described in Chapter 4 will be directly applied here.  
As explained in Chapter 2, acetylation was a fundamental process to enable the precise 
deuterium incorporation in all structural positions to be recovered. However, the reaction 
defined in Chapter 2 was no longer considered suitable for the heterocyclic substrates to be 
investigated here. Furthermore, as will be explained during the development of this chapter, 
steric and electronic parameters could influence the reactivity of every specific molecule 
explored differently. Consequently, in some cases appropriate reactions for measuring the 
H/D exchanges will be specifically introduced. 
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5.2 Simple aminopyridines 
 
Pyridines are very common moieties for biological compounds and drugs.170 Described 
initially by Barnes et al.171 as analogues of nitrobenzene derivatives, these compounds indeed 
show similar electron distribution. However, due to the electron-withdrawing effect of the 
pyridine nitrogen, highest occupied molecular orbital (HOMO) and lowest unoccupied 
molecular orbital (LUMO) energetic levels will be lower than corresponding benzene-
analogues. As arisen from their definition, HOMO and LUMO will be necessarily involved in 
electrophilic and in nucleophilic attacks respectively. In particular, being HOMO 
energetically lower than LUMO, the reactivity towards electrophilic aromatic substitution is 
strongly reduced.  
For this reason, it was necessary to choose a set of pyridine derivatives with electron-
donating groups, so that their reactivity towards electrophilic aromatic substitution would 
have been enhanced. Aminopyridines were seen as appropriate substrates for this purpose. 
Supplying a non-bondinglone pair, amine nitrogen allows HOMO energetic level to be 
increase. As shown in Scheme 5.1, an eventual conjugation with pi-electron system permits a 
strong activation on alpha and gamma positions prevalently. In particular, these two positions 
will become electron rich, permitting mainly the electrophilic attack (E+) taking place on the 
pyridine ring (Scheme 5.1).  
 
Scheme 5.1.Attack by an electrophilic species (E+) on the pyridine ring of an aminopyridine is favoured 
at the positions adjacent (gamma) or opposite (alpha) to the amino group. 
 
The general basicity of the aminopyridines is considerably higher than the corresponding 
anilines. For example, the pKa of the conjugate acid of 3-aminopyridine is 6.16, whereas the 
pKa of the conjugate acid of aniline is 4.6. In Scheme 5.2 the 3-aminopyridine case was 
reported.According to the work of Elemans et al.172, an excess of a stronger base (K2CO3, 
pKa of conjugate acid = 10.33, 5 eq.) was definitely necessary for acetylating the amino 
group present. (Scheme 5.2). 
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Scheme 5.2.Acetylation of 3-aminopyridine. 
 
This method would be used as part of the procedure for measuring the H/D exchange in the 
deuteration process. The actual process for deuteration is shown in Scheme 5.3. 3-
Aminopyridine was isolated from the mixture in 58% yield and the levels of deuterium 
incorporation at the different positions (obtained by measuring the 1H NMR spectrum of the 
acetylation product) are also shown in Scheme 5.3. 
 
 
Scheme 5.3. Deuteration results for 3-aminopyridine. 
 
The results reported above appear rather odd. Despite the amino group activation on adjacent 
and opposite positions, only the hydrogens on positions 2 and 6 were almost completely 
exchanged, while position 5 (which is neither adjacent nor opposite to the amino group) was 
exchanged to a greater extent than position 4, which is adjacent to the amino group. In the 
literature, there are other examples of electrophilic aromatic substitution reactions of 3-
aminopyridine that have shown similar characteristics. For example, Ammer and Bach173 
studied a new total synthesis of the thiopeptides amythiamicin C and D starting from a 2,6-
dibromo-3-iodopyridine intermediate. In order to obtain this intermediate, the initial step was 
bromination of 3-aminopyridine. The reported result showed that two bromine atoms were 
introduced exclusively at the pyridine positions2 and 6. However, Canibano et al.174 reported 
that monobromination can often be obtained with only 2 equivalents of N-bromosuccinimide. 
Logically, as displayed in Scheme 5.3, the level of H/D exchange in these two positions is 
also considerably high. Additionally, the different deuterium incorporation between them is 
also extremely relevant. Maybe due to a different electronic distribution, electrophilic attack 
in 2 seems particularly preferred. As explained in Chapter 4, platinum catalyst could shift 
along the aromatic ring through a reversible pi-σ conversion. So, a similar mechanism has 
been here proposed for the heterocyclic context. (Scheme 5.4). 
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Scheme 5.4.H/D mechanism on 3-aminopyridine based on pi-σ conversion. 
 
The process is also supposed to carry on all the rest of aromatic carbons. 
In order to expand on our own investigation, a H/D exchange reaction of 3-aminopyridine 
was carried out without the chloroplatinate as a catalyst. The results are indicated in Scheme 
5.5.  
 
 
Scheme 5.5.Acidic-catalyzed deuteration result for 3-aminopyridine. 
 
The result showed the same trend in reactivity as had been shown in the presence of a Pt 
catalyst, but the level of exchange was much lower for most of the positions, again showing 
the better efficiency of the platinum catalyst in such experiments. The exception was position 
2, which showed virtually the same level of incorporation of deuterium as in the Pt catalysed 
reaction, showing that this position is particularly strongly activated. In order to explain this 
particular result, Zoltewicz et al.175 works were relevant. Having studied the inversion of 
reactivity positional order in pyridine, they were able to established interesting aspects. As a 
consequence maybe of electronic disruption on the aromatic ring under such acidic 
conditions, 2,6 carbons were spotted as main H/D exchangeable positions. However, in our 
specific case, 2 position results to be more activated than 6. This could be reasonable 
explained as a consequence of an increased electron density here due to its strict closeness of 
both protonated nitrogen. (Scheme 5.6). 
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Scheme 5.6.Description of possible electronic disruption under acidic conditions.The 
arrows indicate the theoretical pi-elctron cloud flow. 
 
Since these last results, it was logical to extend the investigation to similar substrates, for 
example 2- and 4- aminopyridines. The results obtained in the presence of a Pt catalyst are 
shown in Table 5.1. 
 
Table 5.1.2 and 4-Aminopyridine H/D exchange. 
 
Entry Noc -NH2 D1a D2a D3a D4a D5a D6a Yieldb 
1 26 2 - - 93% 91% 91% 87% 79% 
2 27 4 - 73% 92%     - 92% 73% 23% 
           aDeuterium incorporation calculating through acetylation. 
           bYield calculated through the relation on chapter 2. 
            cStructure number assigned to the deuterated aniline intermediate in the particular experiment, as 
correlated in the experimental section      
 
In 26 (Entry 1, Table 5.1) deuterium has occurred at all positions at a high level. Following 
the considerations described above, it could be useful to consider once more time that acid 
could have disrupt the electronic distribution. In order to confirm this point, Werstiuk et al.97 
studies resulted to be helpful. In their research, 2-phenylpyridine has been investigated as a 
substrate for H/D exchange. Considering phenyl an electron donor substituent similar to 
amine group, it was thought useful to compare these results with that ones in 26. (Scheme 
5.7). Although the experiment set up there was based on only deuterium oxide under drastic 
conditions, strict analogies were arisen from it. Positions 4 and 5 seem in fact receiving an 
almost equal deuteration, but position 5 is increased. This last aspect is maybe a consequence 
of phenyl activation on its opposite position. In our context instead, the acidic conditions 
could have caused a considerable electronic disruption, resulting in the level of exchange 
reported in Table 5.1.  
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Scheme 5.7. Deuteration of 2- phenylpyridine and 2-aminopyridine.2-aminopyridine has been also 
presented in protonated form as a result of acidic conditions. 
 
In addition, the slightly lower level of exchange at positions 6 presumably could reflect the 
lower electron density at that position, but the experiment is not sufficiently discriminating to 
show up any effect at the 4-position, which should also have lower electron density. After 
having referred to kinetic experiments reported in Chapter 2, it was also thought that on 
position 6reverse exchange could occur allowing hydrogen to be introduced back. Coherently 
with Wierstuk’s result, this position could be finally considered particularly active. To finish, 
a comparison of deuterium incorporation between these last two experiments shows once 
more time the impressive efficiency in H/D exchange obtained through Pt catalyst. 
This conclusion is also confirmed by the results with the symmetrical 4-aminopyridine (27). 
The adjacent activated positions (positions 3 and 5) are exchanged to a greater extent than the 
corresponding less active 2 and 6 positions, but the level of deuterium incorporation is still 
considerable also at these positions, which is a great advantage in the use of the Pt catalyst. 
As a further confirmation of what assume above, the electronic density could be shared 
between alpha and beta carbons. In addition, it should be noted that the recovery of product 
from the exchange reaction of 4-aminopyridine was very low. A similar observation (yield 
26%) was made by a colleague for the reaction under Pt-free conditions.126 It is likely that 
this substrate is particularly soluble in water and consequently quite hard to extract into 
organic phase. This is a point that should be addressed if such a highly soluble compound is 
to be exchanged in future. 
 
5.3 Methyl and amino pyridines 
 
As a consequence of the results recovered above, it was necessary to develop a further 
investigation of similar substrates. Pyridines incorporating both methyl and amino groups  
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were chosen for this purpose. Their study gave the opportunity to evaluate the influence that a 
methyl group generates on the pyridine ring for H/D exchange. Furthermore, it was relevant 
to compare how the level of deuterium incorporation on this alkyl chain would be affected by 
its different positions on the ring.  
2-Methyl-3-aminopyridine (28) was the first compound investigated in this set of 
experiments. Although for this substrate and most of all the others in this paragraph the H/D 
exchange measurement described in Scheme 5.2 will be preserved, an alternative way to 
introduce the acetyl group has been explored. As it will be seen, this reaction will result 
useful for acetylating 4-amino-2-methylpyridine. In particular, studies by El-Shishtawyet 
al.176 were helpful for defining this appropriate method for this purpose. (Scheme 5.8). 
 
Scheme 5.8.Acetylation process using acetic anhydride under reflux. 
 
The results obtained here are reported below. (Scheme 5.9). 
 
Scheme 5.9. Deuteration results for 2-methyl-3-aminopyridine. 
 
Even though the amino group controls the regioselectivity, as confirmed by the strong 
deuteration at the opposite and adjacent positions (4 and 6), the methyl group influences, 
interestingly, the activation in 4. Comparing this result with 24 on Scheme 5.3, the H/D 
exchange was strongly increased, passing from 40% to 96%. Coherently with the 
consideration above proposed, it was though that methyl group could forced the electron 
density towards to the rest of aromatic carbons. As a consequence of this, the most of electron 
density could be concentrated around nitrogen ions that means on 4 and 6 positions. As a  
result of this, deuterium distribution appears to respect the electrophilic aromatic susbstitution 
activation.  
4-Methyl-3-aminopyridine (29) was next studied and the results are reported in Scheme 5.10. 
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Scheme 5.10.Deuteration results for 4-methyl-3-aminopyridine. 
 
In this experiment again the amino group seems to direct the H/D exchange. As active 
positions, the 2/6 positions present high percentages of deuterium incorporation while at the 5 
position the level of exchange was much less. As proposed before, methyl group could have 
increased the electron density particularly on position 5 and 6. However, the deuterium 
incorporation recorded on 5 is indicative of a considerable ortho steric effect. The reduced 
chance for platinum to attack carbon 5 could have induced it then to prefer positions 6 and 4 
(thereby involving the methyl group) and, at the same time, increasing the likelihood of 
exchange at those positions.  
Finally, the exchange percentage recorded for the methyl group is higher than (28) (Scheme 
5.9). Maybe due to the activation in 4, the corresponding alkyl chain shows an intense H/D 
exchange (94%). However, according the results reported in Scheme 5.3, the 4-position of 3-
aminopyridine itself does not seem really activated for H/D exchange (40%). A possible 
explanation here could arise from the consideration already set up in Chapter 4. The H/D 
mechanism there proposed involved a η3-allylplatinum intermediates. As mentioned there, 
platinum could be forced to move towards alky chain due to strong steric reasons. As a 
consequence of this, deuterium incorporation results in favouring methyl group instead of 5 
positions. So, the final balance appears to be completely different than in Scheme 5.3. 
In the case of 5-methyl-3-aminopyridine (30, Scheme 5.11), the level of exchange at the 
methyl group is lower (79%) than that for the methyl group of 4-methyl-3-aminopyridine 
(94%). As a completely different situation, here the steric reason maybe could have played a 
not so relevant role. Firstly, the H/D exchange on methyl group is perfectly coherent with 24. 
Secondly, in Scheme 5.3, position 4 resulted to be the less activated (40%). According to the 
pi-electronic disruption, methyl group could have forced the electron density towards to 4 
position, causing consequently the exchange. Furthermore, the two adjacent electron-donor  
groups could have increased its reactivity until to reach the level of 65%. As a result of this, 
the electron activation here seems to have played a key role in comparison of what assumed 
in 4-methyl-3-aminopyridine context.  
 
Chapter 5: Heterocycles for H/D exchange 
 
- 99 - 
 
 
 
Scheme 5.11.Deuteration results for 5-methyl-3-aminopyridine. 
 
A slightly different situation was faced with 6-methyl-3-aminopyridine. (Scheme 5.12). 
 
 
Scheme 5.12.Deuteration results for 6-methyl-3-aminopyridine. 
 
The percentage recorded in position 4 is consistent with the corresponding 3-aminopyridine. 
As already established above, this position seems weakly activated. In particular, the methyl 
group seems to be able to influence its level of activation depending on its position on the 
pyridine ring. For this reason, a possible explanation of the reduced deuteration at the 4-
position of 31(33% against the 40% for 3-aminopyridine) could be due to the deactivating 
presence of the alkyl group at position 6. At position 5, a combination of steric effect and 
electronic deactivation, mediated by the amino group, is responsible for the low level of 
exchange (12%). The strong activation already mentioned on position 2 of the last examples 
is further supported here by the high level of deuteration reported (92%). 
As mentioned before, all the considerations about methyl exchange could be explained in 
terms of η3-allyl system. (Scheme 5.13). Coherently on what assumed on Chapter 4, a similar 
process has been applied on heterocyclic context. 
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Scheme 5.13.H/D mechanism for deuteration results for 2-methyl-3-aminopyridine. 
 
The scheme above describes the hypothetical H/D mechanism for 2-methyl-3-aminopyridine. 
As shown also in Scheme 5.14, amino group could help to stabilize the allyl system formed 
here as a consequence of hydride migration. 
 
 
Scheme 5.14.Different allyl system stability shown by resonance forms. 
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To conclude, Table 5.2 shows an indicative summary for this process in all the other 
substrates used. Although the exchange appears to follow the electron activation on the 
aromatic ring, it seems to mirror the results obtained on methylanilines. (Table 4.2). As 
established above, 2 carbon is the most active position in 3-aminopyridine case. Probably due 
to steric effect caused by amino group beside,in28 the exchange here is less than expected. 
Entry 2 (29) and 3 (30) could be instead strictly connected. In both case, the ortho steric 
effect could cause an increase of deuterium incorporation in adjacent methyl group. Finally, 
in Entry 4 (31) methyl group exchange shows a perfect coherence with the corresponding 
result reported in Scheme 5.3. 
 
Table 5.2.Methyl group H/D exchange on 3-aminopyridines. 
Entry Noa -NH2 -CH3 H/D 
1 28 3 2 85% 
2 29 3 4 94% 
3 30 3 5 79% 
4 31 3 6 83% 
aStructure number assigned to the deuterated aniline 
intermediate in the particular experiment, as correlated in 
the experimental section      
 
The last substrate investigated in this section of work was 2-methyl-4-aminopyridine, which 
allowed us to study the H/D exchange when the amino group occupies a different position. 
(Scheme 5.15). 
  
 
 
Scheme 5.15.Deuteration results for 2-methyl-4-aminopyridine. 
 
The methyl group here seems to be having the same effect on each of the adjacent and 
opposite (3/5) positions. However, the results obtained are quite interesting, particularly when 
compared with that on 27(Table 5.1). As already mentioned, methyl group could have forced 
the electron density towards the aromatic carbons. Lastly, following the considerations above, 
position 2 could have been equally exchange as a consequence of its strong activation.  
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5.4 Quinoline 
 
Following the investigation of relevant heterocyclic substrates, quinoline derivatives were 
seen as another fundamental part of this research. Many alkaloids of these species, which 
provide pharmaceutical properties, are observed in nature.177 Other synthetic drugs are 
commonly used in different therapeutic fields, even though their most important application 
is undoubtedly regards the antibiotic care against malaria.178 
5-Aminoquinoline (33)was the first molecule to be investigated. In order to find the most 
valid acetylation method for this compound, a series of attempts were made. Eventually, the 
reaction already defined in Scheme 5.2 was chosen as the best N-acetylation process. 
In this experiment the results obtained were found to be in line with the general quinoline 
characteristics. (Scheme 5.16). 
 
Scheme 5.16.Deuteration process for-5-aminoquinoline reaction. 
 
As heterocyclic fused rings, quinolines can be studied according to their two different 
components. The substrate investigated can be considered to be sharing a molecule of 
benzene and one of pyridine. The results obtained in this experiment are perfectly consistent 
with the expectation based on this approach. As seen in the case of aniline (see Chapter 2), Pt 
is able to deuterate homogeneously all the positions on this aromatic system. Conversely, on 
the pyridine part, as a consequence of the inactivation towards general electrophilic 
substitutions, only position 3 was efficiently exchanged. The small difference between 
positions 2 (26%) and 4 (13%) could be due to hindrance at position 4.  
Different considerations can be reached instead with the next compound. Preserving the 
method for H/D exchange measurement, 3-aminoquinoline (34)has been investigated. The 
results obtained are reported in Scheme 5.17. 
 
Scheme 5.17.Deuteration process for-3-aminoquinoline reaction. 
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Maybe as a consequence of the hindering effect, the deuterations on position 5 and 8 are 
considerably low. Since they show the same exchange percentage, it was logical to deduce 
that the amino group does not play any particular role, although Garman et al.179 showed that 
in this substrate positions 2 and 4 have the same activation towards H/D exchange, D4, which 
ought to be more hindered, presents considerably higher deuterium incorporation than D2. 
Additionally, because Garman’s experiments were set up in neutral solution, it was natural to 
presume that the acidic condition could have, in similar way described above, influenced the 
electronic activation. Consequently, D4 could be the favourite position because it is farther 
from the nitrogen atom than D2.  
To finish this set, 2-methyl- 4-aminoquinoline (35)was investigated (Scheme 5.18). 
Furthermore, due to its structural similarities with 4-amino-2-methylpyridine (32), it was 
thought to use the same acetylation method reported in Scheme 5.8. 
 
 
Scheme 5.18.Deuteration process for 2-methyl-4-aminoquinoline reaction. 
 
This experiment reflects the common conclusions already discussed above. Positions 5 and 8 
are characterized by a consistent steric hindrance which could have caused the low level of 
deuteration developed. Moreover, the different amino group position here could have played 
a crucial role. As a consequence of all of this, the final exchange in D8 is remarkably low. In 
addition, in order to find an explanation for the result reported on methyl group, an 
appropriate bibliographic research was necessary. No relevant examples were found for 
nucleophilic and electrophilic attack on position 2, hence, it was suggested that carbon on 
position 2 presents an almost complete inactivation here. As already mentioned above, the  
exchange of alkyl susbstituent is directly connected with the activation of the corresponding 
aromatic position. Consequently, low deuterium incorporation was observed.  
The last observation regards the exchange in position 3 on this molecule, which still 
preserves a very good reactivity, confirmed by the high level of H/D exchange, consistently 
with the results reported in Entry 2 (27) Table 5.1. 
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5.5 2-Methylindole 
 
Nowadays, the importance of indoles in biological and pharmaceutical fields is well 
recognized. Many alkaloids and proteins incorporate an indole unit as a primary component 
180
 and recent drug syntheses, in particular indomethacin and its derivatives181, were based on 
it as a building block.182 In light of this, it was thought useful, for this project, to validate our 
method for such a compound and its analogues. 
However, the literature indicates that indole is susceptible to di- and trimerization 
processes.183-184 In fact, as reported by Quarton et al.185 this event is quite common under 
strongly acidic conditions and involves mainly the 3 and 2 indole positions (Scheme 5.19).  
 
Scheme 5.19.Dimerization and trimerization processes for indole. 
 
As a consequence of the problems arisen from such substrates, in particular connected with 
the solubility of the obtained salts, 2-methylindole was chosen for study. Of course, the 
presence of a 2-alkyl chain generates some steric hindrance, which causes problems for 
acetylating on the N-position. For this reason an alternative method was needed. 
In view of these problems, it was decided to follow the procedure described by Seefeld et 
al.186 where N-methylation was realized on the indole derivative.(Scheme 5.20), rather than 
acetylation. 
 
 
Scheme 5.20.1,2-Dimethyl-1H-indole preparation. 
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In order to define a valid method for measuring the H/D exchange, the corresponding 
deuteration process was set up on this substrate. (Scheme 5.21). 
 
Scheme 5.21.Deuteration process for-2-methyl-1H-indole reaction. 
 
The results shown above appear consistent, with a very high degree of exchange, at all 
positions except position 3. Here, an intense H/D exchange was expected due to the particular 
indole characteristic. Actually, in this case, no exchange was observed. It seems highly 
unlikely that this position was completely deactivated towards exchange, since many 
examples in the literature confirm that this position is still activated toward electrophilic 
attack. In particular, Rajesh et al.187were able to carry out nitration at position 3 of 2-
methylindole. This experiment is confirmation that the 3-position is still activated in the 
presence of the 2-methyl group, so the deuterium exchange result needs an alternative 
explanation. One possible explanation involves steric hindrance. In other words, due to the 
presence of a methyl and a benzene group, Pt could have insufficient space for interacting 
with the hydrogen on position 3. However, steric hindrance in other compounds does not  
appear to have been severe enough to have caused such a major effect in other compounds, 
and this explanation is probably not very likely. An alternative explanation might be that this 
position is so highly activated that as a result of contact with water during the the work up the 
exchange process is reversed. The strongly acidic conditions prevailing in the mixture may be 
sufficient to allow complete exchange at such a highly activated position even without the 
presence of the catalyst. 
 
5.6 Conclusions 
 
The experiments set up in this chapter have shown in general very good results both in terms 
of yields and for H/D exchange. Moreover, all the compounds chosen in this section show the 
right compromise between cost efficiency and chemical interest, so that they are relevant to 
and involved in several drug syntheses or biochemical processes. Here, the indolic context 
deserves great consideration, as the supposed activate 3 position has not been deuterated at 
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all. In conclusion, the results obtained could be crucial for the aims of this project, allowing 
us the opportunity to plan future labelled drug synthesis.  
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6.1 Introduction 
 
In this final chapter, a drug investigation will be developed. The possibility of expanding our 
H/D exchange method to pharmaceutical compounds was one of the main priorities of this 
project. It was hoped that use of the procedure would allow fully deuterated drugs to be 
recovered and their metabolic studies in human and animal bodies developed (see Chapter 1). 
Consequently, such compounds were to be subjected to our H/D exchange process and in the 
next few pages we report the results. 
 
6.2 Harmane 
 
Chemically known as 1-methyl-9H-pyrido[3,4-b]indole, harmane is recognised as one of the 
five β-carboline alkaloids of the Peganum Harmala plant (Scheme 6.1). Harmane is also a 
common compound found in different foods; from beef to sardines.188 
 
Scheme 6.1 β-Carboline alkaloids of the plant Peganum Harmala. 
Chapter 6 
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It has long been acknowledged that all of these compounds showed pharmacological 
properties. In particular antitumor189, analgesic190 and vasorelaxant191 effects have been 
reported in the literature. However, their role as inverse agonists on the γ-aminobutyric acid 
(GABA) receptor has been much more defined. As investigated by Chapouthier et al.192, this 
specific interaction caused a diametrically opposite effect to that of the already well-known 
anxiolytic benzodiapine. 
Due to cost and time restrictions, only harmane was investigated among these compounds. 
Despite this, in light of its structural similarities, it could be reasonable to consider the other 
β-carboline alkaloids suitable for experiments identical to that undertaken with harmane 
(Scheme 6.2, Table 6.1). As a consequence, this last aspect could be interpreted as a further 
confirmation of our H/D method efficiency even in this new branch of investigation. 
 
 
Scheme 6.2 Harmane results for H/D exchange. 
 
Additionally, for calculating the H/D exchange, it was necessary to set up the reaction already 
described in the context of indole (Chapter 5, Scheme 5.13). In particular, as a consequence 
of methyl group hindrance, iodomethane was undoubtedly a better electrophilic species than 
acetyl chloride in attacking the N-atom. 
 
The benzene moiety is more activated towards electrophilic attack than pyridine ring; so the 
deuterium incorporation recorded here is a further confirmation. Interestingly, position 3 
seems strongly activated as well. Since Ponce et al.193 were able to brominate β-carboline 
alkaloids at position 3, it was natural to deduce that this carbon could easily be involved in 
other electrophilic processes. Additionally, a comparison with the results obtained with 2-
methyl-3-aminopyridine was helpful. (Scheme 6.3). 
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Scheme 6.3 Comparison of H/D exchange between 2-methyl-3-aminopyridine and harmane. 
 
The scheme above highlights the relevant structural similarities between the two compounds. 
As a result of this, the corresponding positions could be similarly activated, consequently 
causing similar deuterium incorporation. Furthermore, the slight difference shown in C5 
could be due to a more substantial steric effect in the Harmane case. Finally, the same 
conclusion could be proposed for deuterium exchange on the two corresponding methyl 
groups.  
 
6.3 Lidocaine 
 
Pharmacologically defined as an amine derivative of cocaine194, lidocaine has been known 
since 1948 as a local anaesthetic drug. Other different pharmacological properties were soon 
discovered, such as its strong antiarrhytmic effect in 1960, and later, in 1970, its 
anticonvulsant action.195 Nowadays, although there are still many unresolved questions about 
its mechanism of action, it is assumed that a voltage-gated sodium-channel is involved in all 
of these processes. As recently reported by Meng et al.196, lidocaine is able to influence the 
cationic currents ruled by these channels, having clear consequences on the action potential in 
neuronal and muscle cells.  
 
This drug presents a structure that contrasts with the standards set up for this project. 
Chemically indicated as 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide, lidocaine is an 
acetamide derivative (Scheme 6.4). Due to the acidic excess and the drastic temperature 
conditions, which could cause unwanted hydrolysis reactions, no molecules like these were 
explored until now. However, the particular metabolic pathway followed by this drug in the 
human body allowed the corresponding aniline as substrate for H/D exchange studies to be 
used (Scheme 6.4). 
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Scheme 6.4 Lidocaine and its corresponding aniline. 
 
In particular, according to the experimental data, lidocaine is metabolized by cytochrome 
P450 in the liver to its most important metabolite, monoethylglycinexylidide (MEGX), which 
is considered truly responsible for pharmacological activities197; and then, through a N-
desethylation process, to glycinexylidide (GX) (Scheme 6.5). 
 
 
 
Scheme 6.5 Lidocaine metabolism and its metabolite. 
 
As shown in the scheme above, the aromatic structure is preserved in both of the metabolites. 
As a consequence of this, the deuterated aniline, reported in Scheme 6.4, could allow a 
regular bioanalytical investigation along all metabolic pathways. 
For this reason, 2,6-dimethylaniline was explored according to our usual method (Scheme 
6.6). 
 
 
Scheme 6.6 2,6-Dimethylaniline results for H/D exchange. 
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The results reported above show that 2,6-dimethylaniline's aromatic ring could be almost 
completely deuterated. A direct comparison with the 2-methylaniline explored in Chapter 4 
highlights a slight difference at the corresponding 3 and 5 positions (85% against 63% 
reported in Table 4.1).There, the steric hindrance caused by the methyl group restricts the 
level of deuteration at 3 positions. Here instead methyl groups in the para position seems to 
overtake steric effect. Due to symmetrical reason finally, the H/D exchange on both methyl 
groups is identical. 
 
6.4 2-(Piperazin-1-yl)quinoline 
 
Following the results obtained from harmane, it was decided to carry on the investigation of 
other similar substrates. The bibliographic research focused its attention on studies by 
Asagarasu et al.198The aim of this research was to find valid compounds to treat and manage 
irritable bowel syndrome (IBS). Clinical investigations have proved that this disease is 
usually caused by two different serotonin receptors (subtype 1 (5-HT1A) and subtype 3 (5-
HT3).199-200 Pharmacological studies have also shown that using antagonist molecules for one 
(5-HT1A) and agonist molecules for the other (5-HT3) could be a fine therapeutic way for 
defeating the disease. In the light of pharmocophoric considerations, an accurate synthesis of 
different aryl-piperazine derivatives was developed. Due to time restrictions, only one of 
these substrates was chosen as a candidate to be explored in our H/D exchange process. 
Moreover, because of cost reasons, 2-(piperazin-1-yl)quinoline was easily synthesized 
following the procedure shown in Scheme 6.7. 
 
 
 
Scheme 6.7 Synthesis of 2-(piperazin-1-yl)quinoline. 
 
Using this substrate, it was possible to record the results reported below (Scheme 6.8, Table 
6.3). 
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Scheme 6.8 2-(piperazin-1-yl)quinoline H/D exchange. 
 
A statement by Chambers et al.201 relating to selective quinoline fluorination was relevant in 
order to explain the particular deuterium distribution recorded. Firstly, the acidic media is 
able to set up a real electrophilic aromatic substitution, which is also helpful for 
understanding the H/D exchange.202 Following these considerations, and the order of 
reactivity towards electrophiles in quinoline established by Katritzky et al.203,the results 
above are quite controversial. Being more activated than 6 and 7, positions 5 and 8 should 
present the highest deuterium incorporation recorded. Maybe due to steric hindrance, 
attachment of the catalyst at the 5 and 8 positions is inhibited, forcing it to move to the 6 and 
7 positions where, without any steric contribution, it can set up an intense H/D exchange. In 
addition, as previously mentioned, the heterocylic ring shows lowers reactivity towards 
electophilic attack; consequently only 20% of exchange for both of its carbons was recorded. 
Lastly, the total absence of any deuteration process on the piperazine ring is a further 
confirmation of what was already stated in Chapter 4 (Scheme 4.22). In particular, as 
mentioned there, the presence of a nitrogen atom represents a sort of barrier for the catalyst, 
which is consequently not able to interact with the neighbouring carbons. 
 
6.5 Conclusions 
 
The results obtained here have shown that the H/D exchange process might be expanded 
successfully to different kinds of drugs. Additionally, the experiments confirm that this 
method could have certain relevance in the future. In particular, the results recorded above 
show the possibilities to obtain fully deuterated drugs, which could represent a fundamental 
aspect for improving bioanalytical investigations. Although only three biologically active 
compounds were used in the work reported in this chapter, their considerable final H/D 
exchange and yield could encourage further studies on a much larger range of compounds 
with a larger variety of pharmacological activities.
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7.1 Experimental technique 
7.2 General procedure 
7.3 Specific experimental procedure 
 
 
 
7.1 Experimental technique 
 
Starting materials and solvents were purchased from commercial suppliers and they were all 
used without further purification. Column chromatography was carried out using Merck 
Kieselgel 60 H silica on Matrex Silica 60. Analytical thin layer chromatography was carried 
out using aluminium-backed plates coated with Merck Kieselgel 60 GF254 that were 
visualised under UV light (at 254 and/or 360 nm) and/or potassium permanganate stain. 
Melting points (mp) were determined on Kofler hot stage apparatus and are uncorrected. 
Infra-red (IR) spectra were recorded in the range 4000-600 cm-1 on a Perkin-Elmer series 
FTIR spectrometer using KBr plates for most of all samples and nujol mull. Nuclear 
magnetic resonance (NMR) spectra were recorded in CD3OD (unless otherwise stated) using 
an Avance Bruker DPX 400 instrument (400 MHz) or an Avance Bruker DPX 500 (500 
MHz), with 13C recorded at 100 MHz and 125 MHz respectively and reported in ppm; J 
values were recorded in Hz and multiplicities were expressed by the usual convention 
(s=singlet (seen as singular line in the proton decoupled spectra), d= doublet, dd= doublet of  
doublets, dt= doublet of triplets, t= triplet, q= quartet, p= pentlet, sept= septlet, m= multiplet). 
Low resolution mass spectrometric data were determined using a Fisons VG Platform II 
instrument, High resolution mass spectrometric data were obtained on a Waters Q-TOF 
micromass spectrometer. Under vacuum refers to evaporation at reduced pressure using a 
rotary evaporator and diaphragm pump, followed by removal of trace volatiles using a 
vacuum (oil) pump. Microwave experiments were developed in a CEM Discover microwave 
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synthesizer at the temperature and initial power stated, with modulation of power to maintain 
reaction temperature as monitored by the in-built IR sensor. 
 
7.2 General experimental procedures 
 
7.2.1 General procedures A: Deuteration using K2PtCl4 
 
Different substituted derivatives of aniline (1 eq.) in D2O (1 mL) were added to a stirred 
solution of K2PtCl4 (20 mol %.) and DCl (35%) (4 eq.)in D2O (3 mL) .The mixture was 
irradiated at 200 °C (initial power 300 W, pressure 150 psi) in a sealed vessel for 2 hours. 
Then the solution was neutralized by the addition of NaOH (1M, 10 mL) and extracted with 
DCM. The organic extracts were combined, dried over MgSO4, filtered and evaporated under 
vacuum to afford the product. 
 
7.2.2 General procedures B: Deuterium substituted anilines acetylation 
 
Acetyl chloride (1.1 eq.) was added to a stirred, cooled (ice bath) solution of deuterated 
amino compound (1 eq.) in DCM (5 mL), under a N2 atmosphere. The mixture was warmed 
to room temperature (R.T) and stirred for 30 min. A further portion of acetyl chloride (1.1 
eq.) was added and the solution stirred for another 30 min. Hydrochloric acid (1M, 10 mL) 
was added and the organic layer was washed with hydrochloric acid (1M), dried over MgSO4, 
and evaporated under vacuum to afford the product. 
 
7.2.3 General procedures C: Alternative acetylation of deuterated    
aminopyridines 
 
The aminopyridine (1 eq.) was dissolved in acetone (15 mL), and K2CO3 (5 eq.) was added, 
followed by the dropwise addition of acetyl chloride (3 eq.) in acetone (5 mL). The reaction 
mixture was stirred for 3 h. The solution was quenched by water, then the solvent was 
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eliminated in vacuo and then the crude product was extracted with DCM. The organic phase 
was dried over Na2SO4, filtered and evaporated in vacuo to give the product which was 
driedat high vacuum 
 
7.3 Specific experimental procedures 
 
2,4,5,6-Tetradeutero-3-chloroaniline (1)204 
 
 
A solution of 3-chloroaniline (300 mg, 250 µL, 2.3 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (190 mg, 0.46 mmol, 20 mol %.) and DCl (35%) (750 µL, 9.2 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (127 µL, 1.84 mmol, 4 eq. referred to the catalyst amount) was added and 
the mixture was stirred for 30 min, the rest of the the work up followed the general procedure 
A to give the title compound as a brown oil (291 mg, 96%): Found M•+, 133.0401. 
C6H2D4ClN [M•+].requires 133.0401; νmax (KBr) 3437, 3240, 3365, 3224, 1619, 1574, 1432, 
1403, 1376, 1297, and 925;δH (500 MHz; CD3OD) a6.88 (0.06H, s), a6.57(0.06H, s), 
a6.49(0.06H, s), a6.45(0.06H, s), δc(150 MHz, CD3OD) 150.4 (s, C-NH2), 135.6 (s, C-Cl), 
130.8 (t, C-D, JC-D24), 117.9 (t, C-D, JC-D 25), 115.6 (t, C-D, JC-D 24), 114.1 (t, C-D,  JC-D 
24); m/z (EI)133 (50%). 
aSignals arise from the presence of isotopologues. 
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N-(2,4,5,6 Tetradeutero-3-chlorophenyl)acetamide (1a) 
 
Acetyl chloride (106.2µL, 1.49 mmol, 1.1 eq.) was added to a stirred solution of d4-3-
chloroaniline (1) (178 mg, 1.36 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (419.7µL, 2.9 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B. 
Purification by chromatography column, eluting with petroleum ether/ ethyl acetate (2/1) 
gave the title compound as a brown powder (150 mg, 63 %): Found M•+, 173.0540. 
C8H4D4ClNO [M•+] requires 173.0545; mp 59-62 °C; νmax (KBr) 3293, 3248, 3165, 3081, 
2926, 2384, 1669, 1568, 1518, 1391; 1342, and 1303,δH(400 MHz; CD3OD) 7.58 (0.06H, s), 
7.25 (0.06H, s), 7.12 (0.06H, s), 6.93 (0.06H,s), 2.00(3H, s);δc (150 MHz, CD3OD) 171.8 (s, 
C=O), 141.2 (s, C-NH), 135.3 (s, C-Cl), 130.5(t, C-D, JC-D 25), 124.5 (t, C-D, JC-D 25), 120.6 
(t, C-D, JC-D 26), 118.6 (t, C-D, JC-D 26), 23.9 (s, CH3); m/z (EI) 173 (M•+, 20%). 
2,3,4,5,6-Pentadeuteroaniline (2a)205 
 
A solution of aniline (300 mg, 294µL, 0.31 mmol, 1 eq.) in D2O (1 mL) was added to a 
stirred solution of K2PtCl4 (25 mg, 0.64 mmol, 20 mol %.) and DCl (35%) (1.02mL, 1.2 
mmol, 4 eq.)in D2O (3 mL) and reacted according to the general procedures A to give the title 
compound as a brown oil (137 mg, 44%): Found M•+, 98.0892. C6H2D5N [M•+] requires 
98.0891; νmax(KBr) 3357, 3222, 3051, 2513, 1619, 1581, 1474, 1451 and 1261; δH (400 MHz; 
CD3OD) a7.10(0.18H, s), a6.72 (0.27H, s); δc(100 MHz, CD3OD) 147.2 (s, C-NH2), 128.4(t, 
C-D, JC-D 24), 118.4 (t, C-D, JC-D 25), 115.4 (t, C-D, JC-D 27); m/z (EI) 98 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-(2,3,4,5,6-Pentadeuterophenyl)acetamide (2b) 
 
Acetyl chloride (125 µL, 1.76 mmol, 1.1 eq.) was added to a stirred solution of d5-aniline 
(2a) (161 mg, 1.6 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (493.8 µL, 3.52 mmol, 2.2 
eq.) under N2 atmosphere and reacted according to the general procedureB. Purification by 
chromatography column, eluting with petroleum ether/ethyl acetate (3/1) gave the title 
compound as a brown powder (97 mg, 43%): Found M•+, 140.1002. C8H4D5NO [M•+.] 
requires 140.0998, mp 108-112°C; νmax (KBr) 3293, 3249, 3164, 3090, 2926, 2851, 2434, 
1641, 1591; 1469, and 1382; δH(400 MHz; CD3OD) 7.49 (0.18H, s), 7.15 (0.18H, s), 6.94 
(0.09H, s), 1.98 (3H, s); δc (100 MHz,CD3OD) 172.1 (s, C=O), 140.1 (s, C-NH), 129.7 (t, C-
D, JC-D 25), 125.1(t, C-D, JC-D 25), 121.2 (t, C-D, JC-D 25), 24.3 (s, CH3); m/z (EI) 140 (M•+, 
30%). 
2,4,6-Trideuteroaniline (2c)204, 206 
 
A solution of aniline (300 mg, 294µL, 0.31 mmol, 1 eq.) in D2O (1 mL) was added to a 
stirred solution of K2PtCl4 (25 mg, 0.062 mmol, 2 mol %.) and DCl (35%) (102µL, 1.24 
mmol, 0.38 eq.)in D2O (3 mL) and reacted according to the general procedureA to give the 
title compound as brown oil (245 mg, 80%); Found M•+, 96.0764. C6H4D3N [M•+.] requires 
96.0767; νmax(KBr) 3357, 3222, 3051, 2513, 1619, 1581, 1474, 1451 and 1261;δH (400 
MHz;CD3OD) a7.10(1.95H, s), a6.72 (0.27H, m); δc(100 MHz, CD3OD) 147.2 (s, C-NH2), 
128.4(s, C-H), 118.4 (t, C-D, JC-D 25), 115.4 (t, C-D, JC-D 26); m/z (EI) 96 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-(2,4,6-Trideuterophenyl)acetamide (2d) 
 
Acetyl chloride (79.8 µL, 1.12 mmol, 1.1 eq.) was added to a stirred solution of d3-aniline 
(2c) (100 mg, 1.02 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (314.7 µL, 2.24 mmol, 2.2 
eq.) under N2 atmosphere and reacted according to the general procedureB. Purification by 
chromatography column, eluting with petroleum ether/ethyl acetate (3/1) gave the title 
compound as brown powder (93 mg, 66 %): Found M•+, 138.0868. C8H6D3NO[M•+.] requires 
138.0872; mp 103-108 °C; νmax (KBr) 3293, 3254, 3176, 3046, 2913, 2420, 1644; 1858, 
1644, 1578, 1527, 1469 and 1382, δH (400 MHz; CD3OD, 50°C) a7.49 (0.15H, d, JH-H 8.54), a 
7.16 (1.95H, s),a6.94 (0.09H, d, JH-H 7.41 ), 1.98 (3H, s); δc (100 MHz, CD3OD) 172.1 (s, 
C=O), 140.1 (s, C-NH), 129.7 (s, C-H), 125.1 (t, C-D, JC-D 25), 121.2 (t, C-D, JC-D 25), 24.3 
(s,CH3); m/z (EI) 138 (M•+, 95%). 
2,6-Dideutero-4-(1,1,2,2,3,3,4,4,4-nonadeuterobutyl)aniline (3) 
 
A solution of 4-n-butylaniline (300 mg, 317 µL, 2.01 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (166 mg, 0.40 mmol, 20 mol %.) and DCl (35%) (662 µL, 8.04 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedureA. To the solution 
thioglycolic acid (120 µL, 1.6 mmol, 4 eq. referred to the catalyst amount) was added was 
added and the mixture was stirred for 30 min, the rest of the the work up follows the general 
procedure A to give the title compound as a brown oil (160 mg, 50%): Found M•+, 160.1895. 
C10H4D11N [M•+] requires 160.1895; νmax (KBr) 3444, 3349, 3214, 3019, 2901, 1619, 1499, 
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1462, 1442, 1300 and 1256; δH (400 MHz; CD3OD) a6.91(1.13H, s), a6.66(0.22H, m), 
a2.44(0.26H, s), a1.47 (0.88H, m),a1.26 (0.78H, m),a0.86 (0.54H, m); δc(100 MHz, CD3OD) 
145.9(s, C-NH2), 134.1(s, C-C), 129.9 (s, C-H), 117.0(m, C-D), 35.8(m, CD2) , 35.2 (m, 
CD2), 23.3 (m, CD2), 14.3 (m, CD3); m/z (EI) 160 (M•+, 80%). 
aSignals arise from the presence of isotopologues. 
N-[2,6-Dideutero-4-(1,1,2,2,3,3,4,4,4-nonadeuterobutyl)phenyl]acetamide 
(3a) 
 
Acetyl chloride (63.4µL, 0.88 mmol, 1.1 eq.) was added to a stirred solution of d11-4-n-
butylaniline (3) (130 mg, 0.89 mmol, 1 eq.) in DCM (10 mL) and NEt3 on ice (246.9µL, 1.77 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to give 
the title compound as a colourlesspowder (59 mg, 36%): Found M•+, 202.1997. C12H6D11NO 
[M•+] requires 202.2001; mp 101-105 °C; νmax (KBr) 3267, 3124, 2916, 2930, 2854, 1660, 
1514, 1451, 1371 and 1291; δH (400 MHz; CD3OD) 7.43 (0.22H, m), 7.11 (1.13H, s), 2.53 
(0.26H, m), 2.10 (3H, s), 1.53 (0.88H, s), 1.29 (0.78H, m), 0.88 (0.54H, m); δc (150 MHz, 
CD3OD) 171.5 (s, C=O), 139.9 (s, C-NH), 137.3(s, C-C), 129.5(s, C-H), 121.3(m, C-D), 36.0 
(m, CD2), 34.9 (m, CD2), 23.7 (s, CH3) 23.3 (m, CD2), 14.2 (m, CD3); m/z (EI) 202 (M•+, 
85%). 
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2,3,5,6 Tetradeutero-4-methoxyaniline (4) 
 
4-Methoxyaniline (300 mg, 2.43 mmol, 1 eq.) was added to a stirred solution of K2PtCl4 (199 
mg, 0.48 mmol, 20 mol %.) and DCl (35%) (802 µL, 9.72 mmol, 4 eq.)in D2O (3 mL) and 
reacted according to the general procedureA to give the title compound as a black powder (34 
mg, 11 %): Found M•+, 127.0931. C7H5D4NO [M•+] requires127.0935, mp 56-60oC; 
νmax(neat) 2961, 2922, 2850, 2255, 2059, 1574, 1552, 1455 and 1412;δH (400 MHz; CD3OD) 
a6.63 (0.09H, s), a6.52 (0.07H, s),a3.61(2.93H, s); δc(100 MHz, CD3OD) 154.9 (s, C-NH2), 
141.9(s, C-O), 118.6(t, C-D, JC-D 25), 116.1 (t, C-D, JC-D24), 56.5 (s, O-CH3); m/z (EI) 127 
(M•+, 90%). 
aSignals arise from the presence of isotopologues. 
N-[2,3,5,6-Tetradeutero-4-methoxyphenyl]acetamide (4a) 
 
Acetyl chloride (14.2µL, 0.22 mmol, 1.1 eq.) was added to a stirred solution of d4-4-anisidine 
(4) (34 mg, 0.2 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (61.72µL, 0.44 mmol, 2.2 eq.) 
under N2 atmosphere and reacted according to the general procedureB. Purification by 
chromatography column, eluting with petroleum ether/ethyl acetate (2/1) gave the title 
compound as a colourless powder (11 mg, 32%): Found M•+, 169.1040.C9H7D4NO2 [M•+] 
requires 169.1041, mp 137-139 °C; νmax (neat) 3272, 3165, 3097, 2962, 2383, 1762, 1654, 
1594, 1513, 1414 and 1261; δH (400 MHz; CD3OD) 7.38 (0.07H, s), 6.76 (0.09H, s), 3.61 
(2.93H,s), 1.99 (3.00 H, s); δc (150 MHz, CD3OD) 171.3 (s, C=O), 157.8 (s, C-NH), 132.7 (s, 
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C-O), 122.9 (t, C-D, JC-D 25), 125.6 (t, C-D, JC-D 24), 55.9 (s, O-CH3), 23.6 (s, CH3); m/z (EI) 
169 (M•+, 60%). 
2,4,5,6-Tetradeutero-3-methoxyaniline (5) 
 
A solution of 3-methoxyaniline (300 mg, 273 µL, 2.4 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (199 mg, 0.48 mmol, 20 mol %.) and DCl (35%) (790 µL, 9.6 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution, 
thioglycolic acid (133 µL, 1.92 mmol, 4 eq. referred to the catalyst amount) was added was 
added and left under stirring for half an hour; the rest of the work up followed the general 
procedure A to give the title compound as a brown oil (135 mg, 44%): Found M•+ 127.0935. 
C7H5D4NO [M•+] requires 127.0936; νmax (neat) 3367, 2941,2834, 2053, 1859, 1589, 
1463,1300 and 1173; δH (400 MHz; CD3OD) a6.97(0.19H, s), a6.35 (0.12H, s),a6.22 (0.26H, 
s), 3.67 (2.79H, s); δc(100 MHz, CD3OD) 159.5 (s, C-O), 150.2 (s, C-NH2), 131.4(m, C-D), 
109.0 (m, C-D), 107.0 (m, C-D), 104.3 (m, C-D), 55.9 (s, O-CH3); m/z (EI) 112 (M•+- CH3, 
100%). 
aSignals arise from the presence of isotopologues. 
N-[2,4,5,6-Tetradeutero-3-methoxyphenyl]acetamide (5a) 
 
Acetyl chloride (79.3 µL, 1.12 mmol, 1.1 eq.) was added to a stirred solution of d4-3-
methoxyaniline (5) (125 mg, 1.01 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (311µL, 2.22 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B. 
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Purification by chromatography column, eluting with petroleum ether/ ethyl acetate (2/1) 
gave the title compound as a brown oil (28 mg, 21 %): Found M•+, 169.1038. C9H7D4NO2 
[M•+] requires 169.1041; νmax (KBr) 3302, 3251, 3165, 3103, 2932 , 1661, 1575, 1520, 1377, 
1269, and 1117;δH (400 MHz; CD3OD):7.25 (0.07H, s), 7.17 (0.19H, s), 7.02 (0.19H, s), 6.64 
(0.19, s), 3.75 (2.79H, s), 2.09 (3H, s); δc (150 MHz, CD3OD) 170.2 (s, C=O), 160.04(s, C-
NH), 139.5 (s, C-O), 128.8 (m, C-D), 111.7 (m, C-D), 110.01 (m, C-D), 109.1 (m, C-D), 54.1 
(s,O-CH3), 22.4 (s, CH3); m/z (EI) 169 (M•+, 55%). 
2,3,5,6-Tetradeutero-4-fluoroaniline (6) 
 
4-Fluoroaniline (300 mg, 2.7 mmol, 1 eq.) in D2O (1 mL) was added to a stirred solution of 
K2PtCl4 (224 mg, 0.54 mmol, 20 mol %.) and DCl (35%) (890 µL, 10.8 mmol, 4 eq.)in D2O 
(3 mL) and reaction was carried out according to the general procedure A to give the title 
compound as a yellow oil (170 mg, 55%): Found M•+, 115.0731. C6H2D4NF [M•+] requires 
115.0735; νmax(neat) 3436, 3361, 3325, 2963, 2922, 2856, 1623, 1446, 1117 and 803; δH (400 
MHz; DMSO) a6.83 (0.23H, m), a 6.52 (0.07H, m), a2.55 (2H, s); δc (100 MHz, DMSO) 
154.6 (d, C-F, JC-F 230), 145.3 (s, C-NH2), 115.4 (m, C-D), 114.9 (m, C-D); m/z (EI) 115 
(M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-[2,3,5,6-Tetradeutero-4-fluorophenyl]acetamide (6a) 
 
Acetyl chloride (84.6 µL, 1.19 mmol, 1.1 eq.) was added to a cooled (ice bath) stirred 
solution of d4-4-fluoroaniline (6) (170 mg, 1.11 mmol, 1 eq.) and NEt3 on ice (333 µL, 2.38 
mmol, 2.2 eq.) in DCM (5 mL) under N2 atmosphere and reacted according to the general 
procedures B to give the title compound as a brown powder (154 mg, 90%): Found M•+, 
157.0839. C8H4D4NOF [M•+] requires 157.0841, mp 131-136 °C; νmax (neat) 2963, 1660, 
1412, 1260, 1023, 799; δH(400 MHz; CD3OD, 50°C) 7.40 (0.07H, m), 6.90 (0.23H, m) 1.95 
(3H, s); δc (100 MHz, CD3OD) 170.1 (s, C=O), 159.1 (d, C-F, JC-F 230), 134.6 (s, C-NH), 
121.1 (m, C-D), 114.7 (m, C-D), 24.09 (s, CH3); m/z (EI) 157 (M•+, 90%). 
2,3,4,5,6-Pentadeuteroaniline (7)205 
 
A solution of 4-(trifluoromethyl)aniline (300 mg, 231 µL, 1.8 mmol, 1 eq.) in D2O (1 mL) 
was added to a stirred solution of K2PtCl4 (154 mg, 0.37 mmol, 20 mol %.) and DCl (35%) 
(612 µL, 7.44 mmol, 4 eq.)in D2O (3 mL) and reacted according to the general procedure A 
to give the title compound as an orange oil (126 mg, 70%): Found M•+, 98.0892. C6H2D5N 
[M•+] requires 98.0892; νmax (neat) 3493, 3399, 3227, 2962, 2962, 2924, 2850, 1627, 1328 
and 1262; δH (400 MHz; CD3OD) a7.10(0.16H, s), a6.72 (0.08H, s), a6.51 (0.04H, s); δc (100 
MHz, CD3OD) 148.7 (s, C-NH2), 128.4(t, C-D, JC-D 24), 117.5 (t, C-D, JC-D 25), 114.9 (t, C-
D, JC-D 25); m/z (EI) 98 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-[2,3,4,5,6-Pentadeuterophenyl]acetamide (7a) 
 
Acetyl chloride (57.9 µL, 0.77 mmol, 1.1 eq.) was added to a stirred solution of d5-aniline (7) 
(120 mg, 0.07 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (225 µL, 1.54 mmol, 2.2 eq.) 
under N2 atmosphere and reacted according to the general procedure B to give the title 
compound as a brown powder (128 mg, 84%): Found M•+, 140.0998. C8H4D5NO [M•+] 
requires 140.0998, mp 108-111 °C; νmax (neat) 3293, 2963, 2420, 2348, 1640; 1565, 1473, 
1328 and 1261, δH(400 MHz; CD3OD, 50°C) 7.49 (0.07H, s), 7.16 (0.08H, s),6.93 (0.04H,s), 
1.96 (3H, s); δc (100 MHz, CD3OD) 172.07 (s, C=O), 140.1 (s, C-NH), 129.7 (t, C-D, JC-D 
24), 125.1 (t, C-D, JC-D 25), 121.2 (t, C-D, JC-D 25), 24.3 (s, CH3); m/z (EI) 140 (M•+, 80%). 
2,4,5,6-Tetradeutero-3-(trifluoromethyl)aniline (8) 
 
A solution of 3-(trifluoromethyl)aniline (300 mg, 231 µL, 1.86 mmol, 1 eq.) in D2O (1 mL) 
was added to a stirred solution of K2PtCl4 (154 mg, 0.37 mmol, 20 mol %.) and DCl (35%) 
(612 µL, 7.44 mmol, 4 eq.)in D2O (3 mL) and reacted according to the general procedure A 
to give the title compound as a brown oil (125 mg, 40%); Found M•+, 165.0703. C7H2D4F3N 
[M•+] requires 165.0700; νmax (KBr) 3447, 3390, 3229, 1624, 1584, 1619, 1581, 1479, and 
1426; δH (400 MHz; CD3OD) a7.23(0.04H, s), a6.94 (0.04H, s), a6.75 (0.04H,s), a6.74 
(0.04H,s); δc(100 MHz, CD3OD) 150.1 (s, C-NH2), 132.7.4 (m, C-CF3), 130.6 (t, C-D, JC-D 
24), 126.3 (m, CF3), 119.2 (t, C-D, JC-D 25), 114.7 (t, C-D, JC-D 26), 112.2 (t, C-D, JC-D 25); 
m/z (EI) 165 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-[2,4,5,6-Tetradeutero-3-(trifluoromethyl)phenyl]acetamide (8a) 
 
Acetyl chloride (109 µL, 1.53 mmol, 1.1 eq.) was added to a stirred solution of d4-3-
(trifluoromethyl)aniline (8) (230 mg, 1.39 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (429 
µL, 3.06 mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure 
B. Purification by chromatography column, eluting with petroleum ether/ethyl acetate (3/1) 
gave the title compound as a colourless powder (225 mg, 78 %): Found M•+, 207.0805 
C9H4D4F3NO [M•+] requires 207.0809, mp 95-101°C; νmax (KBr) 3304, 3265, 3129, 3070, 
2962, 2972, 1662, 1616, 1580, 1535; 1411, and 1284, δH (400 MHz; CD3OD, 50°C) 7.87 
(0.04H,s), 7.57 (0.04H,s), 7.29 (0.04H,s), 7.18 (0.04H,s), 2.01 (3H, s); δc (100 MHz, CD3OD) 
172.3 (s, C=O), 141.1 (s, C-NH), 132.3(m, C-CF3), 130.04 (t, C-D, JC-D 25), 127.3 (m, 
CF3),124.01 (t, C-D, JC-D 27), 121.3 (t, C-D, JC-D 24), 117.4 (t, C-D, JC-D 27), 24.3 (s, CH3); 
m/z (EI) 207 (M•+, 20%). 
2,6-Dideutero-4-nitroaniline (9)207 
 
4-Nitroaniline (300 mg, 2.17 mmol, 1 eq.) was added to a stirred solution of K2PtCl4 (180 
mg, 0.43 mmol, 20 mol %.) and DCl (35%) (714 µL, 8.68 mmol, 4 eq.)in D2O (3 mL) and 
reacted according to the general procedure A to give the title compound as a brown powder 
(70 mg, 23%): Found M•+, 140.0554. C6H4D2N2O2 [M•+] requires 140.0555; mp 124-128 °C; 
νmax (KBr) 3482, 3455, 3362, 2608, 2505, 2445, 1631, 1577 and 1469; δH (400 MHz; 
CD3OD) a7.87(1.34H, s), a6.51(0.14H, d, JH-H 9.62); δc (100 MHz, CD3OD) 157.5 (s, C-
NO2), 150.5(s, C-NH2), 127.6(s, C-H), 113.8 (t, C-D, JC-D 24); m/z (EI) 140 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-[2,6-Dideutero-4-nitrophenyl]acetamide (9a) 
 
Acetyl chloride (68 µL, 0.9 mmol, 1.1 eq.) was added to a stirred solution of d4-4-nitroaniline 
(124 mg, 0.87 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (268 µL, 1.91 mmol, 2.2 eq.) 
under N2 atmosphere and reacted according to the general procedure B. Purification of 
chromatography column, eluting with petroleum ether/ ethyl acetate (1/1) gave the title 
compound as a brow powder (56 mg, 34%): Found M•+, 182.0655. C8H6D2N2O3 [M•+] 
requires 182.0660, mp>200°C; νmax (KBr) 3271, 3228, 3168, 3097, 2385, 1846, 1682, 1611, 
1558, 1502, 1451, 1345 and 1276; δH (400 MHz; CD3OD, 50°C) 8.07 (1.34H, s), 7.67 
(0.14H, d, JH-H 9.62), 2.06 (3H, s); δc (125 MHz, CD3OD) 172.9 (s, C=O), 146.5 (s, C-NH), 
144.9(s, C-NO2), 126.1(s, C-H), 120.1(t, C-D, JC-D 25), 24.0 (s, CH3); m/z (EI) 182 (M•+, 
50%). 
2,4,5,6-Tetradeutero-3-nitroaniline (10) 
 
3-Nitroaniline (300 mg, 2.17 mmol, 1 eq.) was added to a stirred solution of K2PtCl4 (180 
mg, 0.43 mmol, 20 mol %.) and DCl (35%) (714 µL, 8.68 mmol, 4 eq.)in D2O (3 mL) and 
reacted according to the general procedure A to give the title compound as a yellow powder 
(264 mg, 86%): Found M•+, 142.0676. C6H2D3N [M•+] requires 142.0680; mp 110-116 °C; 
νmax(KBr) 3446, 3398, 2963, 2916, 2848, 2567, 2505, 2437, 1599, 1562, 1522, 1422, 1366, 
and 1261; δH (400 MHz; CD3OD) a7.49(0.06H, s), a7.44(0.06H, s), a7.26 (0.06H, s), 7.01 
(0.06H, s); δc(100 MHz, CD3OD) 150.8 (s, C-NO2), 150.5(s, C-NH2), 130.2 (t, C-D, JC-D 25), 
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121.1 (t, C-D, JC-D 24), 112.02 (t, C-D, JC-D 26), 109.1 (t, C-D, JC-D 26); m/z (EI) 142 (M•+, 
100%). 
aSignals arise from the presence of isotopologues. 
N-[2,4,5,6-Tetradeutero-3-nitrophenyl]acetamide (10a) 
 
Acetyl chloride (110 µL, 1.5 mmol, 1.1 eq.) was added to a stirred solution of d4-3-
nitroaniline (10) (200 mg, 1.4 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (462 µL, 3.3 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B. 
Purification by chromatography column, eluting with petroleum ether/ ethyl acetate (3/1) 
gave the title compound as a colourless powder (195 mg, 80%): Found M•+, 184.0876. 
C8H4D4N2O3 [M•+] requires 184.0873, mp 147-151 °C; νmax (KBr) 3301, 3248, 3174, 3093, 
2922, 2852; 2343, 2301, 11674, 1610, 1582 and 1535, δH (500 MHz; CD3OD) 8.49 (0.06H, 
s), 7.80 (0.06H, s), 7.71 (0.06H, s), 7.41 (0.06H, s), 2.16 (3H, s); δc (125 MHz, CD3OD) 
171.1 (s, C=O), 149.8 (s, C-NO2), 141.2 (s, C-NH), 130.6 (t, C-D, JC-D 25), 125.6 (t, C-D, JC-
D 26), 118.2 (t, C-D, JC-D 26), 115.01 (t, C-D, JC-D 26), 24.0 (s, CH3); m/z (EI) 184 (M•+, 
25%). 
2,6-Dideutero-4-chloroaniline (11)208-209 
 
A solution of 4-chloroaniline (300 mg, 2.3 mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (195 mg, 0.47 mmol, 20 mol %.) and DCl (35%) (778 µL, 9.2 mmol, 4 eq.)in D2O (3 
mL) and reacted according to the general procedure A. To the solution thioglycolic acid (130 
µL, 1.88 mmol, 4 eq. referred to the catalyst amount) was added and the mixture was stirred 
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for 30 min, the rest of the the work up followed the general procedure A to give the title 
compound as a violet powder (264 mg, 86%): Found M•+, 129.0310.C6H4D2ClN [M•+] 
requires 129.0314; mp 64-68 °C;νmax (KBr) 3473, 3427, 3382, 2963, 2533, 1806, 1611, 1583, 
1473, 1453, 1261, and 1092; δH (400 MHz; CD3OD,) a6.95 (1.18H, s), a6.55 (0.10H, m); 
δc(100 MHz, CD3OD) 148.12 (s, C-NH2), 130.09 (s, C-H), 123.69 (s, C-Cl), 117.22 (t, C-D, 
JC-D 24); m/z (EI) 129 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
N-[2,6-dideutero-4-chlorophenyl]acetamide (11a) 
 
Acetyl chloride (152 µL, 2.1 mmol, 1.1 eq.) was added to a stirred solution of d4-4-
chloroaniline (11) (255 mg, 1.9 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (586 µL, 4.18 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to give 
the title compound as a brown powder (283 mg, 84%): Found M•+, 171.0424. C8H6D2 ClNO 
[M•+] requires 171.0420; mp 165-169 °C; νmax (KBr) 3272, 3224, 3150, 3062, 2963 , 1660, 
1571, 1513, 1428, 1396, and 1354, δH (400 MHz; CD3OD) 7.53 (0.10H, m), 7.27 (1.18H, s), 
2.13 (3H, s); δc (150 MHz, CD3OD) 172.2 (s, C=O), 139.3(s, C-NH), 129.8 (s, C-Cl), 
129.6(s, C-H), 122.1 (t, C-D, JC-D 24), 23.8 (s, CH3); m/z (EI) 171 (M•+, 45%). 
4,5,6-Trideutero-2-chloroaniline (12) 
 
A solution of 2-chloroaniline (300 mg, 247 µL, 2.4 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (199 mg, 0.48 mmol, 20 mol %.) and DCl (35%) (778 µL, 9.4 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
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thioglycolic acid (133 µL, 1.92 mmol, 4 eq. referred to the catalyst amount) was added and 
the mixture was stirred for 30 min, the rest of the the work up followed the general procedure 
A to give the title compound as a brown oil (228 mg, 92%): Found M•+, 130.0412 
C6H3D4ClN [M•+] requires 130.0410; νmax (KBr) 3468, 3383, 3365, 3219, 2534, 1615, 15756, 
1464, 1442, 1415, 1372, and 1305; δH (400 MHz; CD3OD, 50°C) a7.16 (0.68H, s), a7.00 
(0.08H, s), a6.79 (0.08H, m), a6.59 (0.08H, s);δc (100 MHz, CD3OD) 144.01 (s, C-NH2), 
129.01 (s, C-H), 127.4 (t, C-D, JC-D 24), 118.9 (s, C-Cl), 118.2 (t, C-D, JC-D 25) , 116.03 (t, 
C-D, JC-D 25); m/z (EI) 130 (M•+, 50%). 
aSignals arise from the presence of isotopologues. 
N-[4,5,6-Trideutero-2-chlorophenyl]acetamide (12a) 
 
Acetyl chloride (55µL, 0.78 mmol, 1.1 eq.) was added to a stirred solution of d4-2-
chloroaniline (12) (93 mg, 0.71 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (216 µL, 1.54 
mmol, 2.2 eq.), under N2 atmosphere and reacted according to the general procedure B. 
Purification by chromatography column, eluting with petroleum ether/ethyl acetate (5/1) gave 
the title compound as a brown powder (50 mg, 41 %): Found M•+, 172.0545. C8H5D3ClNO 
[M•+] requires 172.0549; mp 81-87 °C; νmax (KBr) 3272, 3224, 3150, 3062, 2963, 1660, 1571, 
1513, 1428, 1396, and 1354, δH (400 MHz; CD3OD) 7.73 (0.08H, s), 7.43 (0.68H, s), 7.28 
(0.08H, s), 7.16 (0.08H, m), 2.18 (3H, s); δc (100 MHz, CD3OD) 170.9 (s, C=O), 134.6(s, C-
NH), 129.9(s, C-Cl), 129.4(m, C-D), 127.2 (m, C-D), 127.0 (m, C-D), 126.1 (m, C-D), 22.2 
(s, CH3); m/z (EI) 172 (M•+, 20%). 
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2,3,5,6-Tetradeutero-4-(trideuteromethyl)aniline (13) 
 
A solution of 4-methylaniline (300 mg, 2.8 mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (233 mg, 0.56 mmol, 20 mol %.) and DCl (35%) (921 µL, 11.2 mmol, 4 eq.)in D2O 
(3 mL) and reacted according to the general procedure A. To the solution thioglycolic acid 
(156 µL, 2.24 mmol, 4 eq. referred to the catalyst amount) was added and the mixture was 
stirred for 30 min, the rest of the the work up followed the general procedure A give the title 
compound as a brown/yellow powder (271 mg, 85%): Found M•+, 114.1170. C7H2D7N [M•+] 
requires 114.1174; mp 34-40 °C; νmax (KBr) 3417, 3343, 3220, 3022, 3006, 2499, 1617, 
1597, 1477, 1463,1442, 1294, 1254 and 1239; δH (400 MHz; CD3OD) a6.91 (0.74H, s), a6.91 
(0.12H, s), 2.16(0.23 H, m); δc (150 MHz, CD3OD) 145.3 (s, C-NH2),130.1 (t, C-D, JC-D 24), 
128.5 (s, C-CD3), 116.7 (t, C-D, JC-D 24), 19.8 (m, CD3); m/z (EI) 114 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
N-[2,3,5,6-Tetradeutero-4-(trideuteromethyl)phenyl]acetamide (13a) 
 
Acetyl chloride (85µL, 1.21 mmol, 1.1 eq.) was added to a stirred solution of d7-4-
methylaniline (13) (125 mg, 1.09 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (340 µL, 2.41 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to give 
the title compound as a colourless powder (136 mg, 79%): Found M•+, 156.1281. C9H4D7NO 
[M•+] requires 156.1280; mp 121-125 °C; νmax (KBr) 3289, 3245, 3166, 3092, 3031, 2930, 
2852, 2782, 1660, 1597, 1533, 1367, 1314, 1263, 1038 and 1013; δH (400 MHz; CD3OD) 
7.38 (0.12H, m), 7.15 (0.74H, s), 2.25 (0.23, s), 2.09 (3H, s); δc (100 MHz, CD3OD) 171.5 (s, 
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C=O), 137.2 (s, C-NH), 134.6 (s, C-CD3), 129.8 (t, C-D, JC-D 24), 120.9 (t, C-D, JC-D 24), 
23.7 (s, CH3), 20.0 (m, CD3); m/z (EI) 156 (M•+, 45%). 
2,4,6-Trideutero-3-methylaniline(14)210 
 
A solution of 3-methylaniline (300 mg, 2.8 mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (232 mg, 0.56 mmol, 20 mol %.) and DCl (35%) (923 µL, 11.2 mmol, 4 eq.)in D2O 
(3 mL) and reacted according to the general procedure A. To the solution thioglycolic acid 
(155 µL, 2.24 mmol, 4 eq. referred to the catalyst amount) was added and the mixture was 
stirred for 30 min, the rest of the the work up followed the general procedure Ato give the 
title compound as a yellow oil (303 mg, 97%): Found M•+, 110.1175. C7H6D3N [M•+] requires 
110.1174; νmax (KBr) 3433, 3354, 3219, 3056, 3007, 2921,, 1619, 1585, 1445 and 1403; δH 
(400 MHz; CD3OD) a6.82 (0.55H, s), a6.38 (0.35H, m), a2.05 (1.64H, s), δc(100 MHz, 
CD3OD) 148.6 (s, C-NH2), 140.1 (s, C-CH3), 130.3(s, C-H), 120.7 (m, C-D), 117.7 (t, C-D, 
JC-D 24), 114.3 (m, C-D), 22.7 (s, CH3); m/z (EI) 110 (M•+, 80%). 
aSignals arise from the presence of isotopologues. 
N-[2,4,6-Trideutero-3-methylphenyl]acetamide (14a) 
 
Acetyl chloride (127 µL, 1.79 mmol, 1.1 eq.) was added to a stirred solution of d7-3-
methylaniline (14) (196 mg, 1.63 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (503 µL, 3.57 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to give 
the title compound as a brown powder (240 mg, 92%): Found M•+, 152.1284. C9H8D3NO 
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[M•+] requires 152.1280; mp 48-53 °C; νmax (neat) 3300, 3112, 3059, 2965, 2926, 2393, 2063, 
2065 1661, 1652, 1602, 1575, 1538, 1442, 1393, 1310 and 11266; δH (400 MHz; CD3OD) 
7.35 (0.11H, s), 7.30 (0.09H, m),7.15 (0.55H, s), 6.90 (0.11, m), 2.30 (1.65H, m), 2.10(3H,s); 
δc (150 MHz, CD3OD) 171.8 (s, C=O), 139.7(s, C-NH), 129.5(s, C-CH3), 129.4 (s, C-H), 
125.6 (m, C-D),121.5 (t, C-D, JC-D 25), 118 (m, C-D), 24.05 (s, CH3), 21.62 (s, CH3); m/z 
(EI) 152 (M•+, 65%). 
4,5,6-Trideutero-2-(trideuteromethyl)aniline (15) 
 
A solution of 2-methylaniline (300 mg, 298 µL, 2.8 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (232 mg, 0.56 mmol, 20 mol %.) and DCl (35%) (923 µL, 11.2 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (155 µL, 2.24 mmol, 4 eq. referred to the catalyst amount) was added and 
the mixture was stirred for 30 min, the rest of the the work up followed the general procedure 
A to give the title compound as a brown/yellow oil (264 mg, 85%): Found M•+, 113.1173. 
C7H3D6N [M•+] requires 113.1174; νmax (KBr) 3445, 3369, 3228, 3051, 3006, 2957, 2906, 
2163, 2517,1621, 1581, 1448, 1422, 1380 and 1305; δH (400 MHz; CD3OD) a6.98 (0.07H, 
s),a6.97 (0.54H, s),a6.69 (0.09H, s), a6.65 (0.08,m), 2.08 (0.33H, s); δc (100 MHz, CD3OD) 
146.3 (s, C-NH2), 131.2 (s, C-H), 127.4 (t, C-D, JC-D 24), 124.1 (s, C-CD3), 119.4 (m, C-D), 
116.2 (t, C-D, JC-D 24), 17.5 (m, CD3); m/z (EI) 113 (M•+, 40%). 
aSignals arise from the presence of isotopologues. 
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N-[4,5,6-Trideutero-2-(trideuteromethyl)phenyl]acetamide (15a) 
 
Acetyl chloride (109 µL, 1.5 mmol, 1.1 eq.) was added to a stirred solution of d7-2-
methylaniline (15) (160 mg, 1.4 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (432 µL, 3.07 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure A. 
Purification by chromatography column, eluting with petroleum ether/ethyl actetae (3/1) gave 
the title compound as a brown powder (148 mg, 66 %): Found M•+, 155.1283. C9H5D6NO 
[M•+] requires 155.1280; mp 101-110 °C; νmax (KBr) 3292, 3014, 2925, 2851, 2426, 2050, 
1837, 1636 and 1515; δH (400 MHz; CD3OD) 7.31 (0.09H, s), 7.20 (0.54H, s), 7.15 (0.08H, 
m), 7.11 (0.07, s), 2.20 (0.33H, m), 2.13 (3H, s); δc (150 MHz, CD3OD) 172.1 (s, C=O), 
136.9 (s, C-NH), 134.1 (s, C-CD3), 131.5 (s, C-H), 126.8 (m, C-D), 23.1 (s, CH3), 17.6 (m, 
CD3); m/z (EI) 155 (M•+, 45%). 
2,3,5,6-Tetradeutero-4-(1,1,2,2,2-pentadeutero)ethylaniline (16) 
 
A solution of 4-ethylaniline (300 mg, 309 µL, 2.48 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (205mg, 0.48 mmol, 20 mol %.) and DCl (35%) (816 µL, 9.92 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (136 µL, 1.92 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min,  the rest of the the work up followed the general procedure A 
to give the title compound as a brown oil (180 mg, 56%): Found M•+, 130.1456. C8H2D9N 
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[M•+] requires 130.1456; νmax (KBr) 3349, 2960, 1617, 1477, 1463, 1442, 1301and 1254; δH 
(400 MHz; CD3OD) a6.93 (0.77H, s), a6.67 (0.27H, m), a2.46 (0.17 H, m), a1.05 (0.24 H, m); 
δc (150 MHz, CD3OD) 145.7(s, C-NH2), 135.5(s, C-C), 128.9 (m, C-D ), 116.9 (m, C-D), 
28.1 (m, CD2), 15.8 (m, CD3); m/z (EI) 130 (M•+, 50%). 
aSignals arise from the presence of isotopologues. 
N-[2,3,5,6-tetradeutero-4-(1,1,2,2,2-pentadeuteroethyl)phenyl]acetamide 
(16a) 
 
Acetyl chloride (95µL, 1.34 mmol, 1.1 eq.) was added to a stirred solution of d9-4-
ethylaniline (16) (150 mg, 1.22 mmol, 1 eq.) in DCM (10 mL) and NEt3 on ice (270µL, 2.68 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to give 
the title compound as a brown powder (210 mg, 95%): Found M•+, 172.1560.C10H4D9NO 
[M•+] requires 172.1562; mp 45-49 °C; νmax (KBr) 3298, 3094, 3227, 2962,1664, 1593, 1524, 
1372, 1313 and 1264; δH (400 MHz; DMSO) 7.44 (0.27H, m), 7.15 (0.77H, s), 2.58 (0.17H, 
m), 2.12 (3H, s), 1.19 (0.24H, m); δc (150 MHz, CD3OD) 171.5 (s, C=O), 140.5 (s, C-NH), 
137.3 (s, C-C), 128.6 (t, C-D, JC-D 24), 121.1 (m, C-D), 28.5 (m,CD2), 23.8(s, CH3), 15.3 (m, 
CD3); m/z (EI) 172 (M•+, 65%). 
2,4,5,6-Tetradeutero-3-(1,1,2,2,2-pentadeutero)ethylaniline (17) 
 
A solution of 3-ethylaniline (300 mg, 307 µL, 2.48 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (205mg, 0.48 mmol, 20 mol %.) and DCl (35%)(816 µL, 9.92 mmol, 4 
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eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (141 µL, 1.99 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min, the rest of the the work up followed the general procedure A 
to give the title compound as a brown oil (260 mg, 81%): Found M•+, 130.1452. C8H2D9N 
[M•+] requires 130.1456; νmax(KBr) 3442, 3350, 3220, 2934, 1618, 1518, 1400, 1301, 1258 
and 1053; δH (400 MHz; CD3OD) a6.99 (0.08H, s), a6.59 (0.08H, s), a6.54 (0.16H, s), a2.48 
(0.21H, s), a1.13 (0.28H, s); δc(150 MHz, CD3OD) 148.2(s, C-NH2), 146.1(s, C-C), 129.4 (t, 
C-D, JC-D 24), 118.7(t, C-D, JC-D 24), 116.0 (t, C-D, JC-D 23), 113.8(t, C-D, JC-D 23), 29.1 (m, 
CD2), 15.2 (m, CD3); m/z (EI) 130 (M•+, 80%). 
aSignals arise from the presence of isotopologues. 
N-[2,4,5,6-tetradeutero-3-(1,1,2,2,2-pentadeuteroethyl)phenyl]acetamide 
(17a) 
 
Acetyl chloride (127 µL, 1.79 mmol, 1.1 eq.) was added to a stirred solution of d9-3-
ethylaniline (17) (200 mg, 1.63 mmol, 1 eq.) in DCM (10 mL) and NEt3 on ice (503 µL, 3.59 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to give 
the title compound as a yellow oil (281mg, 87%): Found M•+, 172.1562. C10H4D9NO [M•+] 
requires 172.1562; νmax (KBr) 3301, 3152,3104, 3054, 2931, 2860, 1667, 1537, 1393, 1269, 
1127 and 835; δH (400 MHz; DMSO) 7.37 (0.08H, s), 7.33 (0.08H, s), 7.19 (0.08H, s), 6.93 
(0.08H, s), 2.57 (0.21H, s), 2.11 (3H, s), 1.16 (0.28H, m); δc(150 MHz, CD3OD) 171.4(s, 
C=O), 145.7 (s, C-NH), 139.5(s, C-C), 129.1 (t, C-D, JC-D 24), 124.2 (t, C-D, JC-D 24), 120.2 
(t, C-D, JC-D 24), 118.1(t, C-D, JC-D 25), 28.8 (m, CD2), 23.9 (s, CH3), 15.0 (m, CD3); m/z (EI) 
172 (M•+, 20%). 
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4,5,6-Trideutero-2-(1,1,2,2,2-pentadeutero)ethylaniline (18) 
 
A solution of 2-ethylaniline (300 mg, 293 µL, 2.48 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (205mg, 0.48 mmol, 20 mol %.) and DCl (35%) (816 µL, 9.92 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (136 µL, 1.92 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min, the rest of the the work up followed the general procedure A 
to give the title compound as a yellow oil (239 mg, 75%): Found M•+, 128.1395. C8H4D7N 
[M•+] requires 128.1394; νmax(KBr) 3227, 3184, 3107, 3046, 3012, 2929, 2784, 1648, 1566, 
1524, 1374 and 1272; δH (500 MHz; CD3OD) a6.99 (0.77H, s), a6.94 (0.08H, m), a6.71 
(0.08H, s), a6.66 (0.08H, d, J
 H-H 7.5), a2.49 (0.36H, m), a1.53 (0.24H, m); δc (150 MHz, 
CD3OD) 145.6 (s, C-NH2), 129.9 (s, C-C), 129.2 (s, C-H), 127.3 (m, C-D), 119.4 (m, C-D) , 
116.6 (m, C-D), 24.5 (m, CD2), 13.3 (m, CD3); m/z (EI) 128 (M•+, 50%). 
aSignals arise from the presence of isotopologues. 
N-[4,5,6-Trideutero-2-(1,1,2,2,2-pentadeuteroethyl)phenyl)]acetamide (18a) 
 
Acetyl chloride (56µL, 0.81 mmol, 1.1 eq.) was added to a stirred solution of d8-2-
ethylaniline (18) (96 mg, 0.74 mmol, 1 eq.) in DCM (10 mL) and NEt3 on ice (228.6 µL, 1.63 
mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B. 
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Purification by chromatography column, eluting with petroleum ether/ ethyl acetate (3/1) 
gave the title compound as a yellow powder (39 mg, 31%): Found M•+, 171.1500. 
C10H5D8NO [M•+] requires 171.1499; mp 106-108 °C; νmax (KBr) 3459, 3374, 3227, 3048, 
3006,2936, 1619, 1561 and 1446; δH (400 MHz; DMSO) 7.32 (0.08H, s), 7.21 (0.77H, s), 
7.12 (0.16H, m), 2.55 (0.36H, m), 2.04 (3H, s), 1.05 (0.24H, m); δc (150 MHz, CD3OD) 
172.5 (s, C=O), 140.5 (s, C-NH), 136.3 (s, C-C), 129.8 (s, 1CH), 127.9 (m, C-D), 127.0 (m, 
C-D), 126.9 (m, C-D), 25.3 (m, CD2), 24.2 (s, CH3), 13.5 (m, CD3); m/z (EI) 171 (M•+, 60%). 
4,5,6-Trideutero-2-(1,1,1,3,3,3-hexadeuteroprop-2-yl)aniline (19) 
 
A solution of 2-isopropylaniline (300 mg, 314 µL, 2.22 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (184 mg, 0.44 mmol, 20 mol %.) and DCl (35%) (731 µL, 8.88 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (136 µL, 1.92 mmol, 4 eq. referred to the catalyst amount) was added and 
the mixture was stirred for 30 min, the rest of the the work up follow the general procedure A 
to give the title compound as a brown oil (229 mg, 72%): Found M•+, 144.1615. C9H4D9N 
[M•+] requires 144.1613; νmax (KBr) 3464, 3375, 3228, 3060 , 2929, 2067, 1619, 1561, 1446, 
1383 and 1302; δH (400 MHz; CD3OD) a7.08 (0.94H, s), a6.92 (0.09H, s), a6.70 (0.18H, m), 
a2.97 (0.71H, m), a1.22 (0.98H, d, JH-H 6.98); δc (150 MHz, CD3OD) 144.9 (s, C-NH2), 
134.4(s, C-C), 126.8 (t, C-D, JC-D 24), 126.0 (s, C-H), 119.6 (t, C-D, JC-D 24), 117.0 (t, C-D, 
JC-D 24), 28.0(s, C-H), 22.5 (m, CD3); m/z (EI) 144 (M•+, 30%). 
aSignals arise from the presence of isotopologues. 
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N-[4,5,6-trideutero-2-(1,1,1,3,3,3-hexadeuteroprop-2-yl)phenyl)acetamide 
(19a) 
 
Acetyl chloride (92.43 µL, 1.3 mmol, 1.1 eq.) was added to a stirred solution of d10-2-
isopropylaniline (19) (180 mg, 1.23 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (379µL, 
2.70 mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to 
give the title compound as a yellow powder (162 mg, 72 %): Found M•+, 
186.1787.C11H6D9NO [M•+] requires 186.1781; mp 43-47 °C; νmax (KBr) 3289, 3013, 2959, 
29525, 2780, 2130, 2066, 1653, 1522, 1289, 1011, 973, 694 and 608; δH (400 MHz; CD3OD) 
7.34 (0.95H, s), 7.24 (0.09H, s), 7.18 (0.18H), 3.13 (0.71H, s), 2.14 (3H,s),1.58 (0.98H, d, JH-
H 6.98); δc (150 MHz, CD3OD) 172.7 (s, C=O), 145.6 (s, C-NH), 135.3(s, C-C), 128.0 (m, C-
D), 126.9 (t, C-D, JC-D 24), 126.8 (s, C-H), 28.8 (m, C-H), 23.5 (m, CD3), 22.9 (s, CH3); m/z 
(EI) 186 (M•+, 92%). 
2,6-Dideutero-4-(1,1,1,3,3,3-hexadeuteroprop-2-yl)aniline (20) 
 
A solution of 4-isopropylaniline (300 mg, 303 µL, 2.22 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (182 mg, 0.44 mmol, 20 mol %.) and DCl (35%) (731 µL, 8.88 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (122 µL, 1.76 mmol, 4 eq. referred to the catalyst amount) was added and 
the mixture was stirred for 30 min, the rest of the the work up follow the general procedure A 
to give the title compound as a green oil (209 mg, 62%); Found M•+, 143.1678. C9H5D8N 
[M•+] requires 143.1676; νmax (KBr) 3349, 3216, 3022, 2927, 2889, 2065, 1618, 1477, 1460, 
Chapter 7: Experimental 
 
- 139 - 
 
1259;δH (400 MHz; CD3OD) a6.93 (1.12H, s), a6.68 (0.19H, s), a2.46 (0.72H, s),a1.57(0.53H, 
s); δc(150 MHz, CD3OD) 145.8 (s, C-NH2), 140.2(s, C-C), 127.7 (s, C-H), 116.7 (t, C-D, JC-D 
23), 34.2(s, C-H) , 23.9 (m, CD3); m/z (EI) 143 (M•+, 60%). 
aSignals arise from the presence of isotopologues. 
N-[2,6-Dideutero-4-(1,1,1,3,3,3-hexadeuteroprop-2-yl)phenyl]acetamide 
(20a) 
 
Acetyl chloride (92.43 µL, 1.3 mmol, 1.1 eq.) was added to a stirred solution of d6-4-
isopropylaniline (20) (166 mg, 1.16 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (337 µL, 
2.5 mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to 
give the title compound as a yellow powder (128 mg, 60 %): Found M•+, 185.1783. 
C11H7D8NO[M•+] requires 185.1781; mp 91-100 °C;νmax (KBr) 3284, 3240, 3167, 3095, 
3041, 2963, 2934, 2893, 2065, 1662, 1604, 1540, 1515,1370 and 1306; δH(400 MHz; 
CD3OD) 7.42 (0.19H, m), 7.16 (1.12H, s), 2.82 (0.77H, s), 2.10 (3H,s), 1.18 (0.53H, m); δc 
(150 MHz, CD3OD) 171.6 (s, C=O), 146.1 (s, C-NH), 137.4 (s, C-C), 127.4 (s, C-H), 121.2 
(m, C-D), 34.4 (s, C-H), 23.7 (s, CH3), 13.5 (m, CD3); m/z (EI) 185 (M•+, 90%). 
2,6-Dideutero-4-(1,1,2,2,3,3,3-heptadeuteropropyl)aniline (21) 
 
A solution of 4-n-propylaniline (300 mg, 326 µL, 2.22 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (184 mg, 0.44 mmol, 20 mol %.) and DCl (35%) (732 µL, 8.88 mmol, 4 
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eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (122 µL, 1.76 mmol, 4 eq. referred to the catalyst amount) was added and 
the mixture was stirred for 30 min,the rest of the the work up follow the general procedure A 
to give the title compound as a brown oil (268 mg, 87%): Found M•+, 144.1734. C9H4D9N 
[M•+] requires 144.1738; νmax(KBr) 3354, 3240, 3020, , 2907, 2509, 1581, 2102, 1619, 1258, 
and 1258; δH (400 MHz; CD3OD) a6.93(0.46H, s), a6.68(0.19H, s), a2.46(0.40H, 
s),a1.57(0.57H, s),a0.91(0.42H, s); δc(100 MHz, CD3OD) 144.6 (s, C-NH2), 132.7(s, C-C), 
128.9 (s, C-H), 115.7 (t, C-D, JC-D 24), 36.7(m, CD2) , 24.2 (m, CD2), 12.4 (m, CD3); m/z (EI) 
144 (M•+, 70%). 
aSignals arise from the presence of isotopologues. 
N-[2,6-dideutero-4-(1,1,2,2,3,3,3-heptadeuteropropyl)phenyl]acetamide 
(21a) 
 
Acetyl chloride (70.3 µL, 0.98 mmol, 1.1 eq.) was added to a stirred solution of d9-4-n-
propylaniline (21) (125 mg, 0.89 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (274.6 µL, 
1.96 mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B. 
Purification by chromatography column, eluting with petroleum ether/ ethyl acetate (3/1) 
gave the title compound as a brown powder (63 mg, 39 %): Found M•+, 186.1838. 
C11H6D9NO [M•+] requires 186.1844, mp 82-86 °C; νmax (KBr) 3281, 3168, 3094, 3025, 
2962, 2930, 2854, 2386, 2102, 2067, 1637, 1595 and 1479; δH (400 MHz; CD3OD) 7.30 
(0.19H, m), 6.98 (1.53H, s), 2.39 (0.40H, m), 1.98 (3H,s), 1.45 (0.57H, m), 0.75 (0.42H, m); 
δc (100 MHz, CD3OD) 171.9 (s, C=O), 140.1 (s, C-NH), 137.8 (s, C-C), 130.1(s, C-H), 121.3 
(t, C-D, JC-D 24), 38.0 (m, CD2), 25.3 (m,CD2), 24.2 (s, CH3), 13.5 (m, CD3); m/z (EI) 186 
(M•+, 90%). 
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2,6-Dideutero-4-tert-butylaniline (22) 
 
A solution of 4-tert-butylaniline (300 mg, 318 µL, 2.01 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (166 mg, 0.40 mmol, 20 mol %.) and DCl (35%) (662 µL, 8.04 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (113 µL, 1.60 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min, the rest of the the work up follows the general procedure A 
was added to give the title compound as a brown oil (167 mg, 55%): Found M•+, 151.1334. 
C10H13D2N [M•+] requires 151.1330; νmax (KBr) 3434, 3353, 3215, 3063, 3034, 2927, 2868, 
2253, 1619, 1500, 1216, 1043 and 898; δH (400 MHz; CD3OD) a7.13(1.83H, s), a6.67(0.23H, 
d, JH-H 9.03), a1.25 (7.72H, s); δc (150 MHz, CD3OD) 145.1 (s, C-NH2), 142.1 (s, C-C), 126.5 
(s, C-H), 116.2 (t, C-D, JC-D 25), 34.5 (m, C-CD3), 31.7 (m, CD3); m/z (EI) 151 (M•+, 40%). 
aSignals arise from the presence of isotopologues. 
N-[2,6-dideutero-4-tert-butylphenyl)]acetamide (22a) 
 
Acetyl chloride (65.8 µL, 0.88 mmol, 1.1 eq.) was added to a stirred solution of d2-4-tert-
butylaniline (22) (127 mg, 0.84 mmol, 1 eq.) in DCM (10 mL) and NEt3 on ice (259.5 µL, 
1.85 mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to 
give the title compound as a colourless powder (102 mg, 63%): Found M•+, 193.1435. 
C12H15D2NO [M•+] requires 193.1436; mp 154-159 °C; νmax (KBr) 3289, 3248, 3172, 3096, 
3034, 2958, 2926, 2865, 1688, 1670, 1604, 1537, 1471, 1382, 1321, 1266, 1043, 1010, 969, 
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899 and 765;δH (400 MHz; CD3OD) 7.41 (0.23H, d, JH-H 9.03), 7.34 (1.83H, s), 2.10 (3H, s), 
1.30 (7.72H, s); δc (150 MHz, CD3OD) 171.5 (s, C=O), 148.1 (s, C-NH), 137.0(s, C-C), 
126.4(s, C-H), 120.7 (t, C-D, JC-D 24), 35.0 (m, C-CD3),31.5 (m, CD3), 23.7 (s, CH3); m/z 
(EI) 193 (M•+, 30%). 
1-(2,3,4,5,6-Pentadeuterophenyl)piperazine (23) 
 
A solution of 1-phenylpiperazine (300 mg, 282 µL, 1.85 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (153 mg, 0.37 mmol, 20 mol %.) and DCl (35%) (609 µL, 7.4 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedures A. To the solution 
thioglycolic acid (113 µL, 1.61 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min, the rest of the the work up follow the general procedure A to 
give the title compound as a yellow oil (257 mg, 83%): Found M•+, 167.1470. C10H9D5N2 
[M•+] requires 167.1471; νmax  (neat) 3302, 3047, 2947, 2828, 1575, 1550, 1436, 1381, 1326, 
1274 and 1227; δH (400 MHz; CD3OD) a7.23 (1.00H, s), a7.10 (0.02H, d, JH-H 3.55), a6.96 
(0.02H, d, JH-H 3.55), 3.10 (4H, dt, J1 H-H 16.2, J2 H-H 5.8), 2.95 (4H, dt, J1 H-H 16.2, J2 H-H 5.8); 
δc (150 MHz, CD3OD) 153.0(s, C-NH2), 129.8 (s, C-H), 120.7 (t, C-D, JC-D 25), 117.5 (t, C-
D, JC-D 25), 51.1 (s, CH2), 46.4 (s, CH2); m/z (EI) 167 (M•+, 45%). 
aSignals arise from the presence of isotopologues. 
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1-Acetyl-4-(2,3,4,5,6-pentadeuterophenyl)piperazine (23a) 
 
Acetyl chloride (94.2 µL, 1.20 mmol, 1.1 eq.) was added to a stirred solution of d5-1-
phenylpiperazine (23) (191 mg, 1.09 mmol, 1 eq.) in DCM (10 mL) and NEt3 on ice (242 µL, 
2.40 mmol, 2.2 eq.) under N2 atmosphere and reacted according to the general procedure B to 
give the title compound as a colourless powder (56 mg, 24%): Found M•+, 209.1572. 
C12H11D5N2O [M•+] requires 209.1576; mp 43-48 °C; νmax (KBr) 3282, 2916, 2849,2815, 
1627, 1573, 1428, 1277, 1254, 1226, 1043, 1002 and 985; δH (400 MHz; CD3OD) 7.24 
(1.07H, s), 7.09 (0.02H, d, JH-H 3.55), 6.96 (0.02H, d, JH-H 3.55), 3.73 (4H, dt, J1 H-H 16.2, J2 
H-H 5.8), 3.17 (4H, dt, J1 H-H 16.2, J2 H-H 5.8), 2.14(3H,s); δc (150 MHz, CD3OD) 171.7 (s, 
C=O), 152.4 (s, C-NH), 129.9 (s, C-H), 121.1 (t, C-D, JC-D 24), 117.7 (t, C-D, JC-D 24), 
51.0(s, C-NH), 47.4(s, CH2), 42.7 (s, CH2), 21.1 (s, CH3); m/z (EI) 167 (M•+ - COCH3, 40%). 
2,5,6-Trideutero-3-aminopyridine (24) 
 
A solution of 3-aminopyridine (300 mg, 3.19 mmol, 1 eq) was added to a stirred solution of 
K2PtCl4 (261 mg, 0.63 mmol, 20 mol %.) and DCl (35%) (1 mL, 12.7 mmol, 4 eq) in D2O (3 
mL) and reacted according to the general procedure A. To the solution thioglycolic acid (232 
mg, 178 µL, 2.52 mmol, 4 eq referred to the catalyst amount) was added and the mixture was 
stirred for 30 min, the rest of the the work up follow the general procedure A to give the title 
compound as a colourless powder (181 mg, 58 %): Found M•+, 97.0783. C5H3D3N2 [M•+] 
requires 97.0783; mp 48-51 ºC; νmax (KBr) 3338, 3210, 3210,2522, 1631, 1579, 1441,1414 
and 1260; δH (400 MHz; CD3OD) a7.97 (0.04H, s), a7.76 (0.17H, s), a7.06 (0.26H, s), a6.92 
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(0.60H, s); δc(100 MHz, CD3OD) 146.8 (s, C-NH2), 138.5 (t, C-D, JC-D 29), 137.3 (t, C-D, JC-
D 29), 125.8 (t, C-D, JC-D 27), 123.4 (s, C-H); m/z (EI) 97 (M•+, 100). 
aSignals arise from the presence of isotopologues. 
N-[2,5,6-Trideuteropyridin-3-yl]acetamide (24a) 
 
d3-3-Aminopyridine (24) (89 mg, 0.91 mm, 1 eq.) was dissolved in acetone (15 mL), and 
K2CO3 (626.6 mg, 4.54 mmol, 5 eq.) was added, followed by the dropwise addition of acetyl 
chloride (214 mg, 194 µL, 2.73 mmol, 3 eq.) in acetone (5 ml) and reacted according to the 
general procedure C to give the title compound as a brown powder (82 mg, 64%): Found M•+, 
139.0890. C7H4D3N2O [M•+] requires 139.0888; mp 128-131 °C; νmax (KBr) 3223, 3143, 
2963, 2921, 1842, 1685 and 1673; δH (400 MHz; CD3OD):8.73 (0.04H, s), 8.26 (0.17H, s), 
8.12 (0.60H, s), 7.41 (0.26, s), 2.18 (3H, s); δc (150 MHz, CD3OD) 17202 (s, C=O), 144.6 (t, 
C-D, JC-D 29), 144.2 (t, C-D, JC-D 28), 137.4 (s, C-NH), 128.7(s, C-H), 125.1 (t, C-D, JC-D 28), 
24.4 (s, CH3); m/z (EI) 139 (M•+, 20%). 
2-Deutero-3-aminopyridine (25) 
 
A solution of 3-aminopyridine (300 mg, 3.19 mmol, 1 eq.) was added to a stirred solution of 
DCl (35%) (1 mL, 12.7 mmol, 4 eq.)in D2O (3 mL) and reacted according to the general 
procedure A to give the title compound as a colourless powder (129 mg, 42%): Found M•+, 
95.0595. C5H5DN2 [M•+] requires 95.0594; mp 48-51 ºC; νmax (KBr) 3351, 3175, 3074, 1635, 
1582, 1463 and 1435; δH (400 MHz; CD3OD) a7.97 (0.05H, s), a7.66 (0.79H, dd, J1 H-H 4.45, 
J2 H-H 1.67), a7.00 (1.60H, m); bδc(100 MHz, CD3OD) 146.8 (s, C-NH2), 138.5 (s, C-H), 125.8 
(s, C-H), 123.4 (s, C-H); m/z (EI) 95 (M•+, 100%). 
aSignals arises from the presence of isotopologues. 
bSignal presents at too high deuteration level for recording of 13C. 
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N-[2-Deuteropyridin-3-yl]acetamide (25a) 
 
d1-3-Aminopyridine (25) (113 mg, 1.15 mm, 1 eq.) was dissolved in acetone (15 mL), and 
K2CO3 (729.3 mg, 5.78 mmol, 5 eq.) was added, followed by the dropwise addition of acetyl 
chloride (270 mg, 245 µL, 3.45 mmol, 3 eq.) in acetone (5 ml) and reacted according to the 
general procedure C to give the title compound as a colourless powder (40 mg, 24%): Found 
M•+, 137.0700. C7H7DN2O [M•+] requires 137.0699; mp 127-131 °C; νmax (KBr) 3294, 3237, 
3167,3102, 2887, 2826,1686 and 1607; δH (400 MHz; CD3OD):8.73 (0.05H, s), 8.26 (0.79H, 
dd, J1 H-H 4.45, J2 H-H 1.67), 8.12 (0.80H, dd, J1 H-H 8.37, J2 H-H 1.42) 7.41 (0.80, dd, J1 H-H 8.19, 
J2 H-H 4.80), 2.18 (3H, s); bδc (100 MHz, CD3OD) 172.5 (s, C = O), 145.5(s, C-H), 137.9 (s, 
C-NH), 129.3 (s, C-H), 125.8 (s, C-H), 24.2 (s, CH3); m/z (EI) 137 (M•+, 95%).  
bSignal presents a too high deuteration level for recording on 13C. 
3,4,5,6-Tetradeutero-2-aminopyridine (26) 
 
A solution of 2-aminopyridine (300 mg, 3.19 mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (264 mg, 0.64 mmol, 20 mol %.) and DCL (35%) (1 mL, 12.7 mmol, 4 eq.)in D2O (3 
mL) and reacted according to the general procedure A. To the solution thioglycolic acid (181 
µL, 2.52 mmol, 4 eq. referred to catalyst amount) was added and the mixutre was stirred for 
30 min, the rest of the work up follows the general procedure A to give the title compound as 
a colourless powder (247 mg, 79%): Found M•+, 98.0782. C5H2D4N2 [M•+] requires 98.0784; 
mp 43-49 ºC; νmax (KBr) 3445, 3304, 3305, 3166, 2532, 1629, 1569, 1535 and 1428; δH (400 
MHz; CD3OD,) a7.87 (0.13H, s), a7.44 (0.17H, s), a7.44 (0.09H, s); δc (150 MHz, CD3OD) 
160.8 (s, C-NH2), 147.4 (t, C-D, JC-D 26), 138.8 (t, C-D, JC-D 24), 113.5 (t, C-D, JC-D 26), 
110.0 (t, C-D, JC-D 25); m/z (EI) 98 (M•+, 100). 
aSignals arise from the presence of isotopologues. 
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N-[3,4,5,6-Tetradeuteropyridin-2-yl]acetamide (26a) 
 
d4-2-Aminopyridine (26) (190 mg, 1.9 mm, 1 eq.) was dissolved in acetone (50 mL), and 
K2CO3 (1.34 g, 9.6 mmol, 5 eq.) was added, followed by the dropwise addition of acetyl 
chloride (447.4 mg, 405 µL, 5.7 mmol, 3 eq.) in acetone (5 ml) and reacted according to the 
general procedure C. Purification by chromatography column, eluting with DCM/MeOH 
(100/1) gave the title compound as a brown powder (160 mg, 60 %): Found M•+, 140.0891. 
C7H4D4N2O[M•+] requires 140.0888; mp 56-63 °C; νmax (KBr) 3217, 3139, 3046, 3002, 2321, 
1695, 1549 and 1510; δH (400 MHz; CD3OD): 8.27 (0.13H, s), 8.07 (0.09H, s), 7.75 (0.09H, 
s), 7.09 (0.07H, s); 2.08 (3H, s); δc (100 MHz, CD3OD) 170.7 (s, C=O), 151.6(s, C-NH), 
147.5 (m, C-D), 137.8(m, C-D), 119.2 (m, C-D), 114.1 (m, C-D), 22.7 (s, CH3); m/z (EI) 140 
(M•+, 45%). 
2,3,5,6-Tetradeutero-4-aminopyridine (27) 
 
A solution of 4-aminopyridine (300 mg, 3.19 mmol, 1 eq) was added to a stirred solution of 
K2PtCl4 (264 mg, 0.64 mmol, 20 mol %.) and DCl (35%) (1mL, 12.7 mmol, 4 eq) in D2O (3 
mL) and reacted according to the general procedure A. To the solution thioglycolic acid (181 
µL, 2.52 mmol, 4 eq referred to catalyst amount) was added and the mixutre was stirred for 
30 min, the rest of the work up follows the general procedure A to give the title compound as 
a colourless powder (73 mg, 23%): Found M•+, 98.0782. C5H2D4N2 [M•+] requires 98.0782; 
mp 143-147 ºC; νmax (KBr) 3436, 3304, 3074, 3081, 2531, 1647 and 1576; δH (400 MHz; 
CD3OD) a7.97 (0.53H, s), a6.57 (0.16H, s); δc (150 MHz, CD3OD) 156.8 (s, C-NH2), 149.5 (t, 
C-D, JC-D 26), 110.2 (m, C-D); m/z (EI) 98 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
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N-[2,3,5,6-Tetradeuteropyridin-4-yl]acetamide (27a) 
 
d4-4-Aminopyridine (27) (73 mg, 0.74 mm, 1 eq.) was dissolved in acetone (15 mL), and 
K2CO3 (516mg, 3.74 mmol, 5 eq.) was added, followed by dropwise addition of acetyl 
chloride (174 mg, 157µL, 2.22 mmol, 3 eq.) in acetone (5 ml) and reacted according to the 
general procedure C to give the title compound as a colourless powder (50 mg, 48%): Found 
M•+, 140.0892. C7H4D4N2O [M•+] requires 140.0888; mp 138-141 °C; νmax (KBr) 3444, 3311, 
3146, 3046, 1688, 1615, 1565 and 1508; δH (400 MHz; CD3OD): 8.39(0.16H, s), 7.63(0.53H, 
s), 2.18 (3H, s); δc (150 MHz, CD3OD) 172.4 (s, C=O), 150.7(t, C-D, JC-D 29), 148.0 (s, C-
NH), 114.7 (m, C-D), 24.2 (s, CH3); m/z (EI) 140 (M•+, 98%). 
5,6-Dideutero-3-amino-2-(trideuteromethyl)pyridine (28) 
 
A solution of 3-amino-2-methylpyridine (150 mg, 1.3 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (113 mg, 0.27 mmol, 20 mol %.) and DCl (35%) (454 µL, 5.52 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (76 µL, 1.08 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min, the rest of the work up follow the general procedure A to give 
the title compound as a colourless powder (95 mg, 64%): Found M•+, 114.1061. C6H2D6N2 
[M•+] requires 114.1064; mp 91-97 ºC; νmax (KBr) 3345, 3311, 3164, 2536, 2404, 2367, 2194, 
1631, 1553, 1436, 1264, 1197, 1042 and 877; δH (400 MHz; CD3OD) a7.70 (0.04H, d, JH-H 
5.13),a7.06 (0.33H, s), a6.99 (0.06H d, JH-H 8.05), a2.32 (0.44 H, m); δc (150 MHz, CD3OD) 
144.5 (s, C-NH2), 144.4 (s, C-CD3), 137.9 (t, C-D, JC-D 28), 123.5 (t, C-D, JC-D 25), 123.9 (s, 
C-D, JC-D 27), 19.5 (m, CD3); m/z (EI) 114 (M•+, 75%). 
aSignals arise from the presence of isotopologues. 
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N-[5,6-Dideutero-2-(trideuteromethyl)pyridin-3-yl]acetamide (28a) 
 
The solution of d6-3-amino-2-methylpyridine (28) (88 mg, 0.77 mmol, 1 eq.) in Ac2O (10 
mL, 10.5 mmol, 6 eq.), was refluxed for 2h at 120oC. After cooling to room temperatuere the 
reaction mixture was treated by brine and diluited with NaOH 1M. The aqueous phase has 
been extracted with ethyl acetate (x3). The organics extracts were combined, dried over 
MgSO4, filtered and evaporated under vacuum to obtain colourless powder (50 mg, 41%): 
Found M•+, 156.1169. C8H4D6N2O [M•+] requires 156.1170; mp 46-52 °C; νmax (KBr) 3841, 
3296, 3077, 3006, 2926, 2850, 2785, 1660, 1567, 1511, 1377, 1174, 1013, 954 and 705; δH 
(400 MHz; CD3OD): 8.25 (0.04H, s), 7.88 (0.33H, s), 7.28 (0.04H, s), 2.46 (0.44 H,m), 2.18 
(3H, s); δc (150 MHz, CD3OD): 172.3 (s, C=O), 153.8 (s, C-NH), 146.5 (t, C-D, JC-D 27), 
134.7 (t, C-D, JC-D 24), 134.1 (s, C-CD3), 122.7 (s, C-D, JC-D 27), 23.1 (s, CH3), 20.1 (m, 
CD3); m/z (EI) 156 (M•+, 80%). 
2,6-Dideutero-3-amino-4-(trideuteromethyl)pyridine (29) 
 
A solution of 3-amino-4-methyl-pyridine (300 mg, 2.7 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (224 mg, 0.54 mmol, 20 mol %.) and DCl (35%) (889 µL, 10.8 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (153 µL, 2.16 mmol, 4 eq. referred to catalyst amount) was added and left 
under stirring for half an hour. The rest of the work up follows the general procedure A to 
give the title compound as colourless powder (221 mg, 73%): Found M•+, 113.1001. 
C6H3D5N2 [M•+] requires 113.1001; mp 100-104ºC; νmax (KBr) 3441, 3325, 3201, 2573, 2523, 
2194, 1643, 1587 and 1550; δH (400 MHz; CD3OD,) a7.90 (0.05H, s),a7.70 (0.05H, d, JH-H 
5.03), a7.03 (0.81H, s), a2.14 (0.18H, m); δc(150 MHz, CD3OD) 144.7 (s, C-NH2),138.9 (t, C-
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D, JC-D 27),138.6 (t, C-D, JC-D 27), 132.8 (s, C-C), 126.4 (s, C-H), 16.2 (m, CD3); m/z (EI) 
113 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
N-[2,6-Dideutero-4-(trideuteromethyl)pyridin-3-yl]acetamide (29a) 
 
d5-3-Amino-4-methylpyridine (29) (175 mg, 1.5 mmol, 1 eq.) was dissolved in acetone (20 
mL), and K2CO3 (1.05 g, 7.7 mmol, 5 eq.) was added, followed by the dropwise addition of 
acetyl chloride (353 mg, 319µL, 4.6 mmol, 3 eq.) in acetone (5 ml) and reacted according to 
the general procedure C to give the title compound as a brown powder (113 mg, 48%): Found 
M•+, 155.1107. C8H5D5N2O [M•+] requires 155.1107; mp 98-103 °C; νmax (KBr) 3950, 3158, 
2996, 2806, 1680, 1522, 1445, 1376, 1337, 1292 and 1113; δH (400 MHz; CD3OD): 8.51 
(0.05H, s), 8.23 (0.05H, d, JH-H 5.03), 7.33 (0.81H, s), 2.27 (0.18 H, m), 2.19 (3H, s); bδc (150 
MHz, CD3OD) 172.4 (s, C=O), 146.8 (m, C-D), 144.6 (s, C-NH), 134.9 (s, C-C), 126.9 (s, C-
H), 23.0 (s, CH3), 16.8 (m, CD3); m/z (EI) 155 (M•+, 85%). 
bSignals present a too high deuteration level for recording of 13C. 
2,4,6-Trideutero-3-amino-5-(trideuteromethyl)pyridine (30) 
 
A solution of 3-amino-5-methylpyridine (300 mg, 2.7 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (224 mg, 0.54 mmol, 20 mol %.) and DCl (35%) (889 µL, 10.8 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (153 µL, 2.16 mmol, 4 eq. referred to catalyst amount) was added and the 
mixture was stirred for 30 min, the rest of the work up follows the general procedure A to 
give the title compound as a yellow powder (153 mg, 50%); Found M•+, 114.1064. C6H2D6N2 
[M•+ ] requires 114.1064; mp 53-57 ºC; νmax (KBr) 3334, 3210, 1627, 1589, 1575, 1410, 1389, 
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1259 and 884; δH (400 MHz; CD3OD) a7.76 (0.03H, s), a7.61 (0.03H, s), a6.92 (0.35H, s), 
a2.20 (0.61H, m); δc (150 MHz, CD3OD) 145.9 (s, C-NH2), 138.7 (t, 1CD, JC-D 26.5), 138.6 
(m, C-CD3), 134.3 (t, C-D, JC-D 27), 123.7 (t, C-D,JC-D 29), 17.6 (m, CD3); m/z (EI) 114 (M•+, 
60%). 
aSignals arise from the presence of isotopologues. 
N-[2,4,6-Trideutero-5-(trideuteromethyl)pyridin-3-yl)]acetamide (30a) 
 
d6-3-Amino-5-methylpyridine (30) (100 mg, 0.88 mmol, 1 eq.) was dissolved in acetone (20 
mL), and K2CO3 (607 mg, 4.4 mmol, 5 eq.) was added, followed by the dropwise addition of 
acetyl chloride (207 mg, 187 µL, 2.6 mmol, 3 eq.) in acetone (5 ml) and reacted according to 
the general procedure C to give the title compound as a yellow powder (100 mg, 95%): 
Found M•+, 156.1175. C8H4D6N2O [M•+] requires 156.1171; mp 125-131 °C; νmax (KBr) 
3224, 2922, 1691, 1602, 1531, 1409, 1387, 1289, 1018, 881 and 769; δH (400 MHz; 
CD3OD):8.51 (0.03H, s), 8.09 (0.03H, s), 7.93 (0.35H, s), 2.31 (0.61H,m), 2.15 (3H, s); δc 
(150 MHz, CD3OD) 171.8 (s, C=O), 145.0 (t, C-D, JC-D 26), 138.6 (t, C-D, JC-D 29), 137.0 (s, 
C-NH), 135.2 (m, C-CD3), 128.9 (t, C-D, JC-D 28), 23.8 (s, CH3), 17.7 (m, CD3); m/z (EI) 156 
(M•+, 40%). 
2-Deutero-3-amino-6-(trideuteromethyl)pyridine (31) 
 
A solution of 5-amino-2-methylpyridine (300 mg, 2.7 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (224 mg, 0.54 mmol, 20 mol %.) and DCl (35%) (889 µL, 10.8 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (153 µL, 2.16 mmol, 4 eq referred to catalyst amount) was added and the 
mixutre was stirred for 30 min, the rest of the work up follow the general procedure A to give 
the title compound as a colourless powder (132 mg, 44%); Found M•+, 112.0936. C6H4D4N2 
Chapter 7: Experimental 
 
- 151 - 
 
[M•+] requires 112.0939; mp 78-81 ºC; νmax (KBr) 3396, 3323, 3269, 3030, 2928, 2497, 2402, 
1909, 1635, 1597, 1564, 1460, 1371, 1301, 1250, 1153, 1086, 1042, and 914; δH (400 MHz; 
CD3OD) a7.85 (0.09H, s),a7.04 (0.67H, d, J 8.48), a6.92 (0.92H d, J 8.48), a2.32 (0.50H, 
m);δc(150 MHz, CD3OD) 147.3(s, C-NH2), 143.5(s, C-CD3), 148.7(t, C-D,  JC-D 27), 124.8 
(s, C-H), 124.5 (s, C-H), 22.1 (m, CD3); m/z (EI) 112 (M•+, 80%). 
aSignals arise from the presence of isotopologues. 
N-[2-Deutero-6-(tetradeuteromethyl)pyridin-5-yl]acetamide (31a) 
 
d4-6-Methyl-3-aminopyridine (31) (100 mg, 0.88 mmol, 1 eq.) was dissolved in acetone (20 
mL), and K2CO3 (607 mg, 4.4 mmol, 5 eq.) was added, followed by the dropwise addition of 
acetyl chloride (207 mg, 187 µL, 2.6 mmol, 3 eq.) in acetone (5 ml) and reacted according to 
the general procedure C to give the title compound as a colourless powder (67 mg, 50%): 
Found M•+, 154.1046. C8H4D6N2O [M•+] requires 154.1044; mp 110-116 °C; νmax (KBr) 
3395, 3296, 3232, 3163, 3090, 3009, 2871, 2236, 2151, 2054, 1851, 1685, 1610, 1582, 1463, 
1452, 1295, 1139, 1006 and 826; (400 MHz; CD3OD): 8.58 (0.09H, s), 7.95 (0.67H, d, JH-H 
8.48), 7.26 (0.92H, d, JH-H 8.48), 2.45 (0.50H, m), 2.14 (3H, s); δc (150 MHz, CD3OD) 171.9 
(s, C=O), 154.2 (s, C-NH), 140.8 (m, C-D), 134.8 (s, C 
-CD3), 129.7 (s, C-H),124.7 (s, C-H), 23.6 (s, CH3), 22.4 (m, CD3); m/z (EI) 154 (M•+, 70%). 
3,5,6-Trideutero-4-amino-2-(trideuteromethyl)pyridine (32) 
 
A solution of 4-amino-2-methylpyridine (250 mg, 2.3 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (190 mg, 0.4 mmol, 20 mol %.) and DCl (35%) (754 µL, 9.2 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (113 µL, 1.6 mmol, 4 eq. referred to catalyst amount) was added and the 
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mixutre was stirred for 30 min, the rest of the work up follows the general procedure A to 
give the title compound as a yellow powder (170 mg, 65%): Found M•+, 114.1064. C6H2D6N2 
[M•+] requires 114.1064; mp 93-97 ºC; νmax (KBr) 3424, 3393, 3327, 3197, 2924, 2860, 1640, 
1583, 1546, 1433, 1408, 1261 and 963; δH (400 MHz; CD3OD) a7.83(0.08H, s), a6.42 (0.01H, 
s), a6.38 (0.01H, s), a2.28 (0.24H, s); δc (150 MHz, CD3OD) 158.6 (s, C-NH2), 157.1 (s, C-
CD3), 148.7 (t, C-D, JC-D 26), 109.0 (t, C-D, JC-D 24), 107.6 (t, C-D, JC-D 26), 23.2 (m, CD3); 
m/z (EI) 114 (M•+, 95%). 
aSignals arise from the presence of isotopologues. 
N-[3,5,6-Trideutero-2-(trideuteromethyl)pyridin-4-yl]acetamide (32a) 
 
The solution of d6 4-amino-2-methylpyridine (32) (137 mg, 1.2 mmol, 1 eq.) in Ac2O (119 
µL, 12.6 mmol, 10.5 eq.), was refluxed for 2h at 120oC. Another 10.5 equivalent was added 
and the mixture was left on stirring for 30’.After cooling at room temperature the reaction 
mixture was treated by brine to precipitate the product, which was filtrated off and re-
dissolved in water. The aqueous phase was neutralized with sodium hydroxide and extracted 
with ethyl acetate (3 x 10 mL). The organic phase was dried by Na2SO4 and filtrated. Then 
the solvent was eliminated and the product dried on the high vacuum, giving a 
yellow/colourless powder (156 mg, 83%): Found M•+, 156.1173. C8H4D6N2O [M•+] requires 
156.1170; mp 104-111 ºC; νmax (KBr); 3294,3216, 3137, 3050, 2960, 2325,1681, 1577, 1516, 
1453, 1408, 1372, 1291, 1233, 1078, 1035, 996 and 973; δH (400 MHz; CD3OD): 8.24 
(0.08H,s), 7.49 (0.01H, s), 7.41 (0.01H, s), 2.45 (0.24H, m), 2.15 (3H, s); δc (150 MHz, 
CD3OD) 172.2 (s, C=O), 159.8 (s, C-NH), 149.6 (t, C-D, JC-D 27), 148.1 (s, C-CD3), 113.7 (t, 
C-D, JC-D 26), 111.8 (t, C-D, JC-D 26), 24.3 (s, CH3), 23.5 (m, CD3); m/z (EI) 156 (M•+, 45%). 
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3,6,7,8-Tetradeutero-5-aminoquinoline (33) 
 
A solution of 5-aminoquinoline (300 mg, 2.08 mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (172 mg, 0.42 mmol, 20 mol %.) and DCl (35%) (686 µL, 8.33 mmol, 4 eq.)in D2O 
(3 mL.) and reacted according to the general procedure A. To the solution thioglycolic acid 
(117.9 µL, 1.66 mmol, 4 eq. referred to catalyst amount) was added and the mixutre was 
stirred for 30 min, the rest of the work up follows the general procedure A to give the title 
compound as a yellow powder (234 mg, 76%): Found M•+, 148.0939. C9H4D4N2 [M•+] 
requires 148.0939; mp 195-202 ºC; νmax (KBr) 3283, 3194, 1575, 1417, 1374 and 1356; δH 
(400 MHz; CD3OD) a8.74 (0.74H, s), a8.53 (0.87H, s), a7.51 (0.03H, s), a7.42 (0.03H, s) 
;a7.34 (0.03H, s), a6.86 (0.03H, s); bδc (100 MHz, CD3OD) 150.7 (s, C-H), 149.6 (s, C-NH2), 
146.0 (s, C-C), 133.8 (s, C-H), 121.1 (s, C-C); m/z (EI) 148 (M•+, 55%). 
aSignals arises from the presence of isotopologues. 
bSignals present a too high deuteration level for recording of 13C. 
N-(3,6,7,8-Tetradeuteroquinolin-5-yl)acetamide (33a) 
 
d6-5-Aminoquinoline (33) (244 mg, 1.6 mmol, 1 eq.) was dissolved in acetone (50 mL), and 
K2CO3 (1.1g, 8 mmol, 5 eq.) was added, followed by the dropwise addition of acetyl chloride 
(376 mg, 314µL, 4.6 mmol, 3 eq.) in acetone (5 ml) and reacted according to the general 
procedure C. Purification by chromatography column, eluting with DCM/MeOH (100/1) 
gave the title compound as a yellow powder (113 mg, 32 %): Found M•+, 190.1037. 
C11H6D4N2O [M•+] requires 190.1040; mp 178-183 °C; νmax (KBr) 3269, 3029, 3003, 2417, 
1645, 1532, 1426, 1402, 1381, 1288 and 1263; δH (400 MHz; CD3OD): 8.87 (0.74H, s), 8.49 
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(0.87H, s),7.92 (0.03H, s), 7.76 (0.03H, s), 7.71 (0.03H, s), 7.56 (0.03H, s),2.29 (3H, s), 
δc(150 MHz, CD3OD) 173.0 (s, C=O), 151.2 (s, C-H), 149.1 (s, C-NH), 134.8 (s, C-C), 133.5 
(s, C-H), 130.3 (t, C-D, JC-D 24), 127.0 (m, C-D), 125.0 (s, C-C), 124.1 (m, C-D), 122.1 (t, C-
D, JC-D 24), 22.7 (s, CH3); m/z (EI) 190 (M•+, 35%). 
4,6,7-Trideutero-3-aminoquinoline (34) 
 
A solution of 3-aminoquinoline (300 mg, 2.08 mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (172 mg, 0.42 mmol, 20 mol %.) and DCl (35%) (686 µL, 8.33 mmol, 4 eq.)in D2O 
(3 mL) and reacted according to the general procedure A. To the solution thioglycolic acid 
(117.9 µL, 1.66 mmol, 4 eq. referred to catalyst amount) was added and the mixutre was 
stirred for 30 min, the rest of the work up follow the general procedure A to give the title 
compound as a orange powder (267 mg, 87%): Found M•+, 147.0872. C9H5D3N2 [M•+] 
requires 147.0876; mp 78-83 ºC; νmax (KBr) 3272, 3168, 3077, 2973, 2479, 2401, 2338, 1809, 
1648, 1592, 1560, 1498, 1463 and 1401; δH (400 MHz; CD3OD) a8.43 (0.87H, s), a7.81 
(0.65H, s), a7.62 (0.65 H, s), a7.41 (0.04H, m), a7.33 (0.02H, d, JH-H2.56); δc (150 MHz, 
CD3OD) 144.0 (s, CH), 143.4 (s, C-NH2),142.6 (s, C-C), 131.2 (s, C-C), 128.5 (s, C-H), 
127.7 (t, C-D, JC-D 25), 126.9 (s, C-H), 125.9 (t, C-D, JC-D 24), 115.5 (t, C-D, JC-D 25); m/z 
(EI) 147 (M•+, 100%). 
aSignals arise from the presence of isotopologues. 
N-[4,6,7-Trideuteroquinolin-3-yl]acetamide (34a) 
 
d6-3-Aminoquinoline (34) (180 mg, 1.2 mmol, 1 eq.) was dissolved in acetone (50 mL), and 
K2CO3 (828mg, 6 mmol, 5 eq.) was added, followed by the dropwise addition of acetyl 
chloride (282 mg, 255 µL, 3.6 mmol, 3 eq.) in acetone (5 ml) and reacted according to the 
general procedure C to give the title compound as a colourless powder (207 mg, 90%): Found 
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M•+, 189.0983. C11H7D3N2O [M•+] requires 189.0.981; mp 178-184 °C; νmax (KBr) 3496, 
3252, 3063, 2320, 1670, 1577, 1552, 1435, 1379 and 1276; δH  (400 MHz; CD3OD): 8.87 
(0.87H, s), 8.07 (0.03H, s), 7.96 (0.65H, s), 7.86 (0.65H, s), 7.67 (0.03H, s), 7.57 (0.03H, s), 
2.23 (3H, s); bδc (150 MHz, CD3OD) 172.4 (s, C=O), 145.6 (s, C-H), 145.5 (s, C-C), 134.81 
(s, C-NH), 129.7 (s, C-C), 128.7 (s, C-H), 23.8(s, CH3); m/z (EI) 189 (M•+, 100%). 
bSignals present a too high deuteration level for recording of 13C. 
(3,7,8-Trideutero-2-methylquinolin-4-yl)amine (35) 
 
A solution of 2-methylquinolin-4-amine (300 mg, 1.8 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (149 mg, 0.36 mmol, 20 mol %.) and DCl (35%) (771 µL, 8.33 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (102 µL, 1.4 mmol, 4 eq. referred to catalyst amount) was added and the 
mixutre was stirred for 30 min, the rest of the work up follows the general procedure A to 
give the title compound as a yellow powder (294 mg, 90%): Found M•+, 161.1034. 
C10H7D3N2 [M•+] requires 161.1032; mp 164-168ºC; νmax (KBr) 3398, 3202, 2466, 2414, 
1792, 1658, 1609, 1576, 1485, 1396, 1304, 1212 and 1094; δH (400 MHz; CD3OD) a8.02 
(0.98H, s), a7.74 (0.60 H, s), a7.73 (0.07H, s), a7.38 (0.07H, s), a6.52 (0.07H, s), a2.49 (2.89H, 
s); δc (150 MHz, CD3OD) 160.0 (s, C-CH3), 154.0 (s, C-NH2), 149.3 (s, C-C), 130.2 (t, C-D, 
JC-D 24.5), 127.9 (s, C-H), 124.3 (t, C-D, JC-D 24), 122.5 (s, C-H), 116.7 (s, C-C), 103.4 (t, C-
D, JC-D 23), 24.4 (m, CH3); m/z (EI) 161 (M•+, 100%).  
aSignals arise from the presence of isotopologues. 
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N-[3,7,8-Trideutero-2-methylquinolin-4-yl]acetamide (35a) 
 
The solution of d6-2-methylquinolin-4-amine (35) (189 mg, 1.2 mmol, 1 eq.) in Ac2O (10 
mL, 10.5 mmol, 6 eq.), was refluxed for 2h at 120oC. After cooling at room temperature the 
reaction mixture was treated by brine to precipitate the product, which was filtrated off and 
re-dissolved in water. The aqueous phase was neutralized with sodium hydroxide and 
extracted with ethyl acetate (x3). The organic phase was dried by Na2SO4 and filtrated. Then 
the solvent was eliminated and the product dried on the high vacuum, giving a yellow powder 
(86 mg, 37%): Found M•+, 203.1141. C12H9D3N2O [M•+] requires 203.1138; mp 155-159 °C; 
νmax (KBr) 3244, 3100, 3018, 2921, 2853,1811, 1666, 1611, 1555, 1520, 1363, 1347 and 
1271; δH (400 MHz; CD3OD): 8.19 (0.98H, s), 8.06 (0.07H, s), 7.94 (0.60 H, s),7.74 (0.07H, 
m), 7.58 (0.07H, m), 2.68 (2.89H, s), 2.32 (3H, s); bδc (150 MHz, CD3OD) 172.6 (s, C=O), 
161.0 (s, C-CH3), 149.4 (s, C-C), 143.5 (s, C-NH), 128.7 (s, C-H), 123.7 (s, C-H), 122.4 (s, 
C-C), 106 (s, C-H), 24.9 (s, CH3), 24.1 (s, CH3); m/z (EI) 203 (M•+, 50%). 
bSignals present a too high deuteration level for recording of 13C. 
4,5,6,7-Tetradeutero-2-(trideuteromethyl)-1-H-indole (36) 
 
A solution of 2-methylindole (300 mg, 2.3mmol, 1 eq.) was added to a stirred solution of 
K2PtCl4 (190 mg, 0.46 mmol, 20%mmol.) and DCl (35%) (754 µL, 9.2 mmol, 4 eq.)in D2O 
(3 mL) and reacted according to the general procedure A. To the solution thioglycolic acid 
(130 µL, 1.84 mmol, 4 eq. referred to catalyst amount) was added and the mixutre was stirred 
for 30 min, the rest of the work up follows the general procedure A to give the title compound 
as a colourless powder (207 mg, 65%): Found M•+, 138.1169. C9H2D7N [M•+] requires 
138.1170; mp 44-49 ºC; νmax (KBr) 3386, 2883, 1567, 1530, 1381 and 1328; δH (400 MHz; 
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CD3OD) a7.39 (0.07H, s), a7.25 (0.07H, s), a6.99 (0.07H, s), a6.92 (0.07H, s), a6.08 (1H, s), 
a2.39 (0.21H, m), δc (100 MHz, CD3OD) 138.3(s, C-NH2), 136.9 (s, C-C), 130.5 (s, C-C), 
121.3 (t, C-D, JC-D 25), 120.1 (m, C-D), 111.4 (t, C-D, JC-D 25), 100.8 (s, C-H), 13.3 (m, 
CD3); m/z (EI) 138 (M•+, 40%). 
aSignals arise from the presence of isotopologues. 
4,5,6,7-Tetradeutero-1-methyl-2-(trideuteromethyl)-1-H-indole (36a) 
 
To a solution of d7-2-methylindole (36) (95 mg, 0.7 mmol, 1 eq.) in dry DMF (20 mL), NaH 
(60% dispersion in oil 55.2 mg, 2.3 mmol, 1 eq.) was added in portions. The mixture was 
stirred for 30 min, then methyl iodide (MeI) (156 µL, 2.5 mmol, 1.1 eq.) was added in one 
portion. The reaction became exothermic so it was cooled in an ice bath. After 16 h at RT, the 
reaction was concentrated under vacuum and the residue was taken up in ethyl acetate. The 
solution was concentrated under vacuum and the residue taken up in ethyl acetate. Then the 
mixture was extracted in H2O and in brine, dried on Mg2SO4and concentrated to dryness 
giving a title compound (34 mg, 32%) as a white solid: Found M•+, 152.1330. C10H4D7N 
[M•+] requires 152.1331; mp 40- 44 ºC; νmax (KBr) 2925, 2198, 2119, 2055, 1589, 1558, 
1529, 1451, 1390, 1329 and 1224; δH (400 MHz; CD3OD,) a7.39 (0.07H, s),a7.25(0.07H, s), 
a7.05 (0.07H, s), a6.95 (0.07H, s), a6.16 (1H, s),  a3.61 (3H, s), a2.375 (0.21H, m); δc (150 
MHz, CD3OD) 138.9 (s, C-N), 137.9 (s, C-C), 129.5 (s, C-C), 120.7 (t, C-D, JC-D 24), 119.9 
(m, C-D), 109.3 (t, C-D, JC-D 24), 100.3 (s, C-H), 29.9 (s, CH3), 12.0 (m, CD3); m/z (EI) 152 
(M•+, 100%). 
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3,5,6,7,8-Pentadeutero-1-(trideuteromethyl)-9-H-pyrido[3,4-b]indole (37) 
 
A solution of -1-methyl-9H-pyrido[3,4-b]indole (200 mg, 1.08 mmol, 1 eq.) was added to a 
stirred solution of K2PtCl4 (89.64 mg, 0.22 mmol, 20 mol %.), DCl (35%) (356 µL, 4.33 
mmol, 4 eq.)in D2O (3 mL) and reacted according the general procedure A. To the solution 
thioglycolic acid (56.6 µL, 0.8 mmol, 4 eq. referred to the catalyst amount) was added and the 
mixutre was stirred for 30 min, the rest of the work up follows the general procedure A to 
give the title compound as yellow powder (125 mg, 60%); Found M•+ 190.1349. C12H2D8N2 
[M•+] requires 190.1346; mp 195 ºC-200 ºC; νmax(KBr)3283, 3194, 1575, 1417, 1374, and 
1356; δH (400 MHz; CD3OD) a8.19 (0.06H, d, JH-H5.56), a8.18 (0.06H, s), a7.97 (0.50H, s), 
a7.34 (0.06H, s), a6.86 (0.12H, s), 2.80 (1.14H, m); δc (100 MHz, CD3OD) 150.9(s, C-C), 
150.9 (s, C-C), 130.5 (s, C-C), 121.3 (t, C-D, JC-D 25), 120.1 (m, C-D), 111.4 (t, C-D, JC-D 
25), 100.8 (m, C-D), 13.3 (m, CD3); m/z (EI) 190 (M•+, 100%). 
aSignasl arise from the presence of isotopologues. 
3,5,6,7,8-Pentadeutero-9-methyl-1-(trideuteromethyl)-9H-pyrido[3,4-
b]indole (37a) 
 
To a stirred solution of d8-1-methyl-9H-pyrido[3,4-b]indole (37) (120 mg, 0.6 mmol, 1 eq.) in 
dry DMF(10 mL) and under argon atmosphere, NaH was added in portions. The mixture was 
stirred for 30’, then MeI (93.06, 40.8 µL, 0.66, 1.1 eq.) was added in one portion. The 
reaction became exothermic and was cooled in an ice bath. After 16h, the reaction was 
concentrated under vacuum and the residue was taken up in ethyl acetate. Then the mixture 
was extracted in H2O and brine. The organic phase was dried by Na2SO4 and filtrated. Then 
the solvent was eliminated and the product dried on the high vacuum, giving a brown powder 
Chapter 7: Experimental 
 
- 159 - 
 
(288mg, 40%), the product was purified by chromatography column (DCM 100/ MeOH 1) 
giving a yellow powder (113 mg, 32 %): Found M•+, 204.1056. C13H4D8N2 [M•+] requires 
204.1053; mp 178 °C-183 °C; νmax (KBr) 3269, 3029, 3003, 2417, 1645, 1532, 1426, 1402, 
1381, 1288 and 1263;δH (400 MHz; CD3OD): 8.19 (0.06H,d, JH-H5.56), 8.18 (0.06H, s), 7.91 
(0.50H, s), 7.61 (0.12H, s), 7.52 (0.06H, s), 7.27 (0.06H, s), 4.04 (3H, s), 3.00 (1.14H, s); bδc 
(150 MHz, CD3OD) 151.2 (s, C-C), 149.1 (s, C-CD3), 138.8 (s, C-C), 133.5 (m, C-D), 130.3 
(t, C-D, JC-D 24.5), 127.0 (m, C-D), 125.0 (s, C-C), 124.1 (m, C-D), 122.1 (t, C-D, JC-D 24), 
110.0 (m, C-D), 109.9 (s, C-C), 32.6 (s, CH3), 22.7 (m, CD3); m/z (EI) 204 (M•+, 100%). 
bSignals present a too high deuteration level for recording on 13C. 
3,4,5-Trideutero-2,6-bis(trideuteromethyl)aniline (38) 
 
A solution of 2,6 dimethylaniline (300 mg, 306 µL, 2.47 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4 (203 mg, 0.49 mmol, 20 mol %.) and DCl (35%) (813 µL, 9.88 mmol, 4 
eq.)and reacted according to the general procedure A. To the solution thioglycolic acid (138 
µL, 1.96 mmol,4 eq referred to catalyst amount) was added and the mixture was stirred for 30 
min, the rest of the work up follow the general procedure A to give the title compound as a 
violet oil (300 mg, 97%): Found M•+, 130.1452.C9H3D4N2 [M•+] requires 130.1456; νmax 
(KBr) 3473, 3390, 3235, 3045, 3002, 2955, 2904, 2618, 1621, 1568, 1441, 1422, 1308, 1276, 
1243, 1196, and 1048; δH (400 MHz; CD3OD) a6.85 (0.30H, s), a6.54 (0.06H, s), a2.12 
(0.26H,m); δc (150 MHz, CD3OD) 144.1 (s, C-NH2), 128.9 (s, C-D, JC-D 24), 123.5 (s, C-C), 
118.6 (t, C-D, JC-D 24), 17.0 (sept, CD3, JC-D 19); m/z (EI) 130 (M•+, 30%). 
aSignals arise from the presence of isotopologues. 
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N-[3,4,5-trideutero-2,6-bis(trideuteromethyl)phenyl]acetamide (38a) 
 
Acetyl chloride (122 µL, 2.02 mmol, 1.1 eq.) was added to a stirred solution of d9-2,6-
dimethylaniline (38) (236 mg, 1.8 mmol, 1 eq.) in DCM (5 mL) and NEt3 on ice (523 µL, 
4.05 mmol, 2.2 eq.) and reacted according the general procedure B to give the title compound 
as a colourless powder (233 mg, 75 %): Found M•+, 172.1560. C10H4D9NO [M•+] requires 
172.1562; mp 168-173 °C; νmax (KBr) 3231, 3245, 3130, 3031, 2813, 1713, 1647, 1536, 
1428, 1410, 1369, 1291, 1240, 1041, 1012, 975, 735, 615 and 579; δH (400 MHz; CD3OD) 
7.19 (0.06H, s), 7.07 (0.30H, s), 2.21 (0.26H, s), 2.12 (3H, s); δc (100 MHz, CD3OD) 172.2 
(s, C=O), 136.6(s, C-NH), 135.6 (s, C-CD3), 129.6 (m, C-D), 128.6 (t, C-D, JC-D 24), 22.4 (s, 
CH3), 17.8 (sept, CD3, JC-D 19); m/z (EI) 172 (M•+, 75%).  
5,6,7,8-Tetradeutero-2-(piperazin-1-yl)quinoline (39) 
 
A solution of 2-(piperazin-1-yl)quinoline (200 mg, 0.94 mmol, 1 eq.) was added to a stirred 
solution of K2PtCl4(77.18  mg, 0.19 mmol, 20 mol %.) and DCl (35%) (309 µL, 3.76 mmol, 4 
eq.)in D2O (3 mL) and reacted according to the general procedure A. To the solution 
thioglycolic acid (53 µL, 0.76 mmol, 4 eq. referred to catalyst amount) was added and the 
mixutre was stirred for 30 min, the rest of the work up follows the general procedure A to 
give the title compound as a yellow powder (137 mg, 67%): Found M•+, 217.1517. 
C13H11D4N3 [M•+] requires 217.1517; mp 85-89 ºC; νmax (KBr) 3288, 2986, 2922, 2847, 1609, 
1537, 1488, 1437, 1377, 1280, 1236, 1138, 1116 and 807; δH (400 MHz; CD3OD) a7.99 
(0.80H, d, JH-H 9.20), a7.65 (0.32 H, s), a7.64 (0.32 H, s), a7.15 (0.80H, d, JH-H 9.20), a3.72 
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(4H, m), a2.97(3.93H, m); δc(100 MHz, CD3OD) 159.2(s, C-8a), 148.8 (s, C-2), 138.9 (s, C-
H), 130.1 (m, C-D), 128 (m, C-D), 127.0 (m, C-D), 124.5 (s, C-C), 122.9 (m, C-D), 111.1 (s, 
C-H), 46.9 (s, CH2), 49.4 (s, CH2); m/z (EI) 217 (M•+, 40%). 
aSignals arise from the presence of isotopologues. 
1-[4-(5,6,7,8-Tetradeuteroquinolin-2-yl)piperazin-1-yl]ethanone (39a) 
 
d4-2-(Piperazin-1-yl)quinoline(39) (97 mg, 0.44 mmol, 1 eq.) was solved in DCM (10 ml) at 
0oC, followed by the addition of NEt3 (56.97 µL, 0.44 mmol, 1 eq.). A solution of Ac2O 
(41.79 µL, 0.44 mmol, 1 eq.) in DCM (5 ml) was added dropwise and the mixture has been 
left on stirring for 3h at RT. The resulting solution has been treated with 10% NaHCO3 and it 
has been left on stirring for further 30 min. The mixture was extracted with DCM (x3) and 
the organic phase washed with brine’, dried over NaSO4 and finally the solvent evaporated 
under vacuum to obtain a yellow powder (63 mg, 54%); Found M•+, 259.1623. 
C15H13D4N3O[M•+] requires 259.1623; mp 176-180 oC; νmax (KBr) 3276, 2993, 2897, 2848, 
1659, 1609, 1536, 1493, 1427, 1380, 1349, 1281, 1257, 1235, 1169, 985 and 806; δH (400 
MHz; CD3OD) a8.03 (0.80H, d, JH-H 9.20), a7.67 (0.32H, s), a7.66 (0.32H, s), a7.19 (0.80H, d, 
JH-H 9.20),  a3.83 (2H, m), a3.74 (4H, m), a3.70 (2H, m), 2.17 (3H,s); δc(150 MHz, CD3OD) 
171.9 (s, C=O),158.3 (s, C-8a),148.3 (s, C-2), 139.3 (s, C-H), 128.4 (m, C-D), 126.4 (m, C-
D);b120.7 (s, C-C), 111.1 (s,C-H), 47.20 (s, CH2), 46.4 (s, CH2), 46.2 (s, CH2), 42.5 (s, CH2), 
21.3 (s, CH3); m/z (EI) 259 (M•+, 60%).  
aSignals arise from the presence of isotopologues. 
bTwo signals present a too high deuteration level for recording of 13C. 
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